Abacus Life (ABL) 10-K21 Mar 242023 FY Annual reportFinancial data

Company Profile

COVER

COVER - USD ($)	12 Months Ended
COVER - USD ($)	Dec. 31, 2023	Mar. 20, 2024	Jun. 30, 2023
Document Information [Line Items]
Document Type	10-K
Document Annual Report	true
Document Period End Date	Dec. 31, 2023
Document Transition Report	false
Entity File Number	001-39403
Entity Registrant Name	Abacus Life, Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	85-1210472
Entity Address, Address Line One	2101 Park Center Drive, Suite 200
Entity Address, City or Town	Orlando
Entity Address, State or Province	FL
Entity Address, Postal Zip Code	32835
City Area Code	800
Local Phone Number	561-4148
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	true
ICFR Auditor Attestation Flag	false
Document Financial Statement Error Correction [Flag]	false
Entity Shell Company	false
Entity Public Float			$ 11,651,731
Entity Common Stock, Shares Outstanding		63,694,758
Documents Incorporated by Reference	Documents Incorporated by Reference: Certain portions of the Definitive Proxy Statement for the 2023 Annual Meeting of Shareholders are incorporated by reference into Part III of this Form 10-K.
Entity Central Index Key	0001814287
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	FY
Amendment Flag	false
Common Stock
Document Information [Line Items]
Title of 12(b) Security	Common stock, par value $0.0001 per share
Trading Symbol	ABL
Security Exchange Name	NASDAQ
Warrant
Document Information [Line Items]
Title of 12(b) Security	Warrants, each whole warrant exercisable for one share of common stock at an exercise price of $11.50 per share
Trading Symbol	ABLLW
Security Exchange Name	NASDAQ
9.875% Fixed Rate Senior Notes due 2028
Document Information [Line Items]
Title of 12(b) Security	9.875% Fixed Rate Senior Notes due 2028
Trading Symbol	ABLLL
Security Exchange Name	NASDAQ

Audit Information

Audit Information	12 Months Ended
Audit Information	Dec. 31, 2023
Audit Information [Abstract]
Auditor Name	GRANT THORNTON LLP
Auditor Location	Philadelphia, Pennsylvania
Auditor Firm ID	248

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($)	Dec. 31, 2023	Dec. 31, 2022
CURRENT ASSETS:
Cash and cash equivalents	$ 25,588,668	$ 30,052,823
Equity securities, at fair value	2,252,891	0
Prepaid expenses and other current assets	699,127	116,646
Total current assets	31,776,834	33,282,927
Property and equipment, net	400,720	18,617
Intangible assets, net	29,623,130	0
Goodwill	140,287,000	0
Operating right-of-use assets	1,893,659	77,011
Life settlement policies, at cost	1,697,178	8,716,111
Life settlement policies, at fair value	122,296,559	13,809,352
Available-for-sale securities, at fair value	1,105,935	1,000,000
Other investments, at cost	1,650,000	1,300,000
Other assets	998,945	0
Equity securities, at fair value	96,107	890,829
TOTAL ASSETS	331,826,067	59,094,847
CURRENT LIABILITIES:
Current portion of long-term debt	13,029,632	0
Accrued expenses	4,354,225	0
Accounts payable	0	40,014
Operating lease liabilities	118,058	48,127
Contract liabilities, deposits on pending settlements	507,000	0
Accrued transaction costs	0	908,256
Income taxes payable	751,734	0
Total current liabilities	23,326,331	1,302,409
Operating lease liabilities	1,796,727	29,268
Deferred tax liability	9,199,091	1,363,820
Warrant liability	6,642,960	0
TOTAL LIABILITIES	167,755,991	30,945,150
COMMITMENTS AND CONTINGENCIES
STOCKHOLDERS' EQUITY
Preferred stock, $0.0001 par value; 1,000,000 authorized shares authorized; none issued or outstanding	0	0
Treasury stock - at cost; 146,650 and — shares, respectively	(1,283,062)	0
Additional paid-in capital	199,826,278	704,963
(Accumulated deficit) retained earnings	(34,726,135)	25,487,323
Accumulated other comprehensive income	108,373	1,052,836
Non-controlling interest	138,283	899,538
Total stockholders' equity	164,070,076	28,149,697	[1]
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	331,826,067	59,094,847
Class A Common Stock
STOCKHOLDERS' EQUITY
Class A common stock, $0.0001 par value; 200,000,000 authorized shares; 63,388,823 and 50,369,350 shares issued, respectively	6,339	5,037
Nonrelated Party
CURRENT ASSETS:
Accounts receivable	2,149,111	10,448
CURRENT LIABILITIES:
Other current liabilities	3,400,734	42,227
Long-term debt	89,137,013	28,249,653
Affiliated Entity
CURRENT ASSETS:
Other receivables	1,007,528	2,904,646
CURRENT LIABILITIES:
Other current liabilities	5,236	263,785
Related Party
CURRENT ASSETS:
Accounts receivable	79,509	198,364
CURRENT LIABILITIES:
Long-term debt	37,653,869	0
Former Members
CURRENT LIABILITIES:
Other current liabilities	$ 1,159,712	$ 0

[1]Both the number of shares outstanding and their par value have been retrospectively recast for all prior periods presented to reflect the par value of the outstanding stock of Abacus Life, Inc. as a result of the successful Business Combination.

CONSOLIDATE BALANCE SHEETS (Par

CONSOLIDATE BALANCE SHEETS (Parenthetical) - $ / shares	Dec. 31, 2023	Dec. 31, 2022
Preferred stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized (in shares)	1,000,000	1,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.0001
Common stock, shares authorized (in shares)	200,000,000
Common stock, shares issued (in shares)	63,388,823	50,369,350
Treasury stock (in shares)	146,650	0
Class A Common Stock
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	200,000,000	200,000,000
Common stock, shares issued (in shares)	63,388,823	50,369,350

CONSOLIDATED STATEMENTS OF OPER

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME - USD ($)		12 Months Ended
		Dec. 31, 2023	Dec. 31, 2022
REVENUES:
Investment Income from life insurance policies held using investment method		$ 17,980,987	$ 37,828,829
Change in fair value of life insurance policies (policies held using fair value method)		43,214,390	5,413,751
Total active management revenue		61,195,377	43,242,580
Total revenues		66,401,451	44,713,552
COST OF REVENUES (excluding depreciation and amortization stated below):
Total cost of revenue		6,490,377	5,884,669
Gross Profit		59,911,074	38,828,883
OPERATING EXPENSES:
Sales and marketing		4,905,747	2,596,140
General and administrative (including stock-based compensation)		26,482,571	1,426,865
Loss on change in fair value of debt		2,356,058	90,719
Unrealized loss (gain) on investments		(1,369,112)	1,045,623
Depreciation and amortization expense		3,409,928	4,282
Total operating expenses		35,785,192	5,163,629
Operating Income		24,125,882	33,665,254
OTHER INCOME (EXPENSE):
Loss on change in fair value of warrant liability		(4,204,360)	0
Interest (expense)		(9,866,821)	(42,798)
Interest income		594,764	1,474
Other income (expense)		(146,443)	(347,013)
Total other income (expense)		(13,622,860)	(388,337)
Net income before provision for income taxes		10,503,022	33,276,917
Income tax provision		1,468,535	889,943
NET INCOME		9,034,487	32,386,974
LESS: NET INCOME (LOSS) ATTRIBUTABLE TO NONCONTROLLING INTEREST		(482,139)	704,699
NET INCOME ATTRIBUTABLE TO COMMON STOCKHOLDERS		$ 9,516,626	$ 31,682,275
EARNINGS PER SHARE:
Earnings per share - basic (in dollars per share)		$ 0.17	$ 0.63
Earnings per share - diluted (in dollars per share)		$ 0.16	$ 0.63
Weighted-average stock outstanding - basic (in shares)	[1]	56,951,414	50,369,350
Weighted-average stock outstanding - diluted (in shares)	[1]	57,767,898	50,369,350
NET INCOME		$ 9,034,487	$ 32,386,974
Other comprehensive income, net of tax:
Change in fair value of debt (risk adjusted)		(1,248,330)	1,395,830
Comprehensive income before non-controlling interests		7,786,157	33,782,804
Net and comprehensive income (loss) attributable to non-controlling interests		(800,311)	1,047,693
COMPREHENSIVE INCOME ATTRIBUTABLE TO COMMON STOCKHOLDERS		8,586,468	32,735,111
Portfolio services revenue
REVENUES:
Revenue		1,002,174	1,470,972
Originations revenue
REVENUES:
Revenue		4,203,900	0
Related Party
COST OF REVENUES (excluding depreciation and amortization stated below):
Total cost of revenue		99,456	0
Related Party \| Portfolio services revenue
REVENUES:
Revenue		778,678	818,300
Related Party \| Originations revenue
REVENUES:
Revenue		494,972	0
Nonrelated Party
COST OF REVENUES (excluding depreciation and amortization stated below):
Total cost of revenue		6,390,921	5,884,669
Nonrelated Party \| Portfolio services revenue
REVENUES:
Revenue		223,496	652,672
Nonrelated Party \| Originations revenue
REVENUES:
Revenue		$ 3,708,928	$ 0

[1]Both the number of shares outstanding and their par value have been retrospectively recast for all prior periods presented to reflect the par value of the outstanding stock of Abacus Life, Inc. as a result of the Business Combination.

CONSOLIDATED STATEMENTS OF CHAN

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY - USD ($)		Total		Common Stock	Common Stock Class A Common Stock		Treasury Stock	Additional Paid-In Capital		Retained Earnings (Accumulated Deficits)		Accumulated Other Comprehensive Income		Non- Controlling Interests
Beginning balance (in shares) at Dec. 31, 2021	[1]				50,369,350
Beginning balance at Dec. 31, 2021		$ 766,893	[1]		$ 5,037	[1]	$ 0	$ 704,963	[1]	$ 205,048	[1]	$ 0	[1]	$ (148,155)	[1]
Beginning balance, Treasury stock (in shares) at Dec. 31, 2021							0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Distributions		(6,400,000)								(6,400,000)
Other comprehensive income		1,395,830										1,052,836		342,994
Net Income		$ 32,386,974								31,682,275				704,699
Ending balance (in shares) at Dec. 31, 2022		50,369,350			50,369,350	[1]
Ending balance at Dec. 31, 2022	[1]	$ 28,149,697			$ 5,037		$ 0	704,963		25,487,323		1,052,836		899,538
Ending balance, Treasury stock (in shares) at Dec. 31, 2022		0					0
Beginning balance (in shares) at Dec. 31, 2022		50,369,350			50,369,350	[1]
Beginning balance at Dec. 31, 2022	[1]	$ 28,149,697			$ 5,037		$ 0	704,963		25,487,323		1,052,836		899,538
Beginning balance, Treasury stock (in shares) at Dec. 31, 2022		0					0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Distributions		$ (34,451,607)								(34,451,607)
Deferred transaction costs		(11,397,402)						(555,851)		(10,841,551)
Public warrants		960,900						4,726,500		(3,765,600)
Merger with East Resources Acquisition Company (in shares)					12,980,473
Merger with East Resources Acquisition Company		(2,796,225)			$ 1,298			17,849,052		(20,646,575)
Acquisition of Abacus Settlements, LLC		165,361,332						165,361,332
Proceeds received from SPAC trust		$ 972,262						972,262
Repurchase of common stock (in shares)		(146,650)					(146,650)
Repurchase of common stock		$ (1,283,062)					$ (1,283,062)
Stock-based compensation (in shares)		39,000
Stock-based compensation		$ 10,768,024		$ 4				10,768,020
Transfer of non-controlling interest		0								(24,751)				24,751
Other comprehensive income		(1,248,330)										(944,463)		(303,867)
Net Income		$ 9,034,487								9,516,626				(482,139)
Ending balance (in shares) at Dec. 31, 2023		63,242,173			63,388,823
Ending balance at Dec. 31, 2023		$ 164,070,076			$ 6,339		$ (1,283,062)	$ 199,826,278		$ (34,726,135)		$ 108,373		$ 138,283
Ending balance, Treasury stock (in shares) at Dec. 31, 2023		(146,650)					(146,650)

[1]Both the number of shares outstanding and their par value have been retrospectively recast for all prior periods presented to reflect the par value of the outstanding stock of Abacus Life, Inc. as a result of the successful Business Combination.

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	12 Months Ended
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	Dec. 31, 2023	Dec. 31, 2022
CASH FLOWS FROM OPERATING ACTIVITIES:
Net Income	$ 9,034,487	$ 32,386,974
Adjustments to reconcile net income to net cash provided by/(used in) operating activities:
Depreciation and amortization expense	3,409,928	4,282
Stock-based compensation	10,768,024	0
Amortization of debt issuance costs	43,957	0
Loss on extinguishment of debt	2,086,303	0
Loss on change in fair value of warrant liability	4,204,360	0
Unrealized (gain) loss on investments	(1,369,112)	1,045,623
Unrealized (gain) on policies	(27,889,106)	(5,742,377)
Loss on change in fair value of debt	2,356,058	90,719
Deferred income taxes	466,577	889,943
Non-cash interest expense	2,182,221	0
Non-cash lease expense	17,901	383
Non-cash interest income	(105,935)	0
Changes in operating assets and liabilities:
Accounts receivable	(2,117,411)	(10,448)
Accounts receivable, related party	124,565	(130,873)
Equity securities, at fair value	(89,057)	0
Prepaid expenses and other current assets	(62,994)	(91,741)
Other assets	(522,326)	(1,936,452)
Accounts payable	(40,014)	40,014
Accrued expenses	3,829,825	0
Accrued transaction costs	(908,256)	908,256
Contract liabilities, deposits on pending settlement	(474,217)	0
Other current liabilities	3,358,507	22,037
Income tax payable	751,734	0
Net change in life settlement policies, at fair value	(80,598,101)	(8,066,975)
Net change in life settlement policies, at cost	7,018,933	(8,716,111)
Net cash (used) provided in operating activities	(64,523,149)	10,693,254
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of property and equipment	(189,674)	0
Purchase of other investments	(350,000)	(50,000)
Purchase of available for sale securities	0	(750,000)
Change in due from affiliates	2,781,176	(2,904,646)
Net cash provided (used) in investing activities	2,241,502	(3,704,646)
CASH FLOWS FROM FINANCING ACTIVITIES:
Increase in due to former members	442,283	0
Payment of discounts and financing costs	(5,547,943)	0
Repayment of debt	(26,250,000)	0
Transaction costs	(11,397,402)	0
Repurchase of common stock	(1,283,062)	0
Proceeds received from SPAC trust	972,262	0
Net cash provided by financing activities	57,817,492	22,961,795
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	(4,464,155)	29,950,403
CASH AND CASH EQUIVALENTS AT THE BEGINNING OF THE PERIOD	30,052,823	102,420
CASH AND CASH EQUIVALENTS AT THE END OF THE PERIOD	25,588,668	30,052,823
SUPPLEMENTAL DISCLOSURES:
Life settlement policies receipt in lieu of cash in exchange for the SPV Purchased and Sale Note	10,191,125	0
Life settlement policies distributed to affiliate	(10,191,125)	0
Distribution payable to former members	(717,429)	0
Interest paid	(4,035,526)	0
Income taxes paid, net of refunds	(150,000)	0
Related Party
Adjustments to reconcile net income to net cash provided by/(used in) operating activities:
Non-cash interest expense	2,182,221
CASH FLOWS FROM FINANCING ACTIVITIES:
Issuance of long term debt	25,471,648	0
Capital distribution	(23,533,073)	(6,400,000)
Affiliated Entity
CASH FLOWS FROM FINANCING ACTIVITIES:
Capital distribution	(258,549)	(666,845)
Nonrelated Party
CASH FLOWS FROM FINANCING ACTIVITIES:
Issuance of long term debt	$ 99,201,328	$ 30,028,640

Abacus Settlements LLC - CONDEN

Abacus Settlements LLC - CONDENSED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME - USD ($)		6 Months Ended	12 Months Ended
		Jun. 30, 2023	Dec. 31, 2022
Total revenues			$ 44,713,552
Total cost of revenue			5,884,669
Gross Profit			38,828,883
OPERATING EXPENSES:
General and administrative expenses			1,426,865
Depreciation			4,282
Total operating expenses			5,163,629
Operating Income			33,665,254
OTHER INCOME (EXPENSE):
Interest income			1,474
Interest (expense)			(42,798)
Other income (expense)			(347,013)
Total other income (expense)			(388,337)
Net income before provision for income taxes			33,276,917
Income tax provision			889,943
NET INCOME ATTRIBUTABLE TO COMMON STOCKHOLDERS			$ 31,682,275
WEIGHTED-AVERAGE UNITS USED IN COMPUTING NET INCOME (LOSS) PER UNIT:
Weighted-average stock outstanding - basic (in shares)	[1]		50,369,350
Weighted-average stock outstanding - diluted (in shares)	[1]		50,369,350
NET INCOME/(LOSS) PER UNIT:
Basic earnings per share (in dollars per share)			$ 0.63
Diluted earnings per share (in dollars per share)			$ 0.63
Abacus Settlements, LLC
Origination revenue		$ 13,184,676	$ 25,203,463
Total revenues		13,184,676	25,203,463
Total cost of revenue		9,293,303	16,561,005
Gross Profit		3,891,373	8,642,458
OPERATING EXPENSES:
General and administrative expenses		4,848,580	8,674,425
Depreciation		5,597	12,165
Total operating expenses		4,854,177	8,686,590
Operating Income		(962,804)	(44,132)
OTHER INCOME (EXPENSE):
Interest income		1,917	2,199
Interest (expense)		(11,725)	(8,817)
Other income (expense)		0	273
Total other income (expense)		(9,808)	(6,345)
Net income before provision for income taxes		(972,612)	(50,477)
Income tax provision		2,289	2,018
NET INCOME ATTRIBUTABLE TO COMMON STOCKHOLDERS		$ (974,901)	$ (52,495)
WEIGHTED-AVERAGE UNITS USED IN COMPUTING NET INCOME (LOSS) PER UNIT:
Weighted-average stock outstanding - basic (in shares)		400	400
Weighted-average stock outstanding - diluted (in shares)		400	400
NET INCOME/(LOSS) PER UNIT:
Basic earnings per share (in dollars per share)		$ (2,437.25)	$ (131.24)
Diluted earnings per share (in dollars per share)		$ (2,437.25)	$ (131.24)
Nonrelated Party
Total cost of revenue			$ 5,884,669
Nonrelated Party \| Abacus Settlements, LLC
Origination revenue		$ 3,252,738	7,050,007
Total cost of revenue		2,734,949	5,538,470
Related Party
Total cost of revenue			0
Related Party \| Abacus Settlements, LLC
Origination revenue		9,931,938	18,153,456
Total cost of revenue		$ 6,558,354	$ 11,022,535

[1]Both the number of shares outstanding and their par value have been retrospectively recast for all prior periods presented to reflect the par value of the outstanding stock of Abacus Life, Inc. as a result of the Business Combination.

Abacus Settlements LLC - COND_2

Abacus Settlements LLC - CONDENSED STATEMENTS OF CHANGES IN MEMBERS' EQUITY - USD ($)	Total		Additional Paid-In Capital		Retained Earnings		Abacus Settlements, LLC	Abacus Settlements, LLC Common Units	Abacus Settlements, LLC Additional Paid-In Capital	Abacus Settlements, LLC Retained Earnings
Beginning balance (in shares) at Dec. 31, 2021								400
Beginning balance at Dec. 31, 2021	$ 766,893	[1]	$ 704,963	[1]	$ 205,048	[1]	$ 2,722,995	$ 4,000	$ 80,000	$ 2,638,995
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	31,682,275						(52,495)			(52,495)
Distributions	$ (6,400,000)				(6,400,000)		(659,363)			(659,363)
Ending balance (in shares) at Dec. 31, 2022	50,369,350							400
Ending balance at Dec. 31, 2022	$ 28,149,697	[1]	704,963	[1]	25,487,323	[1]	2,011,137	$ 4,000	80,000	1,927,137
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)							(974,901)			(974,901)
Distributions							(442,283)			(442,283)
Ending balance (in shares) at Jun. 30, 2023								400
Ending balance at Jun. 30, 2023							593,953	$ 4,000	80,000	509,953
Beginning balance (in shares) at Dec. 31, 2022	50,369,350							400
Beginning balance at Dec. 31, 2022	$ 28,149,697	[1]	704,963	[1]	25,487,323	[1]	$ 2,011,137	$ 4,000	$ 80,000	$ 1,927,137
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	9,516,626
Distributions	$ (34,451,607)				(34,451,607)
Ending balance (in shares) at Dec. 31, 2023	63,242,173
Ending balance at Dec. 31, 2023	$ 164,070,076		$ 199,826,278		$ (34,726,135)

[1]Both the number of shares outstanding and their par value have been retrospectively recast for all prior periods presented to reflect the par value of the outstanding stock of Abacus Life, Inc. as a result of the successful Business Combination.

Abacus Settlements LLC - COND_3

Abacus Settlements LLC - CONDENSED STATEMENTS OF CASH FLOWS - USD ($)	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2023	Dec. 31, 2022
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income (loss)		$ 9,516,626	$ 31,682,275
Adjustments to reconcile net income to net cash used in operating activities:
Depreciation expense		63,033	4,282
Amortization of deferred financing fees		43,957	0
Changes in operating assets and liabilities:
Related party receivables		124,565	(130,873)
Accrued payroll and other expenses		3,829,825	0
Contract liability—deposits on pending settlements		(474,217)	0
Accounts payable		(40,014)	40,014
Net cash (used) provided in operating activities		(64,523,149)	10,693,254
CASH FLOWS FROM INVESTING ACTIVITIES:
Net cash provided (used) in investing activities		2,241,502	(3,704,646)
CASH FLOWS FROM FINANCING ACTIVITIES:
Payment of discounts and financing costs		(5,547,943)	0
Net cash provided by financing activities		57,817,492	22,961,795
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS		(4,464,155)	29,950,403
CASH AND CASH EQUIVALENTS:
CASH AND CASH EQUIVALENTS AT THE BEGINNING OF THE PERIOD	$ 30,052,823	30,052,823	102,420
CASH AND CASH EQUIVALENTS AT THE END OF THE PERIOD		25,588,668	30,052,823
Abacus Settlements, LLC
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income (loss)	(974,901)		(52,495)
Adjustments to reconcile net income to net cash used in operating activities:
Depreciation expense	19,157		25,184
Amortization expense	40,278		80,138
Amortization of deferred financing fees	11,725		7,817
Non-cash lease expense	1,210		1,631
Changes in operating assets and liabilities:
Related party receivables	397,039		187,622
Other receivables	101,203		(82,455)
Prepaid expenses	(198,643)		89,366
Other current assets	(26,211)		0
Other non-current assets			(7,246)
Certificate of deposit	0		656,250
State security deposit			(233)
Accrued payroll and other expenses	(17,466)		31,020
Contract liability—deposits on pending settlements	659,067		(1,356,641)
Accounts payable	(36,750)		36,750
Net cash (used) provided in operating activities	(24,292)		(383,292)
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures	(108,394)		(64,099)
Purchase of intangible asset	0		(15,000)
Due from members and affiliates	(74,134)		15,088
Net cash provided (used) in investing activities	(182,528)		(64,011)
CASH FLOWS FROM FINANCING ACTIVITIES:
Due to members	(1,411)		(10,446)
Payment of discounts and financing costs			(23,450)
Distributions to members	(442,283)		(659,363)
Net cash provided by financing activities	(443,694)		(693,259)
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	(650,514)		(1,140,562)
CASH AND CASH EQUIVALENTS:
CASH AND CASH EQUIVALENTS AT THE BEGINNING OF THE PERIOD	1,458,740	$ 1,458,740	2,599,302
CASH AND CASH EQUIVALENTS AT THE END OF THE PERIOD	$ 808,226		$ 1,458,740

DESCRIPTION OF BUSINESS

DESCRIPTION OF BUSINESS	12 Months Ended
DESCRIPTION OF BUSINESS	Dec. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
DESCRIPTION OF BUSINESS	DESCRIPTION OF BUSINESS Organization and Merger Abacus Life, Inc. (the “Company”) was formerly known as East Resources Acquisition Company ("ERES”), a blank check company incorporated in Delaware on May 22, 2020. Abacus Life, Inc. conducts its business through its wholly-owned, consolidated subsidiaries, primarily Abacus Settlements, LLC (“Abacus Settlements”, or “Abacus”) and Longevity Market Assets, LLC (“LMA”), which are Delaware limited liability companies (collectively, the “Companies”). On June 30, 2023, (the “Closing Date”), ERES, LMA and Abacus consummated the combining of the Companies as contemplated by the Merger Agreement dated as of August 30, 2022 (as amended on October 14, 2022 and April 20, 2023) with LMA Merger Sub, LLC, a wholly owned subsidiary of ERES (“LMA Merger Sub”), Abacus Merger Sub, LLC, a wholly owned subsidiary of ERES (“Abacus Merger Sub”), LMA and Abacus (together with LMA, the “Legacy Companies”). Pursuant to the Merger Agreement, on June 30, 2023, (i) LMA Merger Sub merged with and into LMA, with LMA surviving such merger (the “LMA Merger”) and (ii) Abacus Merger Sub merged with and into Abacus, with Abacus surviving such merger (the “Abacus Merger” and, together with the LMA Merger, the “Mergers” and, along with the other transactions contemplated by the Merger Agreement, the “Business Combination”) and the Legacy Companies became direct wholly owned subsidiaries of the Company. On the Closing Date, ERES changed its name to Abacus Life, Inc. The consolidated assets, liabilities and statements of operations and comprehensive income prior to the Business Combination are those of legacy LMA. The shares of common stock and corresponding capital amounts and income per share, prior to the Business Combination, have been retroactively restated based on share reflecting the exchange ratio established in the Business Combination. The equity structure has been recast in all comparative periods up to the Closing Date to reflect the number of shares of the Company’s common stock, $0.0001 par value per share, issued to legacy LMA’s stockholders in connection with the Business Combination. As such, the shares and corresponding capital amounts and income per share related to legacy LMA common stock prior to the Business Combination have been retroactively recast as shares reflecting the exchange ratio of 0.8 established in the Business Combination. Business Activity The Company, through its LMA subsidiary, is a provider of services pertaining to life insurance settlements and offers policy servicing to owners and purchasers of life settlement assets, as well as consulting, valuation, and actuarial services. The Company is also engaged in buying and selling of life settlement policies in which it uses its own capital, and purchases life settlement contracts with the intent to either hold to maturity to receive the associated death claim payout or to sell to another purchaser of life settlement contracts for a gain on the sale. The Company, through its Abacus subsidiary, also is an originator of outstanding life insurance policies as a licensed life settlement provider on behalf of investors (“Financing Entities”). Abacus locates and screens policies for eligibility as a commercially desirable life settlement, including verifying that the policy is in force, obtaining consents and disclosures, and submitting cases for life expectancy estimates, also known, collectively, as origination services. When the sale of a policy is completed, this is deemed “settled” and the policy is then referred to as either a “life settlement” in which the insured’s life expectancy is greater than two years or “viatical settlement,” in which the insured’s life expectancy is less than two years. The Company is not an insurance company, and therefore the Company does not underwrite insurable risks for its own account.

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	12 Months Ended
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	Dec. 31, 2023
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation —In connection with the Business Combination, the Merger is accounted for as a reverse recapitalization with ERES in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”). Under U.S. GAAP, ERES has been treated as the “acquired” company for financial reporting purposes. This determination was primarily based on the LMA stockholders having a relative majority of the voting power of the Company, the LMA stockholders having the authority to appoint a majority of directors on the Board of Directors, and senior management of LMA comprising the majority of the senior management of the post-combination Company. LMA was then determined to be the “acquirer” for financial reporting purposes based on the relative size of LMA as compared to Abacus, represented by their revenue, equity, gross profit and net income. Accordingly, for accounting purposes, the financial statements of the combined entity represents a continuation of the financial statements of LMA with the LMA Merger treated as the equivalent of LMA issuing stock for the net assets of ERES, accompanied by a recapitalization. The net assets of ERES are stated at historical cost, with no goodwill or other intangible assets recorded. The Abacus Merger has been accounted for using the acquisition method of accounting. Under the acquisition method of accounting, the assets and liabilities of Abacus were recorded at the fair value as of the acquisition date. The excess of the purchase price over the estimated fair values of the net assets acquired was recognized as goodwill. As a result of the Business Combination, the Company evaluated if ERES, Abacus, or LMA is the predecessor for accounting purposes. In considering the foregoing principles of predecessor determination and in light of the Company's specific facts and circumstances, management determined that LMA and Abacus are dual predecessors for accounting purposes. The financial statement presentation for Abacus Life, Inc. includes the purchase accounting effects of the Abacus Merger as of the Closing Date with the financial statements of LMA as the comparative period. The predecessor financial statements for Abacus are included separately within this report. The accompanying consolidated financial statements of the Company have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission and are prepared in accordance with U.S. GAAP. Consolidation of Variable Interest Entities —For entities in which the Company has variable interests, the Company first evaluates whether the entity meets the definition of a variable interest entity (“VIE”) or a voting interest entity (“VOE”). If the entity is a VIE, the Company focuses on identifying whether it has the power to direct the activities that most significantly impact the VIE’s economic performance and whether it has the obligation to absorb losses or the right to receive benefits from the VIE. If the Company is the primary beneficiary of a VIE, the assets, liabilities, and results of operations of the VIE will be included in the Company’s condensed consolidated financial statements. The proportionate share not owned by the Company is recognized as noncontrolling interest and net income attributable to noncontrolling interest on the condensed consolidated balance sheets and condensed consolidated statements of operations and comprehensive income, respectively. If the entity is a VOE, the Company evaluates whether it has the power to control the VOE through a majority voting interest or through other arrangements. Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 810, Consolidations , (“ASC 810”) requires the Company to separately disclose on its consolidated balance sheets the assets of consolidated VIEs and liabilities of consolidated VIEs as to which there is no recourse against the Company. As of December 31, 2023, total assets and liabilities of consolidated VIEs were $77,132,592 and $65,031,207, respectively. As of December 31, 2022, total assets and liabilities of consolidated VIEs were $30,073,972 and $27,116,762, respectively. On October 4, 2021, the Company entered into an operating agreement with LMX Series, LLC (“LMX”) and three other unaffiliated investors to obtain a 70% ownership interest in LMX, which was newly formed in August 2021. LMX had no operating activity prior to the operating agreement being signed. LMX has a wholly owned subsidiary, LMATT Series 2024, Inc., a Delaware C corporation. While the Company and three other investors each contributed $100 to LMX, the Company directs the most significant activities by managing the investment offerings, and sponsoring and creating structured investment grade insurance liabilities, and thus was provided a 70% ownership interest. LMX is a VIE and the Company is the primary beneficiary of LMX. The Company has included the results of LMX and its subsidiaries in its consolidated financial statements for the year ended December 31, 2023. On November 30, 2022, LMA Series, LLC, a wholly owned subsidiary of the Company, signed an Operating Agreement to be the sole member of a newly created general partnership, LMA Income Series, GP, LLC. Subsequent to that, LMA Income Series, GP, LLC formed a limited partnership, LMA Income Series, LP and issued partnership interests to limited partners in a private placement offering. It was determined that LMA Series, LLC is the primary beneficiary of LMA Income Series, LP and thus has fully consolidated the limited partnership in its consolidated financial statements for the year ended December 31, 2023. On January 31, 2023, LMA Series, LLC, a wholly owned subsidiary of the Company, signed an Operating Agreement to be the sole member of a newly created general partnership, LMA Income Series II, GP, LLC. Subsequent to that, LMA Income Series II, GP, LLC formed a limited partnership, LMA Income Series II, LP and issued partnership interests to limited partners in a private placement offering. It was determined that LMA Series, LLC is the primary beneficiary of LMA Income Series II, LP and thus has fully consolidated the limited partnership in its consolidated financial statements for the year ended December 31, 2023. Non-Consolidation of Variable Interest Entities —On January 1, 2021, the Company entered into an option agreement with two commonly owned full-service origination, servicing, and investment providers (the “Providers”), in which the Company agreed to fund certain capital needs with an option to purchase the outstanding equity ownership of the Providers (the “Option Agreement”). The Company accounted for its investment in the call options under the Option Agreement as an equity security, pursuant to ASC 321, Investments—Equity Securities . In arriving at this accounting conclusion, the Company first considered whether the call options met the definition of a derivative pursuant to ASC 815, Derivatives and Hedging , and concluded that the options do not provide for net settlement and accordingly are not a derivative. The Company also concluded that the call options do not provide the Company with a controlling financial interest in the legal entity pursuant to ASC 810. The call options include material contingencies prior to exercisability that the Company does not anticipate will be resolved; additionally, the call options are in a legal entity for which the stock price has no readily determinable fair value. The Company’s basis in the call options, pursuant to ASC 321, is zero and accordingly the call options are not reflected in the statement of financial position. The Company provided $144,721 of working capital funding for the year ended December 31, 2023 which is included in other (expense) income on the consolidated statements of operations and comprehensive income and $347,013 of funding for the year ended December 31, 2022. See Note 11, Commitments and Contingencies, for further details. For the years ended December 31, 2023, and 2022, the Providers were considered to be VIEs, but were not consolidated in the Company’s consolidated financial statements due to a lack of the power criterion or the losses/benefits criterion. As of December 31, 2023, the unaudited financial information for the unconsolidated VIEs are as follows: held assets of $601,762 and liabilities of $2,900. As of December 31, 2022, the unaudited financial information for the unconsolidated VIEs are as follows: held assets of $987,964 and liabilities of $358,586. Noncontrolling Interest —Noncontrolling interest represents the share of consolidated entities owned by third parties. At the date of formation or upon acquisition, the Company recognizes noncontrolling interest on the consolidated balance sheets at an amount equal to the noncontrolling interest’s proportionate share of the relative fair value of any assets and liabilities acquired. Noncontrolling interest is subsequently adjusted for the noncontrolling stockholder’s additional contributions, distributions, and the stockholder’s share of the net earnings or losses of each respective consolidated entity. Net income of a consolidated entity is allocated to noncontrolling interests based on the noncontrolling stockholder’s ownership interest during the period. The net income or loss that is not attributable to the Company is reflected in net income (loss) attributable to noncontrolling interests in the consolidated statements of operations and comprehensive income. Use of Estimates —The preparation of U.S. GAAP financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and changes therein, disclosure of contingent assets and liabilities at the date of financial statements, and the reported amounts of revenue and expenses during the reporting periods. Company’s estimates, judgments, and assumptions are continually evaluated based on available information and experience. Because of the use of estimates inherent in the financial reporting process, actual results could differ from the estimates. Estimates are used when accounting for purchase price allocation, the selection of useful lives of property and equipment, valuation of other receivables, valuation of life settlement policies, valuation of other investments and available-for-sale securities, valuation of long-term debt, impairment testing, income taxes, and legal reserves. Life Settlement Policies —The Company accounts for its holdings of life insurance settlement policies in accordance with ASC 325-30, Investments in Insurance Contracts . For all policies purchased after June 30, 2023, the Company accounts for these under the fair value method. For policies purchased before June 30, 2023, the Company elected to use either the fair value method or the investment method (cost, plus premiums paid). The valuation method is chosen upon contract acquisition and is irrevocable. The Company follows ASC 820, Fair Value Measurements and Disclosures , in estimating the fair value of its life insurance policies held at fair value. ASC 820 defines fair value as an exit price representing the amount that would be received if an asset were sold or that would be paid to transfer a liability in an orderly transaction between market participants at the measurement date. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. The Company’s valuation of life settlements is considered to be Level 3. The Company’s valuation model incorporates significant inputs that are not observable and reflect our assumptions about what factors market participants would use in pricing life settlement policies. We develop our inputs based on the best information available to us, including our own data. We believe that our model would be reasonably comparable to a model that an independent third-party would use. Refer to Note 12, Fair Value Measurements, for further details. For policies held at fair value, changes in fair value are reflected in the consolidated statement of operations and comprehensive income under active management revenue in the period the change is calculated. For policies held under the investment method, the Company tests the impairment if we become aware of information indicating that the carrying value plus undiscounted future premiums of a policy may not be recoverable. This information is gathered initially through extensive underwriting procedures at purchase of the settlement contract, as well as through periodic underwriting review that includes medical reports and life expectancy evaluations. The policies held by the Company using the investment method are expected to be owned for a shorter-term, and are actively marketed to potential buyers. The market feedback received through these interactions provides the Company with information related to a potential impairment. If a policy is determined to be impaired, the Company will adjust the carrying value to the fair value determined through the impairment analysis. The Company accounts for cash proceeds from sale and maturity of life insurance settlement policies, as well as cash outflows for premium payments, as operating activities within the consolidated statements of cash flows. Going Concern —Management evaluates at each annual and interim period whether there are conditions or events, considered in the aggregate, that raise substantial doubt about Company’s ability to continue as a going concern within one year after the date that the consolidated financial statements are issued. Management’s evaluation is based on relevant conditions and events that are known and reasonably knowable at the date that the consolidated financial statements are issued. Management has concluded that there are no conditions or events, considered in the aggregate, that raise substantial doubt about Company’s ability to continue as a going concern within one year after the date these consolidated financial statements were issued. Cash and Cash Equivalents —Cash and cash equivalents include short-term and all highly‐liquid debt instruments purchased with an original maturity of three months or less. Fair Value Measurements —The following fair value hierarchy is used in selecting inputs for those assets and liabilities measured at fair value that distinguishes between assumptions based on market data (observable inputs) and the Company’s assumptions (unobservable inputs). The Company evaluates these inputs and recognizes transfers between levels, if any, at the end of each reporting period. The hierarchy consists of three levels: Level 1 —Valuation based on quoted market prices in active markets for identical assets or liabilities that we have the ability to access at the measurement date. Level 2 —Valuation based on inputs other than Level 1 inputs that are observable for the assets or liabilities either directly or indirectly. Level 3 —Valuation based on inputs that reflect our assumptions about what factors market participants would use in pricing the asset or liability. The inputs are developed based on the best available information, including our own data. The Company’s financial instruments consist of cash, cash equivalents, accounts receivables, due to affiliates, equity investments in privately held companies, S&P options, life settlement policies, available for sale securities, market-indexed debt and secured borrowings. Cash, cash equivalents, accounts receivables, and due to affiliates are stated at their carrying value, which approximates fair value due to the short time to the expected receipt or payment date. Equity investments in privately held companies without readily determinable fair values are recognized at fair value on a nonrecurring basis when observable price changes from orderly transactions for identical or similar investments become available. Available-for-sale securities are measured at fair value using inputs that are not readily determinable. Unrealized holding gains and losses are excluded from earnings and reported in other comprehensive income until realized. S&P options are recognized at fair value using quoted market prices in active markets, with changes in fair value included in net income. Market-indexed debt is measured on a quarterly basis, with qualifying changes in fair value recognized in net income, except for the portion of the total change in the fair value of the liability that results from a change in the instrument-specific credit risk, which is separately included in other comprehensive income in accordance with ASC 825-10-45-5. The measurement approach for life settlement policies is included above within the Life Settlement Policies disclosure. Accounts Receivable, Related Party —Related party receivable are amounts owed to the Company by related party customers for services delivered. Management regularly reviews customer accounts for collectability and will record an allowance for these accounts when deemed necessary. Management determines the allowance for credit losses based on a review of outstanding receivables, historical collection experience, current economic conditions, and reasonable and supportable forecasts. Related party receivables are charged off against the allowance for credit losses when deemed uncollectible (after all means of collection have been exhausted and the potential for recovery is deemed remote). Recoveries of related party receivables previously written off are recorded when received. Due to the nature of operations, related party receivables are due primarily from parties which the Company serves. As a result, management deems all amounts due to be collectable. If the financial condition of the Company’s related party customers were to deteriorate, resulting in an impairment of their ability to make payments, additional allowances may be required. The Company did not record material allowance for credit losses as of December 31, 2023 and 2022, respectively. Other Investments —Equity investments without readily determinable fair values include the Company’s investments in privately-held companies in which the Company holds less than a 20% ownership interest and does not have the ability to exercise significant influence. The Company measures these investments at cost, and these investments are adjusted through net earnings when they are deemed to be impaired or when there is an adjustment from observable price changes (referred to as the “measurement alternative”). These investments are included in other investments on the financial statements, at cost on the consolidated balance sheets. In addition, the Company monitors these investments to determine if impairment charges are required based primarily on the financial condition and near-term prospects of these companies Available-for-sale Securities, at Fair Value —The Company has investments in securities that are classified as available-for-sale securities, and which are reflected on the consolidated balance sheets at fair value. These securities solely consist of a convertible promissory note in a private company that was entered into at arms-length. The Company determines the fair value using unobservable inputs by considering the initial investment value, next round financing, and the likelihood of conversion or settlement based on the contractual terms in the agreement. If any unrealized gains and losses on these investments are incurred, these would be included as a separate component of accumulated other comprehensive loss, net of tax, on the consolidated balance sheets. The Company classifies its available-for-sale securities as short-term or long-term based on the nature of the investment, its maturity date and its availability for use in current operations. The Company monitors if the fair value of the securities falls below the amortized cost basis. Credit losses identified are reflected in the allowance for credit losses and any credit losses reversed are recognized in earnings. As of December 31, 2023 and 2022, the fair value of the securities were determined to materially approximate amortized cost basis, thus no unrealized gains or losses were recorded. The Company did not record any allowance for credit losses. The Company writes off uncollectible accrued interest receivable balances in a timely manner. The Company recorded $105,935 and $— of accrued interest on its available-for-sale securities Equity Securities, at Fair Value —The equity securities, at fair value balance consists of S&P 500 put and call options that were purchased through a broker as an economic hedge related to the market-indexed instruments that are included in Long-Term Debt. The Company records these options at fair value and recognizes changes in fair value as part of net income. Property and Equipment, Net —Property and equipment are stated at cost less accumulated depreciation and are depreciated on a straight-line basis over the following estimated useful lives: Estimated Useful Life Computer equipment 5 years Furniture and fixtures 5 years Leasehold improvements Shorter of remaining lease term or estimated useful life Costs incurred for maintenance and repairs that do not extend the useful lives of property and equipment are expensed as incurred. Upon retirement or sale of assets, the cost and related accumulated depreciation are written off and any resulting gain or loss is reflected in the accompanying consolidated statements of operations and comprehensive income. Property and equipment are tested for recoverability whenever events or changes in circumstance indicate that their carrying amounts may not be recoverable. An impairment loss is recognized if the carrying amount of property and equipment is not recoverable and exceeds its fair value. Recoverability is determined based on the undiscounted cash flows expected to result from the use and eventual disposition of the asset or asset group. There were no impairments recognized during the years ended December 31, 2023 and 2022, respectively. Property and equipment to be disposed of are reported at the lower of carrying amount or fair value less cost to sell. Goodwill and Intangible Assets, Net —Goodwill and intangible assets are recorded as a result of the Business Combination. Goodwill represents the excess of the purchase price over the fair value of the assets acquired and liabilities assumed. The Company amortizes identifiable intangible assets with a finite useful life over the period that the intangible asset is expected to contribute directly or indirectly to its future cash flows; however, it does not amortize indefinite lived intangible assets. The Company evaluates goodwill and indefinite intangible assets for recoverability annually in the fourth quarter or on an interim basis should events or changes in circumstances indicate that a carrying amount may not be recoverable. To test for impairment, a qualitative assessment is performed to determine if it is more likely-than-not that the fair value of a reporting unit is less than its carrying value, including goodwill. This initial assessment includes, among other factors, consideration of: (i) past, current and projected future earnings and equity; (ii) recent trends and market conditions; and (iii) valuation metrics involving similar companies that are publicly traded and acquisitions of similar companies, if available. If the more likely-than-not threshold is met, a quantitative impairment test is performed by comparing the estimated fair value with the carrying value. If the carrying value of the net assets associated with the reporting unit exceeds the fair value of the reporting unit, goodwill is considered impaired and will be determined as the amount by which the reporting unit’s carrying value exceeds its fair value, not to exceed the carrying amount of goodwill. The Company’s reporting units are at the operating segment level; each operating segment represents a business and discrete financial information is available and reviewed regularly by management. Determining the fair value of its reporting units is subjective in nature and involves the use of significant estimates and assumptions, including projected net cash flows, discount and long-term growth rates. The Company determines the fair value of its reporting units based on an income approach and market approach, whereby the fair value of the reporting unit is derived from the present value of estimated future cash flows associated with the reporting unit. The assumptions about estimated cash flows include factors such as future premiums, loss and expenses, general and administrative expenses and industry trends. The Company considers historical rates and current market conditions when determining the discount and long-term growth rates to use in its analysis. The Company considers other valuation methods if the facts and circumstances indicate these methods provide a more representative approximation of fair value. Changes in these estimates based on evolving economic conditions or business strategies could result in material impairment charges in future periods. The Company bases its fair value estimates on assumptions it believes to be reasonable. Actual results may differ from those estimates. As of December 31, 2023, there were no events or changes in circumstances that indicated that a carrying amount of goodwill or intangible asset may not be recoverable. The company has insignificant internal-use software accounted under ASC 350-40, Internal-Use Software . The software is amortized on the straight-line basis over an estimated useful life of 3 years. Refer Note 6, Goodwill and Other Intangible Assets, for additional information on goodwill and intangible assets. Revenue Recognition —The Company generally derives its revenue from life settlement servicing and consulting activities (Portfolio Servicing Revenue), life settlement trading activities (Active Management Revenue) and fees, commissions (Origination Services). Portfolio Servicing Revenue — Portfolio servicing is comprised of servicing activities and consulting activities. The Company enters into service agreements with the owners of life settlement contracts and is responsible for maintaining the policy, manages processing of claims in the event of death of the insured and ensuring timely payment of optimized premiums computed to derive maximum return on maturity of the policy. The company neither assumes the ownership of the contracts nor undertakes the responsibility to make the premium payments, which remains with the owner of the policy. These service arrangements have contractual terms typically ranging from one-month to ten years and include fixed charges within its contracts as part of the total transaction price which are recognized on gross basis. To the extent that variable consideration is not constrained, the Company includes an estimate of the variable amount, as appropriate, within the total transaction price and updates its assumptions over the duration of the contract. Variable consideration has not been material. The duties performed by the Company under these arrangements are considered as a single performance obligation that is satisfied on a monthly basis as the customer simultaneously receives and consumes the benefit provided by the Company as the Company performs the service. As such, revenue is recognized for services provided for the corresponding month. Under consulting engagements, the Company provides services typically for the owners of life settlement contracts who are often customers of the servicing business line, or customers of Abacus. These consulting engagements are comprised of valuation, actuarial services, and overall policy assessments related life settlement contracts and are short-term in nature. The performance obligations are typically identified as separate services with a specific deliverable or a group of deliverables to be provided in tandem, as agreed to in the engagement letter or contract. Each service provided under a contract is considered as a performance obligation and revenue is recognized at a point in time when the deliverable or group of deliverables is transferred to the customer. Active Management Revenue — The Company also engages in buying and selling life settlement policies whereby each potential policy is independently researched to determine if it would be a profitable investment. Some of the policies are purchased with the intent to hold to maturity, while others are held for trading to be sold for a gain. The Company elects to account for each investment in life settlement contracts using either the investment method or the fair value method. Once the accounting method is elected for each policy, it cannot be changed. Under the investment method, investments in contracts are based on the initial investment at the purchase price plus all initial direct costs. Continuing costs (e.g., policy premiums, statutory interest and direct external costs, if any) to keep the policy in force are capitalized. Under the fair value method, the company will record the initial investment of the transaction price and remeasures the investment at fair value at each subsequent reporting period. Changes in fair value are reported on earnings when they occur. Upon sale of a life settlement contract, the company will record revenue (gain/loss) for the difference between the agreed-upon purchase price with the buyer, and the carrying value of the contract. Originations Revenue — The Company through its Abacus subsidiary, recognizes revenue from origination activities by acting as a provider of life settlements and viatical settlements representing investors that are interested in purchasing life settlements on the secondary or tertiary market. Revenue from origination services consists of fees negotiated for each purchase and sale of a policy to an investor, which also include any agent and broker commissions received and the reimbursement of transaction costs. See below for revenue disaggregation based upon the source of the policy. The Company originates life settlements policies with third parties that include settlement brokers, life insurance agents, and direct consumers or policyholders. The Company then provides the administration services needed to initiate the transfer of the life settlement policies to investors in exchange for an origination fee. Such transactions are entirely performed through an escrow agent. In these arrangements, the customer is the investor, and the Company has a single performance obligation to originate a life settlement policy for the investor. The consideration transferred upon each policy is negotiated directly with the investor by the Company and is dependent upon the policy death benefits held by each life settlement policy. The revenue is recognized when the performance obligation under the terms of the contracts with customers are satisfied. The Company recognizes revenue from life settlement transactions when the closing has occurred and any right of rescission under applicable state law has expired (i.e., the customer obtains control over the policy and has the right to use and obtain the benefits from the policy). While rescission periods may vary by state, most states grant the owner the right to rescind the contract before the earlier of 30 calendar days after the execution date of the contract or 15 calendar days after life settlement proceeds have been sent to the owner. Purchase and sale of the policies generally occurs simultaneously, and only the fees received, including any agent and broker commissions and transaction costs reimbursed, are recorded as gross revenue. For agent and broker commissions received and transaction costs reimbursed, the Company has determined that it is acting as the principal in the relationship as it maintains control of the services being performed as part of performance obligation prior to facilitating the transfer of the life settlement policy to the investor. While the origination fees are fixed amounts based on the face value of the policy death benefit, there is variable consideration present due to the owners rescission right. When variable consideration is present in a contract, the Company estimates the amount of variable consideration to which it expects to be entitled at contract inception and again at each reporting period until the amount is known. The entity applies the variable consideration c

BUSINESS COMBINATION

BUSINESS COMBINATION	12 Months Ended
BUSINESS COMBINATION	Dec. 31, 2023
Business Combination and Asset Acquisition [Abstract]
BUSINESS COMBINATION	BUSINESS COMBINATION Merger consideration conveyed of $531.8 million was allocated between the Companies based on relative values derived through both the discounted cash flow method within the income approach and the guideline public company method within the market approach. Within the discounted cash flow method, the present values of cash flows reasonably expected to be produced by the Companies from their operations were summed to produce an estimate of the Companies’ business enterprise values on a controlling, marketable basis. The cash flows used in the discounted cash flow analysis were discounted at the weighted average cost of capital of 14.5% for LMA and 16.5% for Abacus. The discounted cash flow method resulted in a business enterprise value range of $380.0 million to $460.0 million for LMA and $180.0 million to $195.0 million for Abacus. Within the market approach, Company applied the guideline public company method, which employs market multiples derived from market prices of stocks of Companies that are engaged in the same or similar lines of business as the Companies and that are actively traded on a free and open market. The guideline public company method resulted in a business enterprise value range of $400.0 million to $440.0 million for LMA and $180.0 million to $190.0 million for Abacus. Management concluded on a business enterprise value of $165.4 million for Abacus and $366.4 million for LMA based upon the relative fair value of the Companies allocated to the consideration transferred. The preliminary purchase price was allocated among the identified assets to be acquired. The primary area of the acquisition accounting that is not yet finalized is our estimate of the impact of acquisition accounting on deferred income taxes. An estimate of deferred income taxes has been recorded in the Company’s books based on information available as of December 31, 2023. As the initial acquisition accounting is based on our preliminary assessments, actual values may differ when final information becomes available. Company believes that the information gathered to date provides a reasonable basis for estimating the preliminary values of deferred taxes recorded. The Company will continue to evaluate this item until it is satisfactorily resolved and adjust our acquisition accounting accordingly, within the allowable measurement period, as defined by ASC 805, Business Combinations, (“ASC 805”). Transaction costs incurred as a result of the Business Combination were recognized within retained earnings / (accumulated deficit) on the consolidated balance sheet as of December 31, 2023. All valuation procedures related to existing assets as no new assets were identified as a result of procedures performed. Goodwill was recognized as a result of the acquisition, which represents the excess fair value of consideration over the fair value of the underlying net assets, largely arising from the extensive industry expertise that has been established by Abacus. This was considered appropriate based on the determination that the Abacus Merger would be accounted for as a business acquisition under ASC 805. Net Assets Identified Fair Value Intangibles $ 32,900,000 Goodwill 140,287,000 Current Assets 1,280,100 Non-Current Assets 901,337 Deferred Tax Liabilities (8,310,966) Accrued Expenses (524,400) Other Liabilities (1,171,739) Total Fair Value $ 165,361,332 Value Conveyed Amount Abacus Purchase Consideration $ 165,361,332 LMA Business Enterprise Value $ 366,388,668 Total Consideration $ 531,750,000 Intangible assets were comprised of the following: Asset Type Fair Value Useful Life Valuation Methodology Customer Relationships-Agents $ 12,600,000 5 years Multi-period excess earnings method Customer Relationships-Financing Entities 11,000,000 8 years Multi-period excess earnings method Internally Developed and Used Technology-APA 1,600,000 2 years Relief from royalty method Internally Developed and Used Technology-Marketplace 100,000 3 years Replacement cost method Trade Name 900,000 Indefinite Relief from royalty method Non-Compete Agreements 4,000,000 2 years With and without method State Insurance Licenses 2,700,000 Indefinite Replacement cost method Total Fair Value $ 32,900,000 Useful lives for customer relationships were developed using attrition data for agents and financing entities which resulted in a useful life of 5 years and 8 years, respectively. Estimates over the useful lives of internally developed and used technology contemplates the period in which the Company expects to utilize the technology and the length of time the technology is expected to maintain recognition and value in the market without significant investment. Non-compete agreements have a useful life commensurate with the executed non-compete agreements in place as a result of the Business Combination. The supplemental pro forma financial information in the table below summarizes the combined results of operations for the Business Combination as if the Companies were combined for both reporting periods. The unaudited supplemental pro forma financial information as presented below is for illustrative purposes and does not purport to represent what the results of operations would actually have been if the business combinations occurred as of the date indicated or what the results would be for any future periods. Unaudited Year Ended December 31, 2023 2022 Proforma revenue $ 79,588,733 $ 69,917,015 Proforma net income 8,541,727 31,629,781

LIFE SETTLEMENT POLICIES

LIFE SETTLEMENT POLICIES	12 Months Ended
LIFE SETTLEMENT POLICIES	Dec. 31, 2023
Investments, All Other Investments [Abstract]
LIFE SETTLEMENT POLICIES	LIFE SETTLEMENT POLICIES As of December 31, 2023, the Company holds 296 life settlem ent policies, of which 287 a re accounted for under the fair value method and 9 are accounted for using the investment method (cost, plus premiums paid). Aggregate face value of policies held at fair value is $520,503,710 as of December 31, 2023, with a corresponding fair v alue of $122,296,559. The aggregate face value of policies accounted for using the investment method is $33,900,000 as of December 31, 2023 , with a corresponding carrying value of $1,697,178. As of December 31, 2022, the Company held 53 life settlement policies, of which 35 were accounted for under the fair value method and 18 were accounted for using the investment method (cost, plus premiums paid). Aggregate face value of policies held at fair value was $40,092,154 as of December 31, 2022, with a corresponding fair value of $13,809,352. The aggregate face value of policies accounted for using the investment method was $42,330,000 as of December 31, 2022, with a corresponding carrying value of $8,716,111. At December 31, 2023, the Company did not have any contractual restrictions on its ability to sell policies, including those held as collateral for the issuance of long-term debt. Refer to Note 13, Long-Term Debt, for further details. Life expectancy reflects the probable number of years remaining in the life of a class of persons determined statistically, affected by such factors as heredity, physical condition, nutrition, and occupation. It is not an estimate or an indication of the actual expected maturity date or indication of the timing of expected cash flows from death benefits. The following tables summarize the Company’s life insurance policies grouped by remaining life expectancy as of December 31, 2023: Policies Carried at Fair Value — Remaining Life Expectancy (Years) Policies Face Value Fair Value 0-1 2 $ 383,461 $ 315,248 1-2 6 4,391,193 1,590,513 2-3 13 20,692,550 10,850,243 3-4 41 66,017,222 22,744,161 4-5 29 57,814,969 19,326,245 Thereafter 196 371,204,315 67,470,149 287 $ 520,503,710 $ 122,296,559 Policies accounted for using the investment method— Remaining Life Expectancy (Years) Number of Life Insurance Policies Face Value Carrying Value 0-1 0 $ — $ — 1-2 1 500,000 329,714 2-3 2 1,500,000 443,544 3-4 1 8,000,000 84,199 4-5 2 500,000 320,110 Thereafter 3 23,400,000 519,611 9 $ 33,900,000 $ 1,697,178 Estimated premiums to be paid by the Company for its portfolio accounted for using the investment method during each of the five succeeding calendar years and thereafter as of December 31, 2023, are as follows: 2024 $ 88,039 2025 100,785 2026 78,850 2027 50,388 2028 32,736 Thereafter 366,103 Total $ 716,901 The Company is required to pay premiums to keep its portion of life insurance policies in force. The estimated total future premium payments could increase or decrease significantly to the extent that actual mortalities of insureds differ from the estimated life expectancies.

PROPERTY AND EQUIPMENT_NET

PROPERTY AND EQUIPMENT—NET	12 Months Ended
PROPERTY AND EQUIPMENT—NET	Dec. 31, 2023
Property, Plant and Equipment [Abstract]
PROPERTY AND EQUIPMENT—NET	PROPERTY AND EQUIPMENT—NET Property and equipment—net composed of the following: December 31, December 31, Computer equipment $ 356,939 $ — Furniture and fixtures 91,125 19,444 Leasehold improvements 22,418 5,902 Property and equipment—gross 470,482 25,346 Less: accumulated depreciation (69,762) (6,729) Property and equipment—net $ 400,720 $ 18,617 Depreciation expense for the years ended December 31, 2023, and 2022, was $63,033 and $4,282, respectively.

GOODWILL AND OTHER INTANGIBLE A

GOODWILL AND OTHER INTANGIBLE ASSETS	12 Months Ended
GOODWILL AND OTHER INTANGIBLE ASSETS	Dec. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
GOODWILL AND OTHER INTANGIBLE ASSETS	GOODWILL AND OTHER INTANGIBLE ASSETS Goodwill of $140,287,000 was recognized as a result of the Business Combination, which represents the excess fair value of consideration over the fair value of the underlying net assets, largely arising from the extensive industry expertise that has been established by Abacus. This was considered appropriate based on the determination that the Abacus Merger would be accounted for as a business acquisition under ASC 805. The estimates of fair value are based upon preliminary valuation assumptions believed to be reasonable, but which are inherently uncertain and unpredictable. Refer to Note 3, Business Combination, for further details. The changes in the carrying amount of goodwill by reportable segments were as follows: Portfolio Servicing Active Management Originations Goodwill at January 1, 2023 $ — $ — $ — Additions — — 140,287,000 Goodwill at December 31, 2023 $ — $ — $ 140,287,000 Intangible Assets Acquired comprised of the following: Asset Type Fair Value Useful Life Valuation Methodology Customer Relationships - Agents $ 12,600,000 5 years Multi-period excess-earnings method Customer Relationships - Financial Relationships 11,000,000 8 years Multi-period excess-earnings method Internally Developed and Used Technology—APA 1,600,000 2 years Relief from Royalty Method Internally Developed and Used Technology—Market Place 100,000 3 years Replacement Cost Method Trade Name 900,000 Indefinite Relief from Royalty Method Non-Compete Agreements 4,000,000 2 years With or Without Method State Insurance Licenses 2,700,000 Indefinite Replacement Cost Method $ 32,900,000 Intangible assets and related accumulated amortization as of December 31, 2023 and 2022 are as follows: December 31, 2023 Definite Lived Intangible Assets: Gross Value Accumulated Amortization Net Book Value Customer Relationships - Agents $ 12,600,000 $ 1,260,000 $ 11,340,000 Customer Relationships - Financial Relationships 11,000,000 687,500 10,312,500 Internally Developed and Used Technology—APA 1,600,000 400,000 1,200,000 Internally Developed and Used Technology—Market Place 100,000 16,667 83,333 Non-Compete Agreements 4,000,000 1,000,000 3,000,000 Balance at December 31, 2023 $ 29,300,000 $ 3,364,167 $ 25,935,833 Indefinite Lived Intangible Assets: Trade Name 900,000 — 900,000 State Insurance Licenses 2,700,000 — 2,700,000 Total Intangible Asset Balance at December 31, 2023 $ 32,900,000 $ 3,364,167 $ 29,535,833 Substantially all intangible assets with finite useful lives are subject to amortization when they are available for their intended use. Amortization expense for definite lived intangible assets was $3,364,167 and $— for the years ended December 31, 2023 and 2022, respectively. Estimated annual amortization of intangible assets for the next five years ending December 31 and thereafter is as follows: 2024 $ 6,728,333 2025 5,328,333 2026 3,911,667 2027 3,895,000 2028 2,635,000 Thereafter 3,437,500 Total $ 25,935,833 The Company also has other insignificant intangible assets of $87,297 as of December 31, 2023. The Company performed the annual goodwill impairment test as of October 1, 2023, which was a qualitative evaluation, and no impairment charges were recorded. The estimated fair value of the Originations reporting unit exceeded its carrying value at the date of its most recent fair value estimate.

AVAILABLE-FOR-SALE SECURITIES,

AVAILABLE-FOR-SALE SECURITIES, AT FAIR VALUE	12 Months Ended
AVAILABLE-FOR-SALE SECURITIES, AT FAIR VALUE	Dec. 31, 2023
Investments, Debt and Equity Securities [Abstract]
AVAILABLE-FOR-SALE SECURITIES, AT FAIR VALUE	AVAILABLE-FOR-SALE SECURITIES, AT FAIR VALUE Convertible Promissory Note —The Company holds a convertible promissory note in a separate unrelated insurance technology company. This unrelated insurance technology company is a producer of life expectancy reports. The Company purchases life expectancy reports and uses them as an input into the valuation methodology for policies held at fair value. In November 2021, the Company purchased a $250,000 note and then purchased an additional note in January 2022 for $250,000 as part of the Tranche 5 offering (“Tranche 5 Promissory Note”). The Tranche 5 Promissory Note pays 6% interest per annum. The Tranche 5 Promissory Note matures on September 30, 2025 (“Maturity Date”) and will be paid in full as to outstanding principal and accrued interest on the Maturity Date unless the Tranche 5 Promissory Note converts prior to the 2025 Maturity Date. Conversion into preferred stock occurs if the technology company engages in an additional equity financing event that yields gross cash proceeds in excess of $1,000,000 (“Next Equity Financing”). In October 2022, the Company purchased an additional convertible promissory note in the same unrelated insurance technology company for $500,000 as part of the Tranche 6 offering (“Tranche 6 Promissory Note” and collectively, the “Convertible Promissory Notes”). The Tranche 6 Promissory Note pays eight percent (8)% interest per annum and matures September 30, 2024 (“2024 Maturity Date”) and will be paid in full as to outstanding principal and accrued interest on the 2024 Maturity Date unless the Tranche 6 Promissory Note converts prior to the 2024 Maturity Date. Conversion into preferred stock occurs if the technology company engages in an additional equity financing event that yields gross cash proceeds in excess of $5,000,000 (“Next Round Securities”). We evaluated our relationship with the unrelated insurance technology company, including our CEO membership in the unrelated insurance technology company’s board of directors, and determined that the Company does not have control over the unrelated insurance technology company’s decision making process. The Company applies the available-for-sale method of accounting for its investment in the Convertible Promissory Note, which is a debt investment. The Convertible Promissory Note does not qualify for either the held-to-maturity method due to the Convertible Promissory Note’s conversion rights or the trading securities method because the Company holds the Convertible Promissory Note as a long-term investment. The Convertible Promissory Notes are measured at fair value at each reporting period-end. Unrealized gains and losses are reported in other comprehensive income until realized. As of December 31, 2023 and 2022, the Company evaluated the fair value of its investment and determined that the fair value approximates the carrying value of $1,105,935, which included $105,935 non-cash interest income and there was no unrealized gain or loss recorded.

OTHER INVESTMENTS AND OTHER NON

OTHER INVESTMENTS AND OTHER NONCURRENT ASSETS	12 Months Ended
OTHER INVESTMENTS AND OTHER NONCURRENT ASSETS	Dec. 31, 2023
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
OTHER INVESTMENTS AND OTHER NONCURRENT ASSETS	OTHER INVESTMENTS AND OTHER NONCURRENT ASSETS Other Investments: Convertible Preferred Stock Ownership —The Company owns convertible preferred stock in two entities, further described below. On July 22, 2020, the Company purchased 224,551 units of an unrelated insurance technology company’s Series Seed Preferred units for $750,000 (“Seed Units”). During December 2022, the Company agreed to purchase 119,760 Series Seed Preferred Units for $400,000 in cash consideration by way of eight monthly payments of $50,000 starting December 15, 2022, resulting in a total of $950,000 investment as of March 31, 2023, $1,100,000 investment as of June 30, 2023 and $1,150,000 investment at September 30, 2023. Upon conversion, the Seed Units held by the Company would represent an 8.6% ownership interest in the technology company. On December 21, 2020, the Company purchased 207,476 shares of a separate unrelated insurance technology company’s Series B-1 preferred stock for $500,000 (“Preferred Stock”). The Preferred Stock is convertible into voting common stock at the option of the Company. Upon conversion, the Preferred Stock would represent less than a 1% ownership interest in the technology company. The Company applies the measurement alternative for its investments in the Seed Units and Preferred Stock because these investments are of an equity nature, and the Company does not have the ability to exercise significant influence over operating and financial policies of entities even in the event of conversion of the Seed Units or Preferred Stock. Under the measurement alternative, the Company records the investment based on original cost, less impairments, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the investee. The Company’s share of income or loss of such companies is not included in the Company’s consolidated statements of operations and comprehensive income. The Company tests its investments for impairment whenever circumstances indicate that the carrying value of the investment may not be recoverable. No im pairment of investments occurred for the years ended December 31, 2023 and 2022. Other Noncurrent Assets- at fair value: S&P Options — The Company is long S&P 500 call options and short S&P 500 put options which were purchased and sold through a broker as an economic hedge related to the market-indexed debt instruments included in the long-term debt note. The value is based on stock owned and quoted market prices in active markets. Changes in fair value are recorded in the Unrealized Loss on Investments line item on the consolidated statements of operations and comprehensive income.

CONSOLIDATION OF VARIABLE INTER

CONSOLIDATION OF VARIABLE INTEREST ENTITIES	12 Months Ended
CONSOLIDATION OF VARIABLE INTEREST ENTITIES	Dec. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
CONSOLIDATION OF VARIABLE INTEREST ENTITIES	CONSOLIDATION OF VARIABLE INTEREST ENTITIES The Company consolidates VIEs for which it is the primary beneficiary or VOEs for which it controls through a majority voting interest or other arrangement. See Note 2, Summary of Significant Accounting Policies, for more information on how the Company evaluates an entity for consolidation. The Company evaluated any entity in which it had a variable interest upon formation to determine whether the entity should be consolidated. The Company also evaluated the consolidation conclusion during each reconsideration event, such as changes in the governing documents or additional equity contributions to the entity. During the year ended December 31, 2023, the Company’s consolidated VIEs, LMA Income Series II LP, LMX Series LLC (LMATT Series 2024, Inc.), and LMA Income Series, LP, had total assets of $77,132,592 and liabilities of $65,031,207. For the year ended December 31, 2022, the Company’s consolidated VIEs, LMATT Series 2024, Inc., Longevity Market Advisors, Regional Investment Services and LMA Income Series, LP, had total assets and liabilities of $30,073,972 and $27,116,762, respectively. The Company did not deconsolidate any entities during the years ended December 31, 2023, or 2022. As of December 31, 2023, the Company held total assets of $601,762 and liabilities of $2,900 in unconsolidated VIEs. As of December 31, 2022, the Company held total assets of $987,964 and liabilities of $358,586 in unconsolidated VIEs.

SEGMENT REPORTING

SEGMENT REPORTING	12 Months Ended
SEGMENT REPORTING	Dec. 31, 2023
Segment Reporting [Abstract]
SEGMENT REPORTING	SEGMENT REPORTING Segment Information —The Business Combination that took place on June 30, 2023, where ERES, LMA and Abacus Settlements consummated the combining of the Companies, triggered a re-organization of Abacus Life Inc., where the legacy Abacus Settlements business and legacy LMA business would both operate under Abacus Life, Inc. subsequent to the Business Combination date. Abacus Settlement’s historically had one operating segment one reportable segment, Originations. LMA historically had two operating segments, (1) Portfolio Servicing and (2) Active Management. As the Business Combination did not occur until the last day of the second quarter, income activity related to Abacus Settlements had not yet been reported by Abacus Life, Inc. as the businesses did not begin operating as a combined Company until July 1, 2023. As such, beginning in the third quarter, the Company now organizes its business into three reportable segments (1) Portfolio Servicing, (2) Active Management and (3) Originations, which all generate revenue and incur expenses in different manners. This segment structure reflects the financial information and reports used by the Company’s management, specifically its chief operating decision maker (CODM), to make decisions regarding the Company’s business, including resource allocations and performance assessments, as well as the current operating focus in compliance with ASC 280, Segment Reporting . The Company’s CODM is the President and Chief Executive Officer. The Company’s reportable segments are not aggregated. The Portfolio Servicing segment generates revenues by providing policy services to customers on a contract basis. The Active Management segment generates revenues by buying, selling, and trading policies and maintaining policies until receipt of death benefits. The Originations segment generates revenue by originating life insurance policy settlements between investors or buyers, and the sellers, who is often the original policy owner. The policies are purchased from owners or other providers through advisors, brokers or directly through the owner. The Company’s method for measuring profitability on a reportable segment basis is gross profit. The CODM does not review disaggregated assets by segment. Revenue related to the Company’s reporting segments is as follows: Years Ended December 31, 2023 2022 Portfolio servicing $ 1,002,174 $ 1,470,972 Active management 61,195,377 43,242,580 Originations 19,247,972 — Segment revenue (including inter-segment) 81,445,523 44,713,552 Intersegment elimination (15,044,072) — Total revenue $ 66,401,451 $ 44,713,552 Information related to the Company’s reporting segments for the years ended December 31, 2023 and 2022 is as follows: Years Ended December 31, 2023 2022 Portfolio servicing $ 278,115 $ 300,235 Active management 59,020,991 38,528,648 Originations 611,968 — Total gross profit 59,911,074 38,828,883 Sales and marketing (4,905,747) (2,596,140) General, administrative and other (including stock-based compensation) (26,482,571) (1,426,865) Depreciation and amortization expense (3,409,928) (4,282) Other (expense) income (146,443) (347,013) Loss on change in fair value of warrant liability (4,204,360) — Interest expense (9,866,821) (42,798) Interest income 594,764 1,474 Gain (Loss) on change in fair value of debt (2,356,058) (90,719) Unrealized (loss) gain on investments 1,369,112 (1,045,623) Provision for income taxes (1,468,535) (889,943) Less: Net gain (loss) attributable to non-controlling interests 482,139 (704,699) Net income attributable to Abacus Life, Inc. $ 9,516,626 $ 31,682,275 Segment gross profit is defined as revenues less cost of revenue, excluding depreciation and amortization. Expenses below the gross profit line are not allocated across operating segments, as they relate primarily to the overall management of the consolidated entity. As of December 31, 2023 and 2022, our operations are confined to the United States.

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	12 Months Ended
COMMITMENTS AND CONTINGENCIES	Dec. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	COMMITMENTS AND CONTINGENCIES Legal Proceedings —Occasionally, the Company may be subject to various proceedings such as lawsuits, disputes, or claims. The Company assesses these proceedings as they arise and accrues a liability when losses are probable and reasonably estimable. Although legal proceedings are inherently unpredictable, the Company is currently not aware of any matters that, if determined adversely to the Company, would individually, or taken together, have a material adverse effect on the Company’s business, financial position, results of operations, or cash flows. Commitment —The Company has entered into a Strategic Services and Expenses Support Agreement (“SSES” or “Expense Support Agreement”) with the Providers in exchange for an option to purchase the outstanding equity ownership of the Providers. Pursuant to the Expense Support Agreement, Abacus Life, Inc. provides financial support and advice for the expenses of the Providers incurred in connection with their life settlement transactions businesses and the Providers are required to hire a life settlement transactions operations employee of an affiliate of Abacus Life, Inc. No later than December 1 of each calendar year, Abacus Life, Inc. provides a budget for the Providers, in which Abacus Life, Inc. commits to extend financial support for all operating expenses up to the budgeted amount. “Operating Expenses” for purposes of the Expense Support Agreement means all annual operating expenses of the Providers incurred in the ordinary course of business, excluding the premiums paid for the Providers insurance coverages that are allocable to the insurance coverage provided to Institutional Life Holdings, LLC (“ILS”), which owns all the outstanding membership interests of the Providers if unrelated to the Providers settlement business. For the years ended December 31, 2023, and 2022, Abacus Life, Inc. incurred $144,721, and $347,013 of expenses, related to the Expense Support Agreement respectively, which is included in the Other (expense) line of the consolidated statements of operations and comprehensive income and have not been reimbursed by the Providers.

FAIR VALUE MEASUREMENTS

FAIR VALUE MEASUREMENTS	12 Months Ended
FAIR VALUE MEASUREMENTS	Dec. 31, 2023
Fair Value Disclosures [Abstract]
FAIR VALUE MEASUREMENTS	FAIR VALUE MEASUREMENTS The Company determines fair value based on assumptions that market participants would use in pricing an asset or a liability in the principal or most advantageous market. When considering market participant assumptions in fair value measurements, the fair value hierarchy as mentioned in Note 2, Summary of Significant Accounting Policies, distinguishes between observable and unobservable inputs. Recurring Fair Value Measurements —The assets and liabilities measured at estimated fair value on a recurring basis and their corresponding placement in the fair value hierarchy are presented in the tables below. Fair Value Hierarchy As of December 31, 2023 Level 1 Level 2 Level 3 Total Assets: Life settlement policies $ — $ — $ 122,296,559 $ 122,296,559 Available-for-sale securities, at fair value — — 1,105,935 1,105,935 Other investments — — 1,650,000 1,650,000 S&P 500 options 2,348,998 — — 2,348,998 Other assets 998,945 — — 998,945 Total assets held at fair value $ 3,347,943 $ — $ 125,052,494 $ 128,400,437 Liabilities: Debt maturing within one year $ — $ — $ 13,029,632 $ 13,029,632 Long-term debt — — 55,318,924 55,318,924 Private placement warrants — — 6,642,960 6,642,960 Total liabilities held at fair value: $ — $ — $ 74,991,516 $ 74,991,516 Fair Value Hierarchy As of December 31, 2022 Level 1 Level 2 Level 3 Total Assets: Life settlement policies $ — $ — $ 13,809,352 $ 13,809,352 Available-for-sale securities, at fair value — — 1,000,000 1,000,000 Other investments — — 1,300,000 1,300,000 S&P 500 options 890,829 — — 890,829 Total assets held at fair value $ 890,829 $ — $ 16,109,352 $ 17,000,181 Liabilities: Long-term debt $ — $ — $ 28,249,653 $ 28,249,653 Total liabilities held at fair value: $ — $ — $ 28,249,653 $ 28,249,653 Life Settlement Policies — For all policies purchased after June 30, 2023, the Company accounts for owned life settlement policy using the fair value method. Prior to June 30, 2023, the Company elected to use either the fair value method or the investment method (cost, plus premiums paid). The valuation method is chosen upon contract acquisition and is irrevocable. For policies carried at fair value, the valuation based on Level 3 inputs that reflect our assumptions about what factors market participants would use in pricing the asset or liability, such as life expectancies and cash flow discount rates. The inputs are developed based on the best available information, including our own data. The valuation model is based on a discounted cash flow analysis and is sensitive to changes in the discount rate used. The Company utilized a blended average discount rate of 21% for policy valuations at December 31, 2023 and 12% for all policies at December 31, 2022, respectively, for policy valuation, which is based on economic and company-specific factors. The Company re-evaluates its discount rates at the end of every reporting period in order to reflect the estimated discount rates that could reasonably be used in a market transaction involving the Company’s portfolio of life settlements. For life settlement policies carried using the investment method, the Company measures these at the cost of the policy plus premiums paid. The policies accounted for using the investment method totaled $1,697,178 at December 31, 2023 and $8,716,111 at December 31, 2022. Discount Rate Sensitivity —21% was determined to be the weighted average discount rate used to estimate the fair value of policies held by LMA and its investment funds. If the discount rate increased or decreased by 2 percentage points and the other assumptions used to estimate fair value remained the same, the change in estimated fair value as of December 31, 2023, would be as follows: As of December 31, 2023 Fair Value Change in Rate Adjustment +2% $ 111,206,993 $ (11,089,566) No change 122,296,559 -2% 130,749,053 8,452,494 Credit Exposure to Insurance Companies —The following table provides information about the life insurance issuer concentrations that exceed 10% of total face value or 10% of total fair value of the Company’s life insurance policies as of December 31, 2023: Carrier Percentage of Percentage of Carrier John Hancock Life Insurance Company (U.S.A.) 28.0 % 20.0 % A+ The following table provides a roll forward of the fair value of life insurance policies for the year ended December 31, 2023: Fair value at December 31, 2022 $ 13,809,352 Policies purchased 186,124,688 Realized gain (loss) on matured/sold policies 19,606,894 Premiums paid (4,281,610) Unrealized gain(loss) on held policies 27,889,106 Change in estimated fair value 43,214,390 Matured/sold policies (125,133,481) Premiums paid 4,281,610 Fair value at December 31, 2023 $ 122,296,559 Long-Term Debt —See Note 13, Long-Term Debt, for background information on the market-indexed debt. The Company has elected the fair value option in accounting for the instruments. Fair value is determined using Level 3 inputs. The valuation methodology is based on the Black-Scholes-Merton option-pricing formula and a discounted cash flow analysis. Inputs to the Black-Scholes-Merton model include (i) the S&P 500 Index price, (ii) S&P 500 Index volatility, (iii) a risk-free rate based on data published by the US Treasury, and (iv) a term assumption based on the contractual term of the LMATT Notes. The discounted cash flow analysis includes a discount rate that is based on the implied discount rate developed by calibrating a valuation model to the purchase price on the initial investment date. The implied discount rate is evaluated for reasonableness by benchmarking it to yields on actively traded comparable securities. The total change in fair value of the debt resulted in a gain of $4,028,189. This gain is comprised of $944,463, net of tax, which is included within accumulated other comprehensive income The following table provides a roll forward of the fair value of the issued notes for the year ended December 31, 2023: Fair value at December 31, 2022 $ 28,249,653 Debt issued to third parties 71,720,713 Debt issued to related parties 35,471,648 Unrealized loss on change in fair value (risk-free) 2,356,058 Unrealized loss on change in fair value (credit-adjusted) included in OCI 1,265,103 Unrealized gain on change in fair value (credit-adjusted) included in equity of NCI 407,028 Change in estimated fair value of debt 4,028,189 Accrued non-cash interest on related party debt 2,182,221 Deferred issuance costs and discounts (1,831,910) Fair value at December 31, 2023 $ 139,820,514 Private Placement Warrants —Simultaneously with the closing of the Initial Public Offering, ERES consummated the sale of 8,900,000 warrants (the “Private Placement Warrants”) to East Sponsor, LLC (the “Sponsor”), which included the sale of an additional 900,000 Private Placement Warrants in connection with the full exercise by the underwriters of their over-allotment option on August 25, 2020, at a price of $1.00 per Private Placement Warrant, for an aggregate purchase price of $8,900,000. Each Private Placement Warrant is exercisable for one share of Class A common stock at a price of $11.50 per share, subject to adjustment. Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that (x) the Private Placement Warrants and the shares of Class A common stock issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions, (y) the Private Placement Warrants will be exercisable on a cashless basis and be non-redeemable so long as they are held by the initial purchasers or their permitted transferees and (z) the Private Placement Warrants and the shares of Class A common stock issuable upon exercise of the Private Placement Warrants will be entitled to registration rights. If the Private Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants. Private Placement Warrants were accounted for as liabilities in accordance with ASC 815-40. The warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented separately in the condensed consolidated statements of operations and comprehensive income. The Private Placement Warrants were considered a Level 3 fair value measurement using a binomial lattice model in a risk-neutral framework. The binomial lattice model’s primary unobservable input utilized in determining the fair value of the Private Placement Warrants is the expected volatility of the common stock. The implied volatility as of the reporting date was derived from observable public warrant traded price provided by Bloomberg LP. The following table presents the key assumptions in the analysis: Private Placement Warrants Expected implied volatility de minimis Risk-free interest rate 4.09% Term to expiration 5.0 years Exercise price $11.50 Common Stock Price $10.03 Dividend Yield —% Equity Securities, at Fair Value: S&P 500 Options —In February 2022, LMATT Series 2024, Inc., which the Company consolidates for financial reporting, purchased and sold S&P 500 call and put options through a broker. The Company purchased and sold additional S&P 500 call options through a broker in June 2022 through their 100% owned and fully consolidated subsidiaries LMATT Growth Series 2.2024, Inc. and LMATT Growth and Income Series 1.2026, Inc. The options are exchange traded, and fair value is determined using Level 1 inputs of quoted market prices as of the consolidated balance sheets dates. Changes in fair value are classified as unrealized (gain)/loss on investments within the consolidated statements of operations and comprehensive income. Financial Instruments Measured at Fair Value on a Nonrecurring Basis —The following financial assets, composed of equity securities without readily determinable fair values, are adjusted to fair value when observable price changes are identified, or an impairment charge is recognized. Such fair value measurements are based predominantly on Level 3 inputs other than financial instruments where the carrying value approximates fair value. Available-for-Sale Investment —The Convertible Promissory Note is classified as an available-for-sale security. Available-for-sale investments are subsequently measured at fair value. Unrealized holding gains and losses are excluded from earnings and reported in other comprehensive income until realized. The Company determines fair value of its available-for-sale investments using unobservable inputs by considering the initial investment value, next round financing, and the likelihood of conversion or settlement based on the contractual terms in the agreement. The Company initially purchased a $250,000 convertible promissory note from the issuer in 2021 and then on January 7, 2022, the Company purchased an additional $250,000 convertible promissory note from the same issuer and then an additional $500,000 in October 2022. As of December 31, 2023 and 2022, the Company evaluated the fair value of its Promissory Note and determined that the fair value approximates the carrying value of $1,105,935 and $1,000,000, which included $105,935 and $— of accrued interest, respectively. Other Investments —The Company determines fair value using Level 3 inputs under the measurement alternative. These investments are recorded at cost, minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer. Impairment is assessed qualitatively. As of December 31, 2023, and 2022, the Company did not identify any impairment indicators and determined that the carrying value of $1,650,000 and $1,300,000, respectively is the fair value for these equity investments in privately held companies, given that there have been no observable price changes. Financial Instruments Where Carrying Value Approximates Fair Value —Th

LONG-TERM DEBT

LONG-TERM DEBT	12 Months Ended
LONG-TERM DEBT	Dec. 31, 2023
Debt Disclosure [Abstract]
LONG-TERM DEBT	LONG-TERM DEBT Outstanding principal balances of Long-term debt comprises of the following: December 31, 2023 December 31, 2022 Cost Fair value Cost Fair value Market-indexed notes: LMATT Series 2024, Inc. $ 9,124,944 $ 9,477,780 $ 9,866,900 $ 8,067,291 LMATT Series 2.2024, Inc. 2,981,480 3,551,852 2,333,391 2,354,013 LMATT Growth & Income Series 1.2026, Inc 492,582 569,862 400,000 400,000 Secured borrowing: LMA Income Series, LP 21,889,444 22,368,209 17,428,349 17,428,349 LMA Income Series II, LP 32,380,852 32,380,852 — — Unsecured borrowing: Fixed Rate Senior Unsecured Notes 35,650,000 35,650,000 — — SPV Purchase and Sale Note 26,538,004 26,538,004 — — Sponsor PIK Note 11,115,865 11,115,865 — — Deferred issuance costs and discounts (1,831,910) (1,831,910) — — Total debt $ 138,341,261 $ 139,820,514 $ 30,028,640 $ 28,249,653 Less current portion of long-term debt $ (11,440,236) $ (13,029,632) — — Total long-term debt $ 126,901,025 $ 126,790,882 $ 30,028,640 $ 28,249,653 Fixed Rate Senior Unsecured Notes On November 10, 2023, the Company issued $35,650,000 in fixed rate senior unsecured notes (“Fixed Unsecured Notes”). The net proceeds after related debt issue costs, were used by the Company to repay the Owl Rock Credit Facility, with the remaining to be used for general corporate purposes. The Fixed Unsecured Notes are based on a fixed interest rate of 9.875% to be paid in quarterly interest payments beginning on February 15, 2024 and mature on November 15, 2028. The Company has the option to redeem the Fixed Unsecured Notes in whole or in part at a price of 100% of the outstanding principal balance on or after November 15, 2027. The notes will be senior unsecured obligations of the Company and will rank equal in right of payment to all of the Company’s other senior unsecured indebtedness from time to time outstanding. Owl Rock Credit Facility On July 5, 2023 (the “Owl Rock Closing Date”), the Company entered into that certain Credit Agreement (the “Owl Rock Credit Facility”), among the Company, as borrower, the several banks and other persons from time to time party thereto (the “Owl Rock Lenders”), and Owl Rock Capital Corporation, as administrative and collateral agent for the Owl Rock Lenders thereunder. The Owl Rock Credit Facility provided credit extensions for (i) an initial term loan in an aggregate principal amount of $25,000,000 upon the closing of the Owl Rock Credit Facility and (ii) optional delayed draw term loans in an aggregate principal amount of up to $25,000,000 that was available for 180 days after the Owl Rock Closing Date, subject to the requirement that on each delayed draw date, the proceeds may have been used for working capital and the business requirements of the enterprise, and to fund acquisitions, investments and other transactions permitted by the loan documentation. The interest rate was based an adjusted term Secured Overnight Financing Rate (“SOFR”), which was calculated as term SOFR plus a 0.10% adjustment for a one-month interest period, a 0.15% adjustment for a three-month interest period, or a 0.25% adjustment for a six-month interest period. It provided a delayed draw commitment fee rate of 0.50% per annum applicable to undrawn commitments during the Delayed Draw Term Loan Availability Period and matured on July 5, 2028. On November 10, 2023, the Company repaid the Owl Rock Credit Facility from the Fixed Unsecured Notes net proceeds after related debt issue costs. In connection with the repayment of the outstanding principal, the Company paid a 4% repayment penalty of $1,000,000 and legal fees of $73,339. The Company also incurred a loss on extinguishment of $2,086,303. The combined total of $3,159,641 is included in interest expense on the consolidated statements of operations and comprehensive income. Sponsor PIK Note On June 30, 2023, in connection with the consummation of the Business Combination and as contemplated by the Merger Agreement, East Sponsor, LLC, a Delaware limited liability company (“Sponsor”), made an unsecured loan to the Company in the aggregate amount of $10,471,648 (the “Sponsor PIK Note”) with an interest rate of 12% per annum compounding semi-annually. Accrued interest is payable in arrears quarterly starting on September 30, 2023 by adding it to the outstanding principal balance. As of December 31, 2023 and 2022, $644,217 and $— in non-cash interest expense was added to the outstanding principal balance, respectively. The Sponsor PIK Note matures on June 30, 2028 and may be prepaid at any time in accordance with its terms without any premium or penalty. LMATT Series 2024, Inc. Market-Indexed Notes: On March 31, 2022, LMATT Series 2024, Inc., which the Company consolidates for financial reporting, issued $10,166,900 in market-indexed private placement notes. The note, titled the Longevity Market Assets Target-Term Series (LMATTS) 2024, is a market-indexed instrument designed to provide upside performance exposure of the S&P 500 Index, while limiting downward exposure. Upon maturity of the note in 2024, the principal, plus the return based upon the S&P 500 Index must be paid. The note has a feature to protect debt holders from market downturns, up to 40%. Any subsequent losses below the 40% threshold will reduce the note on a one-to-one basis. As of December 31, 2023, $9,124,944 of the principal amount remained outstanding. The notes are held at fair value, which represents the exit price, or anticipated price to transfer the liability to a third party. As of December 31, 2023, the fair value of the LMATT Series 2024, Inc. notes was $9,477,780. The notes are secured by the assets of the issuing entities, which includes cash, S&P 500 options, and life settlement policies totaling $9,883,554 as of December 31, 2023. The notes’ agreements do not restrict the trading of life settlement contracts prior to maturity of the note, as total assets of the issuing companies are considered as collateral. There are also no restrictive covenants associated with the notes with which the entities must comply. LMATT Series 2.2024, Inc. Market-Indexed Notes: On September 16, 2022, LMATTS Series 2.2024, Inc., a 100% owned subsidiary, which the Company consolidates for financial reporting, issued $2,333,391 in market-indexed private placement notes. The note, titled the Longevity Market Assets Target-Term Growth Series 2.2024, Inc. (“ LMATTS TM Series 2.2024, Inc.”) is a market-indexed instrument designed to provide upside performance exposure of the S&P 500 Index, while limiting downward exposure. Upon maturity of the note in 2024, the principal, plus the return based upon the S&P 500 Index must be paid. The note has a feature to provide upside performance participation that is capped at 120% of the performance of the S&P 500. A separate layer of the note has a feature to protect debt holders from market downturns by up to 20% if the index price experiences a loss during the investment period. After the underlying index has decreased in value by more than 20%, the investment will experience all subsequent losses on a one-to-one basis. As of December 31, 2023, the entire principal amount remained outstanding. The notes are held at fair value, which represents the exit price, or anticipated price to transfer the liability to a third party. As of December 31, 2023, the fair value of the LMATT Series 2.2024, Inc. notes were $3,551,852. The notes are secured by the assets of the issuing entity, LMATT Series 2.2024, Inc., which includes cash, S&P 500 options, and life settlement policies totaling $3,389,167 as of December 31, 2023. The note agreements do not restrict the trading of life settlement contracts prior to maturity of the note, as total assets of the issuing company are considered as collateral. There are also no restrictive covenants associated with the note with which the entity must comply. LMATT Growth and Income Series 1.2026, Inc. Market-Indexed Notes: On September 16, 2022, LMATTS Growth and Income Series 1.2026, Inc., a 100% owned subsidiary, which the Company consolidates for financial reporting, issued $400,000 in market-indexed private placement notes. The note, titled the Longevity Market Assets Target-Term Growth and Income Series 1.2026, Inc. (“ LMATTS TM Growth and Income Series 1.2026, Inc.”) is a market-indexed instrument designed to provide upside performance exposure of the S&P 500 Index, while limiting downward exposure. Upon maturity of the note in 2026, the principal, plus the return based upon the S&P 500 Index must be paid. The note has a feature to provide upside performance participation that is capped at 140% of the performance of the S&P 500. A separate layer of the note has a feature to protect debt holders from market downturns by up to 10% if the index price experiences a loss during the investment period. After the underlying index has decreased in value by more than 10%, the investment will experience all subsequent losses on a one-to-one basis. This note also includes 4% dividend feature that will be paid annually. As of December 31, 2023, the entire principal amount remained outstanding. The notes are held at fair value, which represents the exit price, or anticipated price to transfer the liability to a third party. As of December 31, 2023, the fair value of the LMATT Growth and Income Series 1.2026, Inc., notes were $569,862. The notes are secured by the assets of the issuing entity, LMATTS Growth and Income Series 1.2026, Inc., which includes cash, S&P 500 options, and life settlement policies totaling $374,458 as of December 31, 2023. The note agreements do not restrict the trading of life settlement contracts prior to maturity of the note, as total assets of the issuing company are considered as collateral. There are also no restrictive covenants associated with the note with which the entity must comply. See additional fair value considerations within Note 12. LMA Income Series, LP and LMA Income Series, GP LLC Secured Borrowing One September 2, 2022, LMA Income Series, GP, LLC, wholly owned and controlled by that LMA Series, LLC, formed a limited partnership, LMA Income Series, LP and subsequently issued partnership interests to limited partners in a private placement offering. The initial term of the offering is three years maturing on December 31, 2025 with the ability to extend for two additional one-year periods at the discretion of the general partner, LMA Income Series, GP, LLC. The limited partners will receive an annual dividend of 6.5% paid quarterly and 25% of returns in excess of a 6.5% internal rate of return capped at 9% which would require a 15% net internal rate of return. The General Partner will receive 75% of returns in excess of a 6.5% internal rate of return to limited partners then 100% in excess of a 15% net internal rate of return. It was determined that LMA Series, LLC is the primary beneficiary of LMA Income Series, LP and thus has fully consolidated the limited partnership in its consolidated financial statements for the year ended December 31, 2023. The private placement offerings proceeds will be used to acquire an actively manage a large and diversified portfolio of financial assets. LMA, through its consolidated subsidiaries, serves as the portfolio manager for the financial asset portfolio, which includes investment sourcing and monitoring. In this role, LMA has the unilateral ability to acquire and dispose of any of the above investments. As the partnership does not represent a business in accordance with ASC 810 and is a consolidated subsidiary that only holds financial assets, this represents a transfer subject to ASC 860-10. As the financial assets are not transferred outside the consolidated group, the proceeds from the offering shall be classified as a liability unless it meets the definition of a participating interest and the derecognition criteria in ASC 860 are met. The transferred interest did not meet the definition of a participating interest as LMA possesses the unilateral ability to direct the sale of the financial assets (ASC 860-10-50-6A(d)). In accordance with ASC 860-30-25-2, as the transfer of the financial assets did not meet the definition of a participating interest, LMA shall recognize the proceeds received from the offering as a secured borrowing. LMA elected to account for the secured borrowing at fair value under the collateralized financing entity guidance within ASC 810-10-30. As of December 31, 2023, the fair value of the secured borrowing was $22,368,209. LMA Income Series II, LP and LMA Income Series II, GP LLC Secured Borrowing On January 31, 2023, LMA Income Series II, GP, LLC, wholly owned and controlled by that LMA Series, LLC, formed a limited partnership, LMA Income Series II, LP and subsequently issued partnership interests to limited partners in a private placement offering. The initial term of the offering is three years maturing on March 31, 2026 with the ability to extend for two additional one-year periods at the discretion of the general partner, LMA Income Series II, GP, LLC. The limited partners will receive annual dividends equal to the Preferred Return Amounts as follows: Capital commitment less than $500,000, 7.5%; between $500,000 and $1,000,000, 7.75%; over $1,000,000, 8%. Thereafter, 100% of the excess to be paid to the General Partner. It was determined that LMA Series, LLC is the primary beneficiary of LMA Income Series, LP and thus has fully consolidated the limited partnership in its consolidated financial statements for the year ended December 31, 2023. The private placement offerings proceeds will be used to acquire an actively manage a large and diversified portfolio of financial assets. LMA, through its consolidated subsidiaries, serves as the portfolio manager for the financial asset portfolio, which includes investment sourcing and monitoring. In this role, LMA has the unilateral ability to acquire and dispose of any of the above investments. As the partnership does not represent a business in accordance with ASC 810 and is a consolidated subsidiary that only holds financial assets, this represents a transfer subject to ASC 860-10. As the financial assets are not transferred outside the consolidated group, the proceeds from the offering shall be classified as a liability unless it meets the definition of a participating interest and the derecognition criteria in ASC 860 are met. The transferred interest did not meet the definition of a participating interest as LMA possesses the unilateral ability to direct the sale of the financial assets (ASC 860-10-50-6A(d)). In accordance with ASC 860-30-25-2, as the transfer of the financial assets did not meet the definition of a participating interest, LMA shall recognize the proceeds received from the offering as a secured borrowing. LMA elected to account for the secured borrowing at fair value under the collateralized financing entity guidance within ASC 810-10-30. As of December 31, 2023, the fair value of the secured borrowing was $32,380,852. SPV Purchase and Sale Note On July 5, 2023, the Company entered into an Asset Purchase Agreement (the “Policy APA”) to acquire certain insurance policies with an aggregate fair market value of $10.0 million from Abacus Investment SPV, LLC, a Delaware limited liability company (“SPV”), in exchange for a payable obligation owed by the Company to SPV (such acquisition transaction under the Policy APA, the “SPV Purchase and Sale”). SPV is jointly owned between the Sponsor and former members of LMA and Abacus. The payable obligation owed by the Company to SPV in connection with the SPV Purchase and Sale is evidenced by a note issued by the Company to SPV in connection with the SPV Investment Facility, as defined below, (the “SPV Purchase and Sale Note”) in an original principal amount equal to the aggregate fair market value of the acquired insurance policies. The SPV Purchase and Sale Note has the same material terms and conditions as the other credit extensions under the SPV Investment Facility. SPV Investment Facility On July 5, 2023, the Company entered into a credit agreement between the Company, as borrower, and the SPV, as lender (the “SPV Investment Facility”) whereby the Company is able to borrow additional funds from SPV. The SPV Investment Facility provides, among other things, for the following: • Requires that certain subsidiaries of the Company guarantee the credit extensions provided under the SPV Investment Facility pursuant to separate documentation; • is unsecured without collateral security provided in favor of SPV and subordinated in right of payment to the Company’s obligations under the Owl Rock Credit Facility, subject to limited specified exceptions and circumstances for permitting early payment; • provides for certain credit extensions in an aggregate principal amount of $25,000,000 included in the Long-term debt, related party line item on the consolidated balance sheets, which includes: (i) an initial credit extension in an original principal amount of $15,000,000 that was funded upon the closing of the SPV Investment Facility, and (ii) the SPV Purchase and Sale Note for the original principal amount of $10,000,000 to finance the purchase of the insurance policies under the Policy APA; • provides for proceeds to be used for payment of certain transaction expenses, general corporate purposes and any other purposes not prohibited by the agreement or applicable law; • matures on July 5, 2026, three years after the closing of the SPV Investment Facility, subject to two automatic extensions of one year each without any amendment of the relevant documentation; • provides for interest to accrue on the SPV Investment Facility at a rate of 12% per annum, payable quarterly, all of which is to be paid in-kind by the Company by increasing the principal amount of the SPV Investment Facility owing to the SPV on each interest payment date. As of September 30, 2023, $750,000 in non-cash interest expense was added to the outstanding principal balance; • provides a default rate that will accrue at 2.00% per annum (subject to applicable subordination restrictions) over the rate otherwise applicable. If cash payment is not permitted due to applicable subordination restrictions or otherwise, such default interest shall be paid in-kind; • provides that no principal payments shall be required prior to maturity; • contains financial and other covenants substantially similar and not materially worse than those contained in the Owl Rock Credit Facility from the perspective of the Company; and • provides for certain specified events of default (including certain events of default subject to grace or cure periods), with the occurrence and during the continuance of such events of default enabling the lender under the SPV Investment Facility to accelerate the obligations under the SPV Investment Facility, among other rights or remedies, subject to applicable subordination restrictions. As of December 31, 2023 and 2022, $1,538,004 and $— in non-cash interest expense was added to the outstanding principal balance, respectively. The following table shows scheduled principal payments by year for our long-term debt as of December 31, 2023: Payments Year 2024 2025 2026 2027 2028 Thereafter Total Market-indexed notes: LMATT Series 2024, Inc. $ 9,477,780 $ — $ — $ — $ — $ — $ 9,477,780 LMATT Series 2.2024, Inc. 3,551,852 — — — — — 3,551,852 LMATT Growth & Income Series 1.2026, Inc. — — 569,862 — — — 569,862 Secured borrowing: LMA Income Series, LP — 22,368,209 — — — — 22,368,209 LMA Income Series II, LP — — 32,380,852 — — — 32,380,852 Unsecured borrowing: Fixed Rate Senior Unsecured Notes — — — — 35,650,000 — 35,650,000 SPV Purchase and Sale Note — — 26,538,004 — — — 26,538,004 Sponsor PIK Note — — — — 11,115,865 — 11,115,865 $ 13,029,632 $ 22,368,209 $ 59,488,718 $ — $ 46,765,865 $ — $ 141,652,424

SHAREHOLDERS' EQUITY

SHAREHOLDERS' EQUITY	12 Months Ended
SHAREHOLDERS' EQUITY	Dec. 31, 2023
Equity [Abstract]
SHAREHOLDERS' EQUITY	SHAREHOLDERS’ EQUITY The Company is authorized to issue up to 200,000,000 shares of common stock, par value $0.0001 per share, and 1,000,000 shares of preferred stock, par value $0.0001 per share. No shares of preferred stock are issued or outstanding. Holders of the Company’s common stock are entitled to one vote for each share. As of December 31, 2023, there were 63,388,823 shares of common stock issued, of which 63,242,173 are outstanding and 146,650 shares were held as treasury stock. Holders of shares were entitled to receive, in the event of a liquidation, dissolution or winding up, ratably the assets available for distribution to the stockholders after payment of all liabilities. The equity structure has been recast in all comparative periods up to the Closing Date to reflect the number of shares of the Company’s common stock, 0.0001 par value per share, issued to legacy LMA’s stockholders in connection with the Business Combination. As such, the shares and corresponding capital amounts and earnings per share related to legacy LMA common stock prior to the Business Combination have been retroactively recast as shares reflecting the exchange ratio of 0.8 established in the Business Combination. As of December 31, 2022, this resulted in 50,369,350 shares of common stock issued and outstanding. Public Warrants As of December 31, 2023, the Company has 17,249,984 Public Warrants outstanding. Each redeemable whole Public Warrant entitles the holder thereof to purchase one share of common stock at a price of $11.50 per full share, subject to adjustment as described. The Public Warrants represent a freestanding financial instrument as it is traded on the Nasdaq under the symbol “ABLLW” and legally detachable and separately exercisable from the related underlying shares of the Company’s common stock. Public Warrants may only be exercised for a whole number of shares. No fractional shares will be issued upon exercise of the Public Warrants. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination and (b) 12 months from the closing of the Proposed Offering. The Public Warrants will expire five years from the completion of a Business Combination, at 5:00 p.m., New York City time, or earlier upon redemption or liquidation. The Company will not be obligated to deliver any shares of Class A common stock pursuant to the exercise of a Public Warrant and will have no obligation to settle such Public Warrant exercise unless a registration statement under the Securities Act with respect to the shares of Class A common stock underlying the warrants is then effective and a prospectus relating thereto is current, subject to the Company satisfying its obligations with respect to registration, or a valid exemption from registration is available. No warrant will be exercisable and the Company will not be obligated to issue a share of Class A common stock upon exercise of a warrant unless the share of Class A common stock issuable upon such warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the warrants. Redemption of Warrants for Cash - Once the warrants become exercisable, the Company may redeem the outstanding Public Warrants for cash: • in whole and not in part; • at a price of $0.01 per Public Warrant; • upon not less than 30 days’ prior written notice of redemption to each warrant holder; and • if, and only if, the last sale price of the Class A common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders. If and when the Public warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale under all applicable state securities laws. However, the Company will not redeem the warrants unless an effective registration statement under the Securities Act covering the shares of Class A common stock issuable upon exercise of the warrants is effective and a current prospectus relating to those shares of Class A common stock is available throughout the 30-day redemption period, except if the warrants may be exercised on a cashless basis and such cashless exercise is exempt from registration under the Securities Act. Redemption of Warrants for Shares of Class A Common Stock - Once the Public warrants become exercisable, the Company may redeem the outstanding warrants for shares of Class A common stock: • in whole and not in part; • at a price equal to a number of shares of Class A common stock to be determined by reference to the agreed table set forth in the warrant agreement based on the redemption date and the “fair market value” of the Class A common stock; • upon not less than 30 days’ prior written notice of redemption to each warrant holder; and • if, and only if, the last sale price of the Class A common stock equals or exceeds $10.00 per share (as adjusted per stock splits, stock dividends, reorganizations, recapitalizations and the like) on the trading day prior to the date on which the Company sends the notice of redemption to the warrant holders. In addition, if (x) the Company issues additional shares of common stock or equity-linked securities for capital raising purposes in connection with the closing of the Company’s initial Business Combination at an issue price or effective issue price of less than $9.20 per share (with such issue price or effective issue price to be determined in good faith by our board of directors), (y) the volume weighted average trading price of the Company’s common stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the “Market Price”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of Market Price and the newly issued price. Further, the $10.00 and $18.00 per share redemption trigger prices will be adjusted to be equal to 100% and 180%, respectively, of the higher of the market value and the newly issued price. If the Company elects to redeem all of the Public Warrants or the common stock is at the time of any exercise of a Public Warrant not listed on a national securities exchange, management has the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. In such event, each holder would pay the exercise price by surrendering the whole warrants for that number of shares of common stock equal to the quotient obtained by dividing (x) the product of the number of shares of common stock underlying the warrants, multiplied by the difference between the exercise price of the warrants and the “fair market value” (defined below) by (y) the fair market value. The “fair market value” shall mean the average reported last sale price of the common stock for the 10 trading days ending on the third trading day prior to the date on which the notice of redemption is sent to the holders of warrants. However, in no instance can the warrant holder unilaterally decide to exercise its Public Warrant on a cashless basis. Upon the Business Combination, the Company accounted for the Public Warrants issued with the IPO as equity instruments. The Company accounted for the warrant as an expense of the IPO resulting in a charge directly to stockholders’ equity. The Company estimates that the fair value of the warrants upon the Business Combination is approximately $4.73 million, or $0.274 per Public Warrant, using the binomial lattice model. The fair value of the warrants is estimated as of the date of grant using the following assumptions: (1) risk-free interest rate of 4.09%, (2) term to expiration of 5.00 years, (3) exercise price of $11.50 and (4) stock price of $10.03. Stock Repurchase Program On December 11, 2023, our Board of Directors authorized a stock repurchase program under which the Company may purchase shares of our common stock for an aggregate purchase price not to exceed $15 million over a period of up to 18 months. Stock repurchases may be made through open market transactions, block trades, accelerated stock repurchases, privately negotiated transactions, derivative transactions or otherwise, certain of which may be made pursuant to a trading plan meeting the requirements of Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, in compliance with applicable state and federal securities laws. The timing, as well as the number and value of stock repurchased under the program, will be determined by the Company at its discretion and will depend on a variety of factors, including our assessment of the intrinsic value of the Company's common stock, the market price of the Company's common stock, general market and economic conditions, available liquidity, compliance with the Company's debt and other agreements, applicable legal requirements, the nature of other investment opportunities available to the Company, and other considerations. The Company is not obligated to purchase any stock under the repurchase program, and the program may be suspended, modified, or discontinued at any time without prior notice. The Company expects to fund the repurchases by using cash on hand and expected free cash flow to be generated in the future. Acquired shares of our common stock are held as treasury stock carried at cost in our consolidated financial statements. In connection with the repurchase program, the Company is authorized to adopt one of more plans pursuant to the provisions of Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. As of December 31, 2023, $13.7 million remained available for repurchase under the authorization approved by the Board of Directors. The authorization for the stock repurchase program may be suspended, terminated, increased or decreased by our Board of Directors at any time without prior notice. The following table summarizes stock repurchase activity under our share repurchase program: Total Number of Shares Purchased Cost of Shares Repurchased Average Price Paid per Share As of December 31, 2022 — $ — $ — December 1, 2023 - December 31, 2023 146,650 1,283,062 8.82 As of December 31, 2023 146,650 $ 1,283,062 $ 8.82

STOCK-BASED COMPENSATION

STOCK-BASED COMPENSATION	12 Months Ended
STOCK-BASED COMPENSATION	Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]
STOCK-BASED COMPENSATION	STOCK- BASED COMPENSATION Long-term Incentive Plan: In October of 2023, the Compensation Committee approved the issuance of 2,468,500 restricted stock units (“RSU’s”) to executives, employees and directors as part of the Company’s 2023 Long-Term Equity Compensation Incentive Plan (“Long-term Incentive Plan”). This plan provides for equity-based awards, including restricted stock units, performance stock units (“PSU”), stock options and unrestricted shares of common stock, may be granted to officers, key employees and directors of the Company. The Company has granted RSUs that provide the right to receive, subject to service based vesting conditions, shares of common stock pursuant to the Equity Plan. After the issuance, 621,500 shares of common stock remained available for issuance of the 3,090,000 shares that are authorized for issuance under the Long-term Incentive Plan. The expense associated with the awards will be based on the fair value of the stock as of the grant date, where the Company will elect to straight line recognition over the vesting period, which is three years. Each RSU entitles the unit holder to one share of common stock when the restriction expires. RSUs have service conditions associated with them that range from one common stock. Shares that are issued upon vesting are newly issued shares from the Long-term Incentive Plan and are not issued from treasury stock. Forfeitures are recorded as they occur. The following table shows a summary of the unvested restricted stock under the 2023 Long-Term Equity Compensation Incentive Plan as of December 31, 2023 as well as activity during the year: Weighted Average Number of shares Grant Date Fair Value Restricted stock units, unvested, December 31, 2022 — $ — Granted 2,468,500 6.16 Vested (39,000) 6.16 Forfeited — — Restricted stock units, unvested, December 31, 2023 2,429,500 6.16 Compensation costs recognized for these restricted stock units were $1,600,760 and $— for the years ended December 31, 2023 and 2022, respectively. $1,278,153 and $322,607 of the 2023 compensation costs is recorded in cost of revenue (including stock-based compensation) and in general and administrative expense (including stock-based compensation) in the consolidated statements of operations and comprehensive income, respectively. As of December 31, 2023, there was approximately $13,605,200 of unrecognized compensation costs related to these restricted stock units which the Company expects to recognize over the next 2.5 years. CEO Restriction Agreement: Effective upon Business Combination close, the Chief Executive Officer (“CEO”) entered into a Restriction Agreement with Abacus Life, Inc. that provides terms for the CEO’s ownership interest grant that were assigned to him from the three original founders of Abacus Settlements. As of the Closing Date as provided in the Merger Agreement amended on April 21, 2023, the CEO received 4,569,922 shares of Restricted Stock. Vesting Conditions. The Company shall issue the shares of Restricted Stock either (a) in certificate form or (b) in book entry form, registered in the CEO’s name, referring to the terms, conditions and restrictions applicable to the shares as outlined below. The CEO’s Ownership Interest Grant (“Restricted Stock”) shall vest as follows: i. 50% of the shares on the 25 th month following the Effective Date, ii. 50% of the shares on the 30 th month following the Effective Date, iii. Additionally, the Restricted Stock will become fully vested upon the first to occur of one of the following events: (i) separation from service due to disability, (ii) death, (iii) separation from service without cause; or (iv) separation from service for good reason. CEO Stock-based compensation expense is recorded in general and administrative expense (including stock-based compensation) summarized as follows: Years Ended December 31, 2023 2022 Stock-based compensation expense $ 9,167,264 $ — Restricted Stock activity relative to the CEO for the year ended December 31, 2023 is summarized as follows: Number of Shares Weighted Average Grant Date Fair Value Outstanding at December 31, 2022 — $ — Granted 4,569,922 10.03 Forfeited — — Settled — — Outstanding at December 31, 2023 4,569,922 $ 10.03 As of December 31, 2023, unamortized stock-based compensation expense for unvested Restricted Stock relative to the CEO was $36,669,054 with a remaining contractual life of 2.0 years.

EMPLOYEE BENEFIT PLAN

EMPLOYEE BENEFIT PLAN	12 Months Ended
EMPLOYEE BENEFIT PLAN	Dec. 31, 2023
Postemployment Benefits [Abstract]
EMPLOYEE BENEFIT PLAN	EMPLOYEE BENEFIT PLAN The Company has a defined contribution plan in the U.S. intended to qualify under Section 401(k) of the Internal Revenue Code (the “401(k) Plan”). The 401(k) Plan covers substantially all employees who meet minimum age and service requirements and allows participants to defer up to 100% of their annual compensation on a pretax basis. The Company matches up to a maximum of 4% of eligible employee contributions and may chose to make additional discretionary contributions to the 401(k) Plan. For the years ended December 31, 2023 and 2022, the Company recognized expenses related to the 401(k) Plan amounting to $183,439 and $22,559, respectively. For the years ended December 31, 2023 and 2022, the Company did not make discretionary contributions.

INCOME TAXES

INCOME TAXES	12 Months Ended
INCOME TAXES	Dec. 31, 2023
Income Tax Disclosure [Abstract]
INCOME TAXES	INCOME TAXES Before June 30, 2023, the Company elected to file as an S corporation for Federal and state income tax purposes, as such, the Company incurred no Federal or state income taxes, except for income taxes related to their consolidated VIEs and subsidiaries which are taxable C corporations. These VIEs and subsidiaries include LMATT Series 2024, Inc., the wholly owned subsidiary of LMX, which is consolidated into LMA as a VIE, as well as LMATT Growth Series 2.2024, Inc., a wholly owned subsidiary of LMATT Growth Series, Inc., and LMATTS Growth and Income Series 1.2026, Inc., a wholly owned subsidiary of LMATT Growth and Income Series, Inc., all of which are 100% owned subsidiaries and fully consolidated. Accordingly, the provision for income taxes was attributable to amounts for LMATT Series 2024, Inc., LMATT Growth Series, Inc., and LMATT Growth and Income Series, Inc. For the years ended December 31, 2023 and 2022, the Company recorded provision for income taxes of $1,468,535 and $889,943, respectively. The effective tax rate is 14.0% for the year ended December 31, 2023. The existence of non-taxable flow-through entities within the Company as well as a change in tax status of certain entities upon the Business Combination caused the effective tax rate to vary from the statutory rate. The effective rate for the year ended December 31, 2022 was 2.7% due to the impact of state income taxes and the release of the Company’s valuation allowance, as there was sufficient evidence of the Company’s ability to generate future taxable income at December 31, 2022. The components of the provision for income taxes are as follows: For the Years Ended December 31, 2023 2022 Current provision: Federal $ 706,686 $ — State 195,679 — Foreign — — Total current tax 902,365 — Deferred provision: Federal 469,109 737,376 State 97,061 152,567 Foreign — — Total deferred tax 566,170 889,943 Provision for income taxes $ 1,468,535 $ 889,943 The Company did not have any unrecognized tax benefits relating to uncertain tax positions as of December 31, 2023, and 2022, and did not recognize any interest or penalties related to uncertain tax positions as of December 31, 2023, and 2022. The effective income tax rate differs from the federal statutory income tax rate applied to the profit loss before provision for income taxes due to the following: For the Years Ended December 31, 2023 2022 Income tax benefit computed at federal statutory rate $ 2,205,635 $ 6,988,538 Restricted stock award deductions limited by IRC 162(m) 2,069,993 — Change in tax status 1,414,469 — Effect of pass through entities and noncontrolling interests (3,812,977) (6,147,453) State income taxes, net of federal tax benefit (332,567) 174,024 Other (76,018) — Valuation allowance — (125,166) Income tax at effective rate $ 1,468,535 $ 889,943 The effects of temporary differences that give rise to significant components of deferred tax assets and liabilities at December 31, are as follows : 2023 2022 Deferred tax assets: Basis difference related to life insurance policy sales $ 1,798,639 $ 109,902 Warrant liability 1,683,658 — Interest expense carryforward 740,657 — Stock-based compensation 598,274 — Right of use liability 455,380 — Change in fair value of debt 405,804 — Change in fair value of investments — 264,196 Net operating loss carryforwards 21,470 167,554 5,703,882 541,652 Less: valuation allowance — — Deferred tax assets 5,703,882 541,652 Deferred tax liabilities: Basis difference in intangible assets (7,480,659) — Change in fair value of life insurance policies (policies held at fair value method) (4,318,194) (1,454,588) Basis difference in investments (2,398,987) — Change in fair value of debt — (450,884) Other (705,133) — Deferred tax liabilities (14,902,973) (1,905,472) Net deferred tax liability $ (9,199,091) $ (1,363,820) The components of the Company’s net deferred tax assets are subject to realizability analysis in accordance with ASC 740, Income Taxes . Based on this analysis, the Company determined that sufficient positive evidence existed at December 31, 2023 and 2022 to support not recording a valuation allowance recorded against net operating loss tax attributes. The Company has $84,709 of Federal Net Operating Losses and $84,709 State Net Operating Losses that can be carried forward indefinitely. The Federal Net Operating Losses may be used to offset 80% of taxable income in a given year. The Company did not have any unrecognized tax benefits relating to uncertain tax positions at December 31, 2023 and 2022 and did not recognize any interest or penalties related to uncertain tax position at December 31, 2023 and 2022 . The Company does not anticipate that changes in its unrecognized tax benefits will have a material impact on the consolidated statements of operations and comprehensive income during 2024 . The Company’s tax returns are subject to examination by relevant taxing authorities. None of the Company’s tax returns are under audit. As of December 31, 2023, tax years for 2020, 2021, and 2022 are subject to examination by the relevant tax authorities.

RELATED-PARTY TRANSACTIONS

RELATED-PARTY TRANSACTIONS	12 Months Ended
RELATED-PARTY TRANSACTIONS	Dec. 31, 2023
Related Party Transactions [Abstract]
RELATED-PARTY TRANSACTIONS	RELATED-PARTY TRANSACTIONS As of December 31, 2023 and 2022, $5,236 and $263,785, respectively, were due to former members and affiliates primarily for reimbursable transaction costs as well as distributions to former members of $1,159,712 as a part of the Business Combination as of December 31, 2023. As of December 31, 2023 and 2022, $1,007,528 and $2,904,646, respectively, was due from affiliates, respectively. The majority of the due from affiliate amount as of December 31, 2022 represents transaction costs incurred by the Company related to the planned business combination in which ERES had committed to reimburse the Company upon the consummation of the merger. The SPV Purchase and Sale Note of $25,000,000 was recorded as a related party transaction due to transfers of cash and policies between the Company and the SPV, which is jointly owned by the Sponsor and former members of LMA and Abacus. Also, the Sponsor PIK Note for $10,471,648 is also recorded as a related party transaction due to the relationship between the Sponsor and the Company. Refer to Note 13, Long-Term Debt, for more information. The Company has a related-party relationship with Nova Trading (US), LLC (“Nova Trading”), a Delaware limited liability company and Nova Holding (US) LP, a Delaware limited partnership (“Nova Holding” and collectively with Nova Trading, the “Nova Funds”). The Company also earns service revenue related to policy and administrative services on behalf of Nova Funds. The servicing fee is equal to 50 basis points (0.50%) times the monthly invested amount in policies held by Nova Funds divided by 12. The Company earned $778,678 and $818,300 in service revenue related to Nova Funds for the years ended December 31, 2023 and 2022, respectively. As of December 31, 2023, and 2022, there were $79,509 and $196,289, respectively owed from the Nova Funds, which are included as related-party receivables in the accompanying consolidated balance sheets. The Company also originates policies for the Nova Funds. For its origination services to the Nova Funds, the Company earns origination fees equal to the lesser of (i) 2% of the net death benefit for the policy or (ii) $20,000. In addition to the Nova Funds, the Company also has other affiliated investors that provide origination services. For the year ended December 31, 2022, the Company did not earn any related party origination revenue for the Nova Funds. For the year ended December 31, 2023, revenue earned, and contracts originated are below. Year Ended December 31, 2023 Origination fee revenue $ 259,517 Transaction reimbursement revenue 235,455 Total $ 494,972 Cost $ 99,456 Face value $ 46,650,000 Total policies 7 Average Age 70

LEASES

LEASES	12 Months Ended
LEASES	Dec. 31, 2023
Leases [Abstract]
LEASES	LEASES During 2023, the Company amended the lease with the lessor to swap office spaces, increase square footage, and extend the lease term from July 31, 2023 to December 31, 2029. The Company applied the lease modification guidance to account for the amendment to the lease. The commencement date for the amended lease was December 8, 2023, the date the lessor allowed the Company to take possession of the space. The amended lease provided for a leasehold improvement allowance, a monthly lease abatement from August to December 2024, and an option terminate. The Company remeasured the ROU assets and the lease liabilities as of the commencement date. The Company determined that the termination option is not reasonably certain of exercise based on an evaluation of the contract, the termination fee, market and asset-based factors, and therefore does not exclude periods covered by the termination option. The Company’s right-of-use assets and lease liabilities for its operating lease consisted of the following amounts as of December 31, 2023 and 2022: As of December 31, Assets: 2023 2022 Operating lease right-of-use assets $ 1,893,659 $ 77,011 Liabilities: Operating lease liability, current 118,058 48,127 Operating lease liability, non-current 1,796,727 29,268 Total lease liability $ 1,914,785 $ 77,395 The Company recognizes lease expense for its operating leases within general, administrative, and other expenses on the Company’s consolidated statements of operations and comprehensive income. The Company’s lease expense for the periods presented consisted of the following: Years Ended December 31, 2023 2022 Operating lease cost $ 207,508 $ 48,784 Variable lease cost 16,103 3,664 Total lease cost $ 223,611 $ 52,448 The following table shows supplemental cash flow information related to lease activities for the periods presented: Years Ended December 31, 2023 2022 Cash paid for amounts included in the measurement of the lease liability Operating cash outflows for operating leases $ 201,200 $ 48,399 ROU assets obtained in exchange for new lease liabilities 1,782,726 — The table below shows a weighted-average analysis for lease terms and discount rates for all operating leases for the periods presented: Years Ended December 31, 2023 2022 Weighted-average remaining lease term (in years) 6.01 1.58 Weighted-average discount rate 9.67 % 3.36 % Future minimum noncancellable lease payments under the Company’s operating leases on an undiscounted basis reconciled to the respective lease liability at December 31, 2023 are as follows: Operating leases 2024 $ 118,058 2025 471,239 2026 485402 2027 499,980 2028 514,946 Thereafter 530,391 Total operating lease payments (undiscounted) 2,620,016 Less: Imputed interest (705,231) Lease liability as of December 31, 2023 $ 1,914,785

EARNINGS PER SHARE

EARNINGS PER SHARE	12 Months Ended
EARNINGS PER SHARE	Dec. 31, 2023
Earnings Per Share [Abstract]
EARNINGS PER SHARE	EARNINGS PER SHARE Basic earnings per share represents income available to ordinary stockholders divided by the weighted average number of common stock outstanding during the reported period. Treasury stock is excluded from the weighted average number of shares of common stock outstanding. During 2023, we repurchased 146,650 shares of our common stock. Net income per ordinary share is computed by dividing net income by the weighted-average number of ordinary shares outstanding during the period. The Company has not considered the effect of the Public and Private Placement Warrants to purchase an aggregate of 26,150,000 shares in the calculation of diluted income per ordinary share, since the average market price of the Company’s Class A common stock for the year ended December 31, 2023 was below the warrants’ $11.50 exercise price. We compute diluted earnings per share using the weighted average number of common shares outstanding plus the dilutive effect of outstanding RSUs computed using the treasury stock method. Basic and diluted weighted average shares outstanding and earnings per share were as follows: For Years Ended December 31, 2023 2022 Net income attributable to common stockholders (same for diluted earnings per share) $ 9,516,626 $ 31,682,275 Weighted-average common shares outstanding for basic earnings per share 56,951,414 50,369,350 Restricted stock units 816,484 — Shares used for diluted earnings per share 57,767,898 50,369,350 Earnings per share: Basic earnings per share $ 0.17 $ 0.63 Diluted earnings per share $ 0.16 $ 0.63

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	12 Months Ended
SUBSEQUENT EVENTS	Dec. 31, 2023
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	SUBSEQUENT EVENTS The Company evaluated subsequent events and transactions from the consolidated balance sheet date through the date at which the consolidated financial statements were issued. Fixed Rate Senior Unsecured Notes On February 15, 2024 , the Company issued an additional $25,000,000 as part of the previously issued Fixed Unsecured Notes. The net proceeds, after related debt issue costs, were used by the Company for general corporate purposes. The Fixed Rate Senior Unsecured Notes are based on a fixed interest rate of 9.875% to be paid in quarterly interest payments beginning on May 15, 2024 and mature on November 15, 2028. Conversion of Public Warrants —On January 18, 2024, the Company’s share price reached the warrant exercise price of $11.50. Certain public warrant holders redeemed their warrants for the Company’s common stock. As of March 15, 2024, the Company received $3,506,753 from 304,935 exercised public warrants. LMA Income Series II, LP and LMA Income Series II, GP LLC Secured Borrowin g—Subsequent to year end, LMA Income Series II, GP, LLC through the LMA Income Series II, LP admitted additional limited partners into the fund. The additional limited partnership interests amounted to $18,042,641 as of March 20, 2024. LMA Income Series II, GP plans to continue admitting new limited partners throughout 2024 and beyond. In addition to new partnership interests, an amendment to the limited partnership was signed to add redemption opportunities for limited partners and extend the maturity date of the fund. The first redemption date changed to March 31, 2026, but limited partners can elect to stay in the fund at the same terms prior to the amendment. If a limited partners elect to stay invested, the next redemption date would be June 30, 2027 with a final maturity date of December 31, 2028.

Abacus Settlements LLC - DESCRI

Abacus Settlements LLC - DESCRIPTION OF THE BUSINESS	12 Months Ended
Abacus Settlements LLC - DESCRIPTION OF THE BUSINESS	Dec. 31, 2023
Subsidiary of Limited Liability Company or Limited Partnership [Line Items]
DESCRIPTION OF THE BUSINESS	DESCRIPTION OF BUSINESS Organization and Merger Abacus Life, Inc. (the “Company”) was formerly known as East Resources Acquisition Company ("ERES”), a blank check company incorporated in Delaware on May 22, 2020. Abacus Life, Inc. conducts its business through its wholly-owned, consolidated subsidiaries, primarily Abacus Settlements, LLC (“Abacus Settlements”, or “Abacus”) and Longevity Market Assets, LLC (“LMA”), which are Delaware limited liability companies (collectively, the “Companies”). On June 30, 2023, (the “Closing Date”), ERES, LMA and Abacus consummated the combining of the Companies as contemplated by the Merger Agreement dated as of August 30, 2022 (as amended on October 14, 2022 and April 20, 2023) with LMA Merger Sub, LLC, a wholly owned subsidiary of ERES (“LMA Merger Sub”), Abacus Merger Sub, LLC, a wholly owned subsidiary of ERES (“Abacus Merger Sub”), LMA and Abacus (together with LMA, the “Legacy Companies”). Pursuant to the Merger Agreement, on June 30, 2023, (i) LMA Merger Sub merged with and into LMA, with LMA surviving such merger (the “LMA Merger”) and (ii) Abacus Merger Sub merged with and into Abacus, with Abacus surviving such merger (the “Abacus Merger” and, together with the LMA Merger, the “Mergers” and, along with the other transactions contemplated by the Merger Agreement, the “Business Combination”) and the Legacy Companies became direct wholly owned subsidiaries of the Company. On the Closing Date, ERES changed its name to Abacus Life, Inc. The consolidated assets, liabilities and statements of operations and comprehensive income prior to the Business Combination are those of legacy LMA. The shares of common stock and corresponding capital amounts and income per share, prior to the Business Combination, have been retroactively restated based on share reflecting the exchange ratio established in the Business Combination. The equity structure has been recast in all comparative periods up to the Closing Date to reflect the number of shares of the Company’s common stock, $0.0001 par value per share, issued to legacy LMA’s stockholders in connection with the Business Combination. As such, the shares and corresponding capital amounts and income per share related to legacy LMA common stock prior to the Business Combination have been retroactively recast as shares reflecting the exchange ratio of 0.8 established in the Business Combination. Business Activity The Company, through its LMA subsidiary, is a provider of services pertaining to life insurance settlements and offers policy servicing to owners and purchasers of life settlement assets, as well as consulting, valuation, and actuarial services. The Company is also engaged in buying and selling of life settlement policies in which it uses its own capital, and purchases life settlement contracts with the intent to either hold to maturity to receive the associated death claim payout or to sell to another purchaser of life settlement contracts for a gain on the sale. The Company, through its Abacus subsidiary, also is an originator of outstanding life insurance policies as a licensed life settlement provider on behalf of investors (“Financing Entities”). Abacus locates and screens policies for eligibility as a commercially desirable life settlement, including verifying that the policy is in force, obtaining consents and disclosures, and submitting cases for life expectancy estimates, also known, collectively, as origination services. When the sale of a policy is completed, this is deemed “settled” and the policy is then referred to as either a “life settlement” in which the insured’s life expectancy is greater than two years or “viatical settlement,” in which the insured’s life expectancy is less than two years. The Company is not an insurance company, and therefore the Company does not underwrite insurable risks for its own account.
Abacus Settlements, LLC
Subsidiary of Limited Liability Company or Limited Partnership [Line Items]
DESCRIPTION OF THE BUSINESS	DESCRIPTION OF THE BUSINESS Abacus Settlements, LLC d/b/a Abacus Life (“Abacus”) was formed in 2004 in the state of New York. In 2016, the Company obtained its licensure in Florida and re-domesticated to that state. On June 13, 2023, the Company re-domesticated to Delaware. Abacus acts as a purchaser of outstanding life insurance policies (“Provider”) on behalf of investors (“Financing Entities”) by locating policies and screening them for eligibility for a life settlement, including verifying that the policy is in force, obtaining consents and disclosures, and submitting cases for life expectancy estimates, also known as origination services. When the sale of a policy is completed, this is deemed “settled” and the policy is then referred to as either a “life settlement” in which the insured’s life expectancy is greater than two years or “viatical settlement,” in which the insured’s life expectancy is less than two years. Abacus is not an insurance company, and therefore Abacus does not underwrite insurable risks for its own account. On August 30, 2022, Abacus entered into an Agreement and Plan of Merger (the “Merger Agreement”) with East Resources Acquisition Company (“ERES”), which was subsequently amended on October 14, 2022. As part of the Merger Agreement, the holders of Abacus’ common units together with the holders of Longevity Markets Assets, LLC (“LMA”), a commonly owned affiliate, will receive aggregate consideration of $531,750,000, payable in a number of newly issued shares of ERES Class A common stock, par value $0.0001 per share (“ERES Class A common stock”), with a value ascribed to each share of ERES Class A common stock of $10.00 and, to the extent the aggregate transaction proceeds exceed $200.0 million, at the election of Abacus’ and LMA’s members, up to $20.0 million of the aggregate consideration will be payable in cash to the Abacus’ and LMA’s members. The transaction closed on June 30, 2023 upon stockholder approval and customary closing conditions.

Abacus Settlements LLC - SUMMAR

Abacus Settlements LLC - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	12 Months Ended
	Dec. 31, 2023
Subsidiary of Limited Liability Company or Limited Partnership [Line Items]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation —In connection with the Business Combination, the Merger is accounted for as a reverse recapitalization with ERES in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”). Under U.S. GAAP, ERES has been treated as the “acquired” company for financial reporting purposes. This determination was primarily based on the LMA stockholders having a relative majority of the voting power of the Company, the LMA stockholders having the authority to appoint a majority of directors on the Board of Directors, and senior management of LMA comprising the majority of the senior management of the post-combination Company. LMA was then determined to be the “acquirer” for financial reporting purposes based on the relative size of LMA as compared to Abacus, represented by their revenue, equity, gross profit and net income. Accordingly, for accounting purposes, the financial statements of the combined entity represents a continuation of the financial statements of LMA with the LMA Merger treated as the equivalent of LMA issuing stock for the net assets of ERES, accompanied by a recapitalization. The net assets of ERES are stated at historical cost, with no goodwill or other intangible assets recorded. The Abacus Merger has been accounted for using the acquisition method of accounting. Under the acquisition method of accounting, the assets and liabilities of Abacus were recorded at the fair value as of the acquisition date. The excess of the purchase price over the estimated fair values of the net assets acquired was recognized as goodwill. As a result of the Business Combination, the Company evaluated if ERES, Abacus, or LMA is the predecessor for accounting purposes. In considering the foregoing principles of predecessor determination and in light of the Company's specific facts and circumstances, management determined that LMA and Abacus are dual predecessors for accounting purposes. The financial statement presentation for Abacus Life, Inc. includes the purchase accounting effects of the Abacus Merger as of the Closing Date with the financial statements of LMA as the comparative period. The predecessor financial statements for Abacus are included separately within this report. The accompanying consolidated financial statements of the Company have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission and are prepared in accordance with U.S. GAAP. Consolidation of Variable Interest Entities —For entities in which the Company has variable interests, the Company first evaluates whether the entity meets the definition of a variable interest entity (“VIE”) or a voting interest entity (“VOE”). If the entity is a VIE, the Company focuses on identifying whether it has the power to direct the activities that most significantly impact the VIE’s economic performance and whether it has the obligation to absorb losses or the right to receive benefits from the VIE. If the Company is the primary beneficiary of a VIE, the assets, liabilities, and results of operations of the VIE will be included in the Company’s condensed consolidated financial statements. The proportionate share not owned by the Company is recognized as noncontrolling interest and net income attributable to noncontrolling interest on the condensed consolidated balance sheets and condensed consolidated statements of operations and comprehensive income, respectively. If the entity is a VOE, the Company evaluates whether it has the power to control the VOE through a majority voting interest or through other arrangements. Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 810, Consolidations , (“ASC 810”) requires the Company to separately disclose on its consolidated balance sheets the assets of consolidated VIEs and liabilities of consolidated VIEs as to which there is no recourse against the Company. As of December 31, 2023, total assets and liabilities of consolidated VIEs were $77,132,592 and $65,031,207, respectively. As of December 31, 2022, total assets and liabilities of consolidated VIEs were $30,073,972 and $27,116,762, respectively. On October 4, 2021, the Company entered into an operating agreement with LMX Series, LLC (“LMX”) and three other unaffiliated investors to obtain a 70% ownership interest in LMX, which was newly formed in August 2021. LMX had no operating activity prior to the operating agreement being signed. LMX has a wholly owned subsidiary, LMATT Series 2024, Inc., a Delaware C corporation. While the Company and three other investors each contributed $100 to LMX, the Company directs the most significant activities by managing the investment offerings, and sponsoring and creating structured investment grade insurance liabilities, and thus was provided a 70% ownership interest. LMX is a VIE and the Company is the primary beneficiary of LMX. The Company has included the results of LMX and its subsidiaries in its consolidated financial statements for the year ended December 31, 2023. On November 30, 2022, LMA Series, LLC, a wholly owned subsidiary of the Company, signed an Operating Agreement to be the sole member of a newly created general partnership, LMA Income Series, GP, LLC. Subsequent to that, LMA Income Series, GP, LLC formed a limited partnership, LMA Income Series, LP and issued partnership interests to limited partners in a private placement offering. It was determined that LMA Series, LLC is the primary beneficiary of LMA Income Series, LP and thus has fully consolidated the limited partnership in its consolidated financial statements for the year ended December 31, 2023. On January 31, 2023, LMA Series, LLC, a wholly owned subsidiary of the Company, signed an Operating Agreement to be the sole member of a newly created general partnership, LMA Income Series II, GP, LLC. Subsequent to that, LMA Income Series II, GP, LLC formed a limited partnership, LMA Income Series II, LP and issued partnership interests to limited partners in a private placement offering. It was determined that LMA Series, LLC is the primary beneficiary of LMA Income Series II, LP and thus has fully consolidated the limited partnership in its consolidated financial statements for the year ended December 31, 2023. Non-Consolidation of Variable Interest Entities —On January 1, 2021, the Company entered into an option agreement with two commonly owned full-service origination, servicing, and investment providers (the “Providers”), in which the Company agreed to fund certain capital needs with an option to purchase the outstanding equity ownership of the Providers (the “Option Agreement”). The Company accounted for its investment in the call options under the Option Agreement as an equity security, pursuant to ASC 321, Investments—Equity Securities . In arriving at this accounting conclusion, the Company first considered whether the call options met the definition of a derivative pursuant to ASC 815, Derivatives and Hedging , and concluded that the options do not provide for net settlement and accordingly are not a derivative. The Company also concluded that the call options do not provide the Company with a controlling financial interest in the legal entity pursuant to ASC 810. The call options include material contingencies prior to exercisability that the Company does not anticipate will be resolved; additionally, the call options are in a legal entity for which the stock price has no readily determinable fair value. The Company’s basis in the call options, pursuant to ASC 321, is zero and accordingly the call options are not reflected in the statement of financial position. The Company provided $144,721 of working capital funding for the year ended December 31, 2023 which is included in other (expense) income on the consolidated statements of operations and comprehensive income and $347,013 of funding for the year ended December 31, 2022. See Note 11, Commitments and Contingencies, for further details. For the years ended December 31, 2023, and 2022, the Providers were considered to be VIEs, but were not consolidated in the Company’s consolidated financial statements due to a lack of the power criterion or the losses/benefits criterion. As of December 31, 2023, the unaudited financial information for the unconsolidated VIEs are as follows: held assets of $601,762 and liabilities of $2,900. As of December 31, 2022, the unaudited financial information for the unconsolidated VIEs are as follows: held assets of $987,964 and liabilities of $358,586. Noncontrolling Interest —Noncontrolling interest represents the share of consolidated entities owned by third parties. At the date of formation or upon acquisition, the Company recognizes noncontrolling interest on the consolidated balance sheets at an amount equal to the noncontrolling interest’s proportionate share of the relative fair value of any assets and liabilities acquired. Noncontrolling interest is subsequently adjusted for the noncontrolling stockholder’s additional contributions, distributions, and the stockholder’s share of the net earnings or losses of each respective consolidated entity. Net income of a consolidated entity is allocated to noncontrolling interests based on the noncontrolling stockholder’s ownership interest during the period. The net income or loss that is not attributable to the Company is reflected in net income (loss) attributable to noncontrolling interests in the consolidated statements of operations and comprehensive income. Use of Estimates —The preparation of U.S. GAAP financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and changes therein, disclosure of contingent assets and liabilities at the date of financial statements, and the reported amounts of revenue and expenses during the reporting periods. Company’s estimates, judgments, and assumptions are continually evaluated based on available information and experience. Because of the use of estimates inherent in the financial reporting process, actual results could differ from the estimates. Estimates are used when accounting for purchase price allocation, the selection of useful lives of property and equipment, valuation of other receivables, valuation of life settlement policies, valuation of other investments and available-for-sale securities, valuation of long-term debt, impairment testing, income taxes, and legal reserves. Life Settlement Policies —The Company accounts for its holdings of life insurance settlement policies in accordance with ASC 325-30, Investments in Insurance Contracts . For all policies purchased after June 30, 2023, the Company accounts for these under the fair value method. For policies purchased before June 30, 2023, the Company elected to use either the fair value method or the investment method (cost, plus premiums paid). The valuation method is chosen upon contract acquisition and is irrevocable. The Company follows ASC 820, Fair Value Measurements and Disclosures , in estimating the fair value of its life insurance policies held at fair value. ASC 820 defines fair value as an exit price representing the amount that would be received if an asset were sold or that would be paid to transfer a liability in an orderly transaction between market participants at the measurement date. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. The Company’s valuation of life settlements is considered to be Level 3. The Company’s valuation model incorporates significant inputs that are not observable and reflect our assumptions about what factors market participants would use in pricing life settlement policies. We develop our inputs based on the best information available to us, including our own data. We believe that our model would be reasonably comparable to a model that an independent third-party would use. Refer to Note 12, Fair Value Measurements, for further details. For policies held at fair value, changes in fair value are reflected in the consolidated statement of operations and comprehensive income under active management revenue in the period the change is calculated. For policies held under the investment method, the Company tests the impairment if we become aware of information indicating that the carrying value plus undiscounted future premiums of a policy may not be recoverable. This information is gathered initially through extensive underwriting procedures at purchase of the settlement contract, as well as through periodic underwriting review that includes medical reports and life expectancy evaluations. The policies held by the Company using the investment method are expected to be owned for a shorter-term, and are actively marketed to potential buyers. The market feedback received through these interactions provides the Company with information related to a potential impairment. If a policy is determined to be impaired, the Company will adjust the carrying value to the fair value determined through the impairment analysis. The Company accounts for cash proceeds from sale and maturity of life insurance settlement policies, as well as cash outflows for premium payments, as operating activities within the consolidated statements of cash flows. Going Concern —Management evaluates at each annual and interim period whether there are conditions or events, considered in the aggregate, that raise substantial doubt about Company’s ability to continue as a going concern within one year after the date that the consolidated financial statements are issued. Management’s evaluation is based on relevant conditions and events that are known and reasonably knowable at the date that the consolidated financial statements are issued. Management has concluded that there are no conditions or events, considered in the aggregate, that raise substantial doubt about Company’s ability to continue as a going concern within one year after the date these consolidated financial statements were issued. Cash and Cash Equivalents —Cash and cash equivalents include short-term and all highly‐liquid debt instruments purchased with an original maturity of three months or less. Fair Value Measurements —The following fair value hierarchy is used in selecting inputs for those assets and liabilities measured at fair value that distinguishes between assumptions based on market data (observable inputs) and the Company’s assumptions (unobservable inputs). The Company evaluates these inputs and recognizes transfers between levels, if any, at the end of each reporting period. The hierarchy consists of three levels: Level 1 —Valuation based on quoted market prices in active markets for identical assets or liabilities that we have the ability to access at the measurement date. Level 2 —Valuation based on inputs other than Level 1 inputs that are observable for the assets or liabilities either directly or indirectly. Level 3 —Valuation based on inputs that reflect our assumptions about what factors market participants would use in pricing the asset or liability. The inputs are developed based on the best available information, including our own data. The Company’s financial instruments consist of cash, cash equivalents, accounts receivables, due to affiliates, equity investments in privately held companies, S&P options, life settlement policies, available for sale securities, market-indexed debt and secured borrowings. Cash, cash equivalents, accounts receivables, and due to affiliates are stated at their carrying value, which approximates fair value due to the short time to the expected receipt or payment date. Equity investments in privately held companies without readily determinable fair values are recognized at fair value on a nonrecurring basis when observable price changes from orderly transactions for identical or similar investments become available. Available-for-sale securities are measured at fair value using inputs that are not readily determinable. Unrealized holding gains and losses are excluded from earnings and reported in other comprehensive income until realized. S&P options are recognized at fair value using quoted market prices in active markets, with changes in fair value included in net income. Market-indexed debt is measured on a quarterly basis, with qualifying changes in fair value recognized in net income, except for the portion of the total change in the fair value of the liability that results from a change in the instrument-specific credit risk, which is separately included in other comprehensive income in accordance with ASC 825-10-45-5. The measurement approach for life settlement policies is included above within the Life Settlement Policies disclosure. Accounts Receivable, Related Party —Related party receivable are amounts owed to the Company by related party customers for services delivered. Management regularly reviews customer accounts for collectability and will record an allowance for these accounts when deemed necessary. Management determines the allowance for credit losses based on a review of outstanding receivables, historical collection experience, current economic conditions, and reasonable and supportable forecasts. Related party receivables are charged off against the allowance for credit losses when deemed uncollectible (after all means of collection have been exhausted and the potential for recovery is deemed remote). Recoveries of related party receivables previously written off are recorded when received. Due to the nature of operations, related party receivables are due primarily from parties which the Company serves. As a result, management deems all amounts due to be collectable. If the financial condition of the Company’s related party customers were to deteriorate, resulting in an impairment of their ability to make payments, additional allowances may be required. The Company did not record material allowance for credit losses as of December 31, 2023 and 2022, respectively. Other Investments —Equity investments without readily determinable fair values include the Company’s investments in privately-held companies in which the Company holds less than a 20% ownership interest and does not have the ability to exercise significant influence. The Company measures these investments at cost, and these investments are adjusted through net earnings when they are deemed to be impaired or when there is an adjustment from observable price changes (referred to as the “measurement alternative”). These investments are included in other investments on the financial statements, at cost on the consolidated balance sheets. In addition, the Company monitors these investments to determine if impairment charges are required based primarily on the financial condition and near-term prospects of these companies Available-for-sale Securities, at Fair Value —The Company has investments in securities that are classified as available-for-sale securities, and which are reflected on the consolidated balance sheets at fair value. These securities solely consist of a convertible promissory note in a private company that was entered into at arms-length. The Company determines the fair value using unobservable inputs by considering the initial investment value, next round financing, and the likelihood of conversion or settlement based on the contractual terms in the agreement. If any unrealized gains and losses on these investments are incurred, these would be included as a separate component of accumulated other comprehensive loss, net of tax, on the consolidated balance sheets. The Company classifies its available-for-sale securities as short-term or long-term based on the nature of the investment, its maturity date and its availability for use in current operations. The Company monitors if the fair value of the securities falls below the amortized cost basis. Credit losses identified are reflected in the allowance for credit losses and any credit losses reversed are recognized in earnings. As of December 31, 2023 and 2022, the fair value of the securities were determined to materially approximate amortized cost basis, thus no unrealized gains or losses were recorded. The Company did not record any allowance for credit losses. The Company writes off uncollectible accrued interest receivable balances in a timely manner. The Company recorded $105,935 and $— of accrued interest on its available-for-sale securities Equity Securities, at Fair Value —The equity securities, at fair value balance consists of S&P 500 put and call options that were purchased through a broker as an economic hedge related to the market-indexed instruments that are included in Long-Term Debt. The Company records these options at fair value and recognizes changes in fair value as part of net income. Property and Equipment, Net —Property and equipment are stated at cost less accumulated depreciation and are depreciated on a straight-line basis over the following estimated useful lives: Estimated Useful Life Computer equipment 5 years Furniture and fixtures 5 years Leasehold improvements Shorter of remaining lease term or estimated useful life Costs incurred for maintenance and repairs that do not extend the useful lives of property and equipment are expensed as incurred. Upon retirement or sale of assets, the cost and related accumulated depreciation are written off and any resulting gain or loss is reflected in the accompanying consolidated statements of operations and comprehensive income. Property and equipment are tested for recoverability whenever events or changes in circumstance indicate that their carrying amounts may not be recoverable. An impairment loss is recognized if the carrying amount of property and equipment is not recoverable and exceeds its fair value. Recoverability is determined based on the undiscounted cash flows expected to result from the use and eventual disposition of the asset or asset group. There were no impairments recognized during the years ended December 31, 2023 and 2022, respectively. Property and equipment to be disposed of are reported at the lower of carrying amount or fair value less cost to sell. Goodwill and Intangible Assets, Net —Goodwill and intangible assets are recorded as a result of the Business Combination. Goodwill represents the excess of the purchase price over the fair value of the assets acquired and liabilities assumed. The Company amortizes identifiable intangible assets with a finite useful life over the period that the intangible asset is expected to contribute directly or indirectly to its future cash flows; however, it does not amortize indefinite lived intangible assets. The Company evaluates goodwill and indefinite intangible assets for recoverability annually in the fourth quarter or on an interim basis should events or changes in circumstances indicate that a carrying amount may not be recoverable. To test for impairment, a qualitative assessment is performed to determine if it is more likely-than-not that the fair value of a reporting unit is less than its carrying value, including goodwill. This initial assessment includes, among other factors, consideration of: (i) past, current and projected future earnings and equity; (ii) recent trends and market conditions; and (iii) valuation metrics involving similar companies that are publicly traded and acquisitions of similar companies, if available. If the more likely-than-not threshold is met, a quantitative impairment test is performed by comparing the estimated fair value with the carrying value. If the carrying value of the net assets associated with the reporting unit exceeds the fair value of the reporting unit, goodwill is considered impaired and will be determined as the amount by which the reporting unit’s carrying value exceeds its fair value, not to exceed the carrying amount of goodwill. The Company’s reporting units are at the operating segment level; each operating segment represents a business and discrete financial information is available and reviewed regularly by management. Determining the fair value of its reporting units is subjective in nature and involves the use of significant estimates and assumptions, including projected net cash flows, discount and long-term growth rates. The Company determines the fair value of its reporting units based on an income approach and market approach, whereby the fair value of the reporting unit is derived from the present value of estimated future cash flows associated with the reporting unit. The assumptions about estimated cash flows include factors such as future premiums, loss and expenses, general and administrative expenses and industry trends. The Company considers historical rates and current market conditions when determining the discount and long-term growth rates to use in its analysis. The Company considers other valuation methods if the facts and circumstances indicate these methods provide a more representative approximation of fair value. Changes in these estimates based on evolving economic conditions or business strategies could result in material impairment charges in future periods. The Company bases its fair value estimates on assumptions it believes to be reasonable. Actual results may differ from those estimates. As of December 31, 2023, there were no events or changes in circumstances that indicated that a carrying amount of goodwill or intangible asset may not be recoverable. The company has insignificant internal-use software accounted under ASC 350-40, Internal-Use Software . The software is amortized on the straight-line basis over an estimated useful life of 3 years. Refer Note 6, Goodwill and Other Intangible Assets, for additional information on goodwill and intangible assets. Revenue Recognition —The Company generally derives its revenue from life settlement servicing and consulting activities (Portfolio Servicing Revenue), life settlement trading activities (Active Management Revenue) and fees, commissions (Origination Services). Portfolio Servicing Revenue — Portfolio servicing is comprised of servicing activities and consulting activities. The Company enters into service agreements with the owners of life settlement contracts and is responsible for maintaining the policy, manages processing of claims in the event of death of the insured and ensuring timely payment of optimized premiums computed to derive maximum return on maturity of the policy. The company neither assumes the ownership of the contracts nor undertakes the responsibility to make the premium payments, which remains with the owner of the policy. These service arrangements have contractual terms typically ranging from one-month to ten years and include fixed charges within its contracts as part of the total transaction price which are recognized on gross basis. To the extent that variable consideration is not constrained, the Company includes an estimate of the variable amount, as appropriate, within the total transaction price and updates its assumptions over the duration of the contract. Variable consideration has not been material. The duties performed by the Company under these arrangements are considered as a single performance obligation that is satisfied on a monthly basis as the customer simultaneously receives and consumes the benefit provided by the Company as the Company performs the service. As such, revenue is recognized for services provided for the corresponding month. Under consulting engagements, the Company provides services typically for the owners of life settlement contracts who are often customers of the servicing business line, or customers of Abacus. These consulting engagements are comprised of valuation, actuarial services, and overall policy assessments related life settlement contracts and are short-term in nature. The performance obligations are typically identified as separate services with a specific deliverable or a group of deliverables to be provided in tandem, as agreed to in the engagement letter or contract. Each service provided under a contract is considered as a performance obligation and revenue is recognized at a point in time when the deliverable or group of deliverables is transferred to the customer. Active Management Revenue — The Company also engages in buying and selling life settlement policies whereby each potential policy is independently researched to determine if it would be a profitable investment. Some of the policies are purchased with the intent to hold to maturity, while others are held for trading to be sold for a gain. The Company elects to account for each investment in life settlement contracts using either the investment method or the fair value method. Once the accounting method is elected for each policy, it cannot be changed. Under the investment method, investments in contracts are based on the initial investment at the purchase price plus all initial direct costs. Continuing costs (e.g., policy premiums, statutory interest and direct external costs, if any) to keep the policy in force are capitalized. Under the fair value method, the company will record the initial investment of the transaction price and remeasures the investment at fair value at each subsequent reporting period. Changes in fair value are reported on earnings when they occur. Upon sale of a life settlement contract, the company will record revenue (gain/loss) for the difference between the agreed-upon purchase price with the buyer, and the carrying value of the contract. Originations Revenue — The Company through its Abacus subsidiary, recognizes revenue from origination activities by acting as a provider of life settlements and viatical settlements representing investors that are interested in purchasing life settlements on the secondary or tertiary market. Revenue from origination services consists of fees negotiated for each purchase and sale of a policy to an investor, which also include any agent and broker commissions received and the reimbursement of transaction costs. See below for revenue disaggregation based upon the source of the policy. The Company originates life settlements policies with third parties that include settlement brokers, life insurance agents, and direct consumers or policyholders. The Company then provides the administration services needed to initiate the transfer of the life settlement policies to investors in exchange for an origination fee. Such transactions are entirely performed through an escrow agent. In these arrangements, the customer is the investor, and the Company has a single performance obligation to originate a life settlement policy for the investor. The consideration transferred upon each policy is negotiated directly with the investor by the Company and is dependent upon the policy death benefits held by each life settlement policy. The revenue is recognized when the performance obligation under the terms of the contracts with customers are satisfied. The Company recognizes revenue from life settlement transactions when the closing has occurred and any right of rescission under applicable state law has expired (i.e., the customer obtains control over the policy and has the right to use and obtain the benefits from the policy). While rescission periods may vary by state, most states grant the owner the right to rescind the contract before the earlier of 30 calendar days after the execution date of the contract or 15 calendar days after life settlement proceeds have been sent to the owner. Purchase and sale of the policies generally occurs simultaneously, and only the fees received, including any agent and broker commissions and transaction costs reimbursed, are recorded as gross revenue. For agent and broker commissions received and transaction costs reimbursed, the Company has determined that it is acting as the principal in the relationship as it maintains control of the services being performed as part of performance obligation prior to facilitating the transfer of the life settlement policy to the investor. While the origination fees are fixed amounts based on the face value of the policy death benefit, there is variable consideration present due to the owners rescission right. When variable consideration is present in a contract, the Company estimates the amount of variable consideration to which it expects to be entitled at contract inception and again at each reporting period until the amount is known. The entity applies the variable consideration c
Abacus Settlements, LLC
Subsidiary of Limited Liability Company or Limited Partnership [Line Items]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation —The accompanying condensed financial statements are presented in accordance with the rules and regulations of the Securities and Exchange Commission (“SEC”) and are prepared in accordance with generally accepted accounting principles in the United States of America (“US GAAP”). Use of Estimates —The preparation of US GAAP financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and changes therein, and disclosure of contingent assets and liabilities at the date of financial statements and the reports amounts of revenue and expenses during the reporting periods. Abacus’ estimates, judgments, and assumptions are continually evaluated based on available information and experience. Because of the use of estimates inherent in the financial reporting process, actual results could differ from the estimates. Estimates are used when accounting for revenue recognition and related costs, the selection of useful lives of property and equipment, impairment testing, valuation of other receivables from clients, income taxes, and legal reserves. Going Concern —Management evaluates at each annual and interim period whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date that the financial statements are issued. Management’s evaluation is based on relevant conditions and events that are known and reasonably knowable at the date that the financial statements are issued. Management has concluded that there are no conditions or events, considered in the aggregate, that raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date these financial statements were issued. Other receivables —Other receivables include origination fees for policies in which the rescission period has ended, but the funds have not been received yet from financing entities. These fees were collected in the subsequent month. Abacus provides an allowance for credit losses equal to the estimated collection losses that will be incurred in collection of all receivables. Management determines the allowance for credit losses based on a review of outstanding receivables, historical collection experience, current economic conditions, and reasonable and supportable forecasts. Account balances are charged off against the allowance for credit losses after all means of collection have been exhausted and the potential for recovery is deemed remote. Abacus does not have any material allowance for credit losses as of June 30, 2023 or December 31, 2022. If the financial condition of Abacus’ customers were to deteriorate, resulting in an impairment of their ability to make payments, additional allowances may be required. Abacus did not record material allowance for credit losses as of June 30, 2023, and December 31, 2022, respectively. Concentrations —All of Abacus’ revenues are derived from life settlement transactions in which Abacus represents Financing Entities that purchased existing life insurance policies. One financing entity, a company in which the Abacus’ members own interests, represented 23% and 60% of Abacus’ revenues in six months ended June 30, 2023 and year ended December 31, 2022, respectively. Abacus originates policies through three different channels: Direct to Consumer, Agent, and Broker. Two brokers represented the sellers for over 10% of Abacus’ life settlement commission expense during the period six months ended June 30, 2023. No single broker represented the sellers for over 10% of Abacus’ life settlement commission expense during the year ended December 31, 2022. Abacus maintains cash deposits with a major financial institution, which from time to time may exceed federally insured limits. Abacus periodically assesses the financial condition of the institution and believes that the risk of loss is minimal. Advertising

Abacus Settlements LLC - SEGMEN

Abacus Settlements LLC - SEGMENT REPORTING	12 Months Ended
Abacus Settlements LLC - SEGMENT REPORTING	Dec. 31, 2023
Subsidiary of Limited Liability Company or Limited Partnership [Line Items]
SEGMENT REPORTING	SEGMENT REPORTING Segment Information —The Business Combination that took place on June 30, 2023, where ERES, LMA and Abacus Settlements consummated the combining of the Companies, triggered a re-organization of Abacus Life Inc., where the legacy Abacus Settlements business and legacy LMA business would both operate under Abacus Life, Inc. subsequent to the Business Combination date. Abacus Settlement’s historically had one operating segment one reportable segment, Originations. LMA historically had two operating segments, (1) Portfolio Servicing and (2) Active Management. As the Business Combination did not occur until the last day of the second quarter, income activity related to Abacus Settlements had not yet been reported by Abacus Life, Inc. as the businesses did not begin operating as a combined Company until July 1, 2023. As such, beginning in the third quarter, the Company now organizes its business into three reportable segments (1) Portfolio Servicing, (2) Active Management and (3) Originations, which all generate revenue and incur expenses in different manners. This segment structure reflects the financial information and reports used by the Company’s management, specifically its chief operating decision maker (CODM), to make decisions regarding the Company’s business, including resource allocations and performance assessments, as well as the current operating focus in compliance with ASC 280, Segment Reporting . The Company’s CODM is the President and Chief Executive Officer. The Company’s reportable segments are not aggregated. The Portfolio Servicing segment generates revenues by providing policy services to customers on a contract basis. The Active Management segment generates revenues by buying, selling, and trading policies and maintaining policies until receipt of death benefits. The Originations segment generates revenue by originating life insurance policy settlements between investors or buyers, and the sellers, who is often the original policy owner. The policies are purchased from owners or other providers through advisors, brokers or directly through the owner. The Company’s method for measuring profitability on a reportable segment basis is gross profit. The CODM does not review disaggregated assets by segment. Revenue related to the Company’s reporting segments is as follows: Years Ended December 31, 2023 2022 Portfolio servicing $ 1,002,174 $ 1,470,972 Active management 61,195,377 43,242,580 Originations 19,247,972 — Segment revenue (including inter-segment) 81,445,523 44,713,552 Intersegment elimination (15,044,072) — Total revenue $ 66,401,451 $ 44,713,552 Information related to the Company’s reporting segments for the years ended December 31, 2023 and 2022 is as follows: Years Ended December 31, 2023 2022 Portfolio servicing $ 278,115 $ 300,235 Active management 59,020,991 38,528,648 Originations 611,968 — Total gross profit 59,911,074 38,828,883 Sales and marketing (4,905,747) (2,596,140) General, administrative and other (including stock-based compensation) (26,482,571) (1,426,865) Depreciation and amortization expense (3,409,928) (4,282) Other (expense) income (146,443) (347,013) Loss on change in fair value of warrant liability (4,204,360) — Interest expense (9,866,821) (42,798) Interest income 594,764 1,474 Gain (Loss) on change in fair value of debt (2,356,058) (90,719) Unrealized (loss) gain on investments 1,369,112 (1,045,623) Provision for income taxes (1,468,535) (889,943) Less: Net gain (loss) attributable to non-controlling interests 482,139 (704,699) Net income attributable to Abacus Life, Inc. $ 9,516,626 $ 31,682,275 Segment gross profit is defined as revenues less cost of revenue, excluding depreciation and amortization. Expenses below the gross profit line are not allocated across operating segments, as they relate primarily to the overall management of the consolidated entity. As of December 31, 2023 and 2022, our operations are confined to the United States.
Abacus Settlements, LLC
Subsidiary of Limited Liability Company or Limited Partnership [Line Items]
SEGMENT REPORTING	SEGMENT REPORTING

Abacus Settlements LLC - REVENU

Abacus Settlements LLC - REVENUE	12 Months Ended
Abacus Settlements LLC - REVENUE	Dec. 31, 2023
Abacus Settlements, LLC
Subsidiary of Limited Liability Company or Limited Partnership [Line Items]
REVENUE	REVENUE Disaggregated Revenue— The following table presents a disaggregation of Abacus’ revenue by major sources: Six Months Ended Year Ended December 31, 2023 2022 Agent $ 7,143,016 $ 12,156,552 Broker 4,675,973 9,938,808 Client direct 1,365,687 3,108,103 Total $ 13,184,676 $ 25,203,463

Abacus Settlements LLC - INCOME

Abacus Settlements LLC - INCOME TAXES	12 Months Ended
Abacus Settlements LLC - INCOME TAXES	Dec. 31, 2023
Subsidiary of Limited Liability Company or Limited Partnership [Line Items]
INCOME TAXES	INCOME TAXES Before June 30, 2023, the Company elected to file as an S corporation for Federal and state income tax purposes, as such, the Company incurred no Federal or state income taxes, except for income taxes related to their consolidated VIEs and subsidiaries which are taxable C corporations. These VIEs and subsidiaries include LMATT Series 2024, Inc., the wholly owned subsidiary of LMX, which is consolidated into LMA as a VIE, as well as LMATT Growth Series 2.2024, Inc., a wholly owned subsidiary of LMATT Growth Series, Inc., and LMATTS Growth and Income Series 1.2026, Inc., a wholly owned subsidiary of LMATT Growth and Income Series, Inc., all of which are 100% owned subsidiaries and fully consolidated. Accordingly, the provision for income taxes was attributable to amounts for LMATT Series 2024, Inc., LMATT Growth Series, Inc., and LMATT Growth and Income Series, Inc. For the years ended December 31, 2023 and 2022, the Company recorded provision for income taxes of $1,468,535 and $889,943, respectively. The effective tax rate is 14.0% for the year ended December 31, 2023. The existence of non-taxable flow-through entities within the Company as well as a change in tax status of certain entities upon the Business Combination caused the effective tax rate to vary from the statutory rate. The effective rate for the year ended December 31, 2022 was 2.7% due to the impact of state income taxes and the release of the Company’s valuation allowance, as there was sufficient evidence of the Company’s ability to generate future taxable income at December 31, 2022. The components of the provision for income taxes are as follows: For the Years Ended December 31, 2023 2022 Current provision: Federal $ 706,686 $ — State 195,679 — Foreign — — Total current tax 902,365 — Deferred provision: Federal 469,109 737,376 State 97,061 152,567 Foreign — — Total deferred tax 566,170 889,943 Provision for income taxes $ 1,468,535 $ 889,943 The Company did not have any unrecognized tax benefits relating to uncertain tax positions as of December 31, 2023, and 2022, and did not recognize any interest or penalties related to uncertain tax positions as of December 31, 2023, and 2022. The effective income tax rate differs from the federal statutory income tax rate applied to the profit loss before provision for income taxes due to the following: For the Years Ended December 31, 2023 2022 Income tax benefit computed at federal statutory rate $ 2,205,635 $ 6,988,538 Restricted stock award deductions limited by IRC 162(m) 2,069,993 — Change in tax status 1,414,469 — Effect of pass through entities and noncontrolling interests (3,812,977) (6,147,453) State income taxes, net of federal tax benefit (332,567) 174,024 Other (76,018) — Valuation allowance — (125,166) Income tax at effective rate $ 1,468,535 $ 889,943 The effects of temporary differences that give rise to significant components of deferred tax assets and liabilities at December 31, are as follows : 2023 2022 Deferred tax assets: Basis difference related to life insurance policy sales $ 1,798,639 $ 109,902 Warrant liability 1,683,658 — Interest expense carryforward 740,657 — Stock-based compensation 598,274 — Right of use liability 455,380 — Change in fair value of debt 405,804 — Change in fair value of investments — 264,196 Net operating loss carryforwards 21,470 167,554 5,703,882 541,652 Less: valuation allowance — — Deferred tax assets 5,703,882 541,652 Deferred tax liabilities: Basis difference in intangible assets (7,480,659) — Change in fair value of life insurance policies (policies held at fair value method) (4,318,194) (1,454,588) Basis difference in investments (2,398,987) — Change in fair value of debt — (450,884) Other (705,133) — Deferred tax liabilities (14,902,973) (1,905,472) Net deferred tax liability $ (9,199,091) $ (1,363,820) The components of the Company’s net deferred tax assets are subject to realizability analysis in accordance with ASC 740, Income Taxes . Based on this analysis, the Company determined that sufficient positive evidence existed at December 31, 2023 and 2022 to support not recording a valuation allowance recorded against net operating loss tax attributes. The Company has $84,709 of Federal Net Operating Losses and $84,709 State Net Operating Losses that can be carried forward indefinitely. The Federal Net Operating Losses may be used to offset 80% of taxable income in a given year. The Company did not have any unrecognized tax benefits relating to uncertain tax positions at December 31, 2023 and 2022 and did not recognize any interest or penalties related to uncertain tax position at December 31, 2023 and 2022 . The Company does not anticipate that changes in its unrecognized tax benefits will have a material impact on the consolidated statements of operations and comprehensive income during 2024 . The Company’s tax returns are subject to examination by relevant taxing authorities. None of the Company’s tax returns are under audit. As of December 31, 2023, tax years for 2020, 2021, and 2022 are subject to examination by the relevant tax authorities.
Abacus Settlements, LLC
Subsidiary of Limited Liability Company or Limited Partnership [Line Items]
INCOME TAXES	INCOME TAXES Since Abacus elected to file as an S corporation for federal and State income tax purposes, Abacus incurred no federal or state income taxes. Accordingly, provision for income taxes is attributable to minimum state tax payments that are due regardless of their S corporation status and income position. For the three months ended June 30, 2023, Abacus did not record provision for income taxes. For the six months ended June 30, 2023 and year ended December 31, 2022, Abacus recorded provision for income taxes of $2,289 and $2,018, respectively, which consist of state minimum taxes for state taxes that have been paid and settled during the period. The effective tax rate was approximately (0.24%) for the six months ended June 30, 2023, compared to (4.00)% for the year ended December 31, 2022. Given Abacus' S Corporation status, temporary book and tax differences do not create a deferred tax asset or liability on the balance sheets. Accordingly, an assessment of realizability of any deferred tax asset balances is not relevant.

Abacus Settlements LLC - RETIRE

Abacus Settlements LLC - RETIREMENT PLAN	12 Months Ended
Abacus Settlements LLC - RETIREMENT PLAN	Dec. 31, 2023
Abacus Settlements, LLC
Subsidiary of Limited Liability Company or Limited Partnership [Line Items]
RETIREMENT PLAN	RETIREMENT PLAN Abacus provides a defined contribution plan to its employees, Abacus Settlements LLC 401(k) Profit Sharing Plan & Trust (the “Plan”). All eligible employees are able to participate in voluntary salary reduction contributions to the Profit-Sharing Plan. All employees who have completed one year of service with Abacus are eligible to receive employer-matching contributions. Abacus may match contributions to the Plan, up to 4% of compensation. For six months ended June 30, 2023 and year ended December 31, 2022, Abacus made no discretionary contribution to the Plan.

Abacus Settlements LLC - RELATE

Abacus Settlements LLC - RELATED-PARTY TRANSACTIONS	12 Months Ended
Abacus Settlements LLC - RELATED-PARTY TRANSACTIONS	Dec. 31, 2023
Subsidiary of Limited Liability Company or Limited Partnership [Line Items]
RELATED-PARTY TRANSACTIONS	RELATED-PARTY TRANSACTIONS As of December 31, 2023 and 2022, $5,236 and $263,785, respectively, were due to former members and affiliates primarily for reimbursable transaction costs as well as distributions to former members of $1,159,712 as a part of the Business Combination as of December 31, 2023. As of December 31, 2023 and 2022, $1,007,528 and $2,904,646, respectively, was due from affiliates, respectively. The majority of the due from affiliate amount as of December 31, 2022 represents transaction costs incurred by the Company related to the planned business combination in which ERES had committed to reimburse the Company upon the consummation of the merger. The SPV Purchase and Sale Note of $25,000,000 was recorded as a related party transaction due to transfers of cash and policies between the Company and the SPV, which is jointly owned by the Sponsor and former members of LMA and Abacus. Also, the Sponsor PIK Note for $10,471,648 is also recorded as a related party transaction due to the relationship between the Sponsor and the Company. Refer to Note 13, Long-Term Debt, for more information. The Company has a related-party relationship with Nova Trading (US), LLC (“Nova Trading”), a Delaware limited liability company and Nova Holding (US) LP, a Delaware limited partnership (“Nova Holding” and collectively with Nova Trading, the “Nova Funds”). The Company also earns service revenue related to policy and administrative services on behalf of Nova Funds. The servicing fee is equal to 50 basis points (0.50%) times the monthly invested amount in policies held by Nova Funds divided by 12. The Company earned $778,678 and $818,300 in service revenue related to Nova Funds for the years ended December 31, 2023 and 2022, respectively. As of December 31, 2023, and 2022, there were $79,509 and $196,289, respectively owed from the Nova Funds, which are included as related-party receivables in the accompanying consolidated balance sheets. The Company also originates policies for the Nova Funds. For its origination services to the Nova Funds, the Company earns origination fees equal to the lesser of (i) 2% of the net death benefit for the policy or (ii) $20,000. In addition to the Nova Funds, the Company also has other affiliated investors that provide origination services. For the year ended December 31, 2022, the Company did not earn any related party origination revenue for the Nova Funds. For the year ended December 31, 2023, revenue earned, and contracts originated are below. Year Ended December 31, 2023 Origination fee revenue $ 259,517 Transaction reimbursement revenue 235,455 Total $ 494,972 Cost $ 99,456 Face value $ 46,650,000 Total policies 7 Average Age 70
Abacus Settlements, LLC
Subsidiary of Limited Liability Company or Limited Partnership [Line Items]
RELATED-PARTY TRANSACTIONS	RELATED-PARTY TRANSACTIONS Abacus has a related-party relationship with Nova Trading (US), LLC (“Nova Trading”), a Delaware limited liability company and Nova Holding (US) LP, a Delaware limited partnership (“Nova Holding” and collectively with Nova Trading, the “Nova Funds”) as the owners of Abacus jointly own 11% of the Nova Funds. For the six months ended June 30, 2023 and year ended December 31, 2022, Abacus originated 72 and 333 policies, respectively, for the Nova Funds with a total value of $96,674,080 and $481,648,010, respectively. For its origination services to the Nova Funds, Abacus earns origination fees equal to the lesser of (i) 2% of the net death benefit for the policy or (ii) $20,000. For three months ended June 30, 2023 and 2022, and for the six months ended June 30, 2023 and nine months ended September 30, 2022, revenue earned, and contracts originated are as follows: Six Months Ended Year Ended December 31, 2023 2022 Origination fee revenue $ 2,952,837 $ 6,586,922 Commissions and transaction reimbursement revenue 140,960 8,656,885 Total $ 3,093,797 $ 15,243,806 Cost $ 11,656,637 $ 87,143,005 Face value 96,674,080 481,648,010 Total policies 72 333 Average Age 75 75

Abacus Settlements LLC - SUBSEQ

Abacus Settlements LLC - SUBSEQUENT EVENT	12 Months Ended
Abacus Settlements LLC - SUBSEQUENT EVENT	Dec. 31, 2023
Subsidiary of Limited Liability Company or Limited Partnership [Line Items]
SUBSEQUENT EVENT	SUBSEQUENT EVENTS The Company evaluated subsequent events and transactions from the consolidated balance sheet date through the date at which the consolidated financial statements were issued. Fixed Rate Senior Unsecured Notes On February 15, 2024 , the Company issued an additional $25,000,000 as part of the previously issued Fixed Unsecured Notes. The net proceeds, after related debt issue costs, were used by the Company for general corporate purposes. The Fixed Rate Senior Unsecured Notes are based on a fixed interest rate of 9.875% to be paid in quarterly interest payments beginning on May 15, 2024 and mature on November 15, 2028. Conversion of Public Warrants —On January 18, 2024, the Company’s share price reached the warrant exercise price of $11.50. Certain public warrant holders redeemed their warrants for the Company’s common stock. As of March 15, 2024, the Company received $3,506,753 from 304,935 exercised public warrants. LMA Income Series II, LP and LMA Income Series II, GP LLC Secured Borrowin g—Subsequent to year end, LMA Income Series II, GP, LLC through the LMA Income Series II, LP admitted additional limited partners into the fund. The additional limited partnership interests amounted to $18,042,641 as of March 20, 2024. LMA Income Series II, GP plans to continue admitting new limited partners throughout 2024 and beyond. In addition to new partnership interests, an amendment to the limited partnership was signed to add redemption opportunities for limited partners and extend the maturity date of the fund. The first redemption date changed to March 31, 2026, but limited partners can elect to stay in the fund at the same terms prior to the amendment. If a limited partners elect to stay invested, the next redemption date would be June 30, 2027 with a final maturity date of December 31, 2028.
Abacus Settlements, LLC
Subsidiary of Limited Liability Company or Limited Partnership [Line Items]
SUBSEQUENT EVENT	SUBSEQUENT EVENT On June 30, 2023, Abacus consummated the merger with LMA. Abacus has evaluated its subsequent events through August 14, 2023, the date that the financial statements were issued and determined that there were no events that occurred that required disclosure.

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	12 Months Ended
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	Dec. 31, 2023
Subsidiary of Limited Liability Company or Limited Partnership [Line Items]
Basis of Presentation and Unaudited Condensed Consolidated Financial Statements	Basis of Presentation —In connection with the Business Combination, the Merger is accounted for as a reverse recapitalization with ERES in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”). Under U.S. GAAP, ERES has been treated as the “acquired” company for financial reporting purposes. This determination was primarily based on the LMA stockholders having a relative majority of the voting power of the Company, the LMA stockholders having the authority to appoint a majority of directors on the Board of Directors, and senior management of LMA comprising the majority of the senior management of the post-combination Company. LMA was then determined to be the “acquirer” for financial reporting purposes based on the relative size of LMA as compared to Abacus, represented by their revenue, equity, gross profit and net income. Accordingly, for accounting purposes, the financial statements of the combined entity represents a continuation of the financial statements of LMA with the LMA Merger treated as the equivalent of LMA issuing stock for the net assets of ERES, accompanied by a recapitalization. The net assets of ERES are stated at historical cost, with no goodwill or other intangible assets recorded. The Abacus Merger has been accounted for using the acquisition method of accounting. Under the acquisition method of accounting, the assets and liabilities of Abacus were recorded at the fair value as of the acquisition date. The excess of the purchase price over the estimated fair values of the net assets acquired was recognized as goodwill. As a result of the Business Combination, the Company evaluated if ERES, Abacus, or LMA is the predecessor for accounting purposes. In considering the foregoing principles of predecessor determination and in light of the Company's specific facts and circumstances, management determined that LMA and Abacus are dual predecessors for accounting purposes. The financial statement presentation for Abacus Life, Inc. includes the purchase accounting effects of the Abacus Merger as of the Closing Date with the financial statements of LMA as the comparative period. The predecessor financial statements for Abacus are included separately within this report.
Consolidation of Variable Interest Entities	Consolidation of Variable Interest Entities —For entities in which the Company has variable interests, the Company first evaluates whether the entity meets the definition of a variable interest entity (“VIE”) or a voting interest entity (“VOE”). If the entity is a VIE, the Company focuses on identifying whether it has the power to direct the activities that most significantly impact the VIE’s economic performance and whether it has the obligation to absorb losses or the right to receive benefits from the VIE. If the Company is the primary beneficiary of a VIE, the assets, liabilities, and results of operations of the VIE will be included in the Company’s condensed consolidated financial statements. The proportionate share not owned by the Company is recognized as noncontrolling interest and net income attributable to noncontrolling interest on the condensed consolidated balance sheets and condensed consolidated statements of operations and comprehensive income, respectively. If the entity is a VOE, the Company evaluates whether it has the power to control the VOE through a majority voting interest or through other arrangements. Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 810, Consolidations , (“ASC 810”) requires the Company to separately disclose on its consolidated balance sheets the assets of consolidated VIEs and liabilities of consolidated VIEs as to which there is no recourse against the Company. As of December 31, 2023, total assets and liabilities of consolidated VIEs were $77,132,592 and $65,031,207, respectively. As of December 31, 2022, total assets and liabilities of consolidated VIEs were $30,073,972 and $27,116,762, respectively. On October 4, 2021, the Company entered into an operating agreement with LMX Series, LLC (“LMX”) and three other unaffiliated investors to obtain a 70% ownership interest in LMX, which was newly formed in August 2021. LMX had no operating activity prior to the operating agreement being signed. LMX has a wholly owned subsidiary, LMATT Series 2024, Inc., a Delaware C corporation. While the Company and three other investors each contributed $100 to LMX, the Company directs the most significant activities by managing the investment offerings, and sponsoring and creating structured investment grade insurance liabilities, and thus was provided a 70% ownership interest. LMX is a VIE and the Company is the primary beneficiary of LMX. The Company has included the results of LMX and its subsidiaries in its consolidated financial statements for the year ended December 31, 2023. On November 30, 2022, LMA Series, LLC, a wholly owned subsidiary of the Company, signed an Operating Agreement to be the sole member of a newly created general partnership, LMA Income Series, GP, LLC. Subsequent to that, LMA Income Series, GP, LLC formed a limited partnership, LMA Income Series, LP and issued partnership interests to limited partners in a private placement offering. It was determined that LMA Series, LLC is the primary beneficiary of LMA Income Series, LP and thus has fully consolidated the limited partnership in its consolidated financial statements for the year ended December 31, 2023. On January 31, 2023, LMA Series, LLC, a wholly owned subsidiary of the Company, signed an Operating Agreement to be the sole member of a newly created general partnership, LMA Income Series II, GP, LLC. Subsequent to that, LMA Income Series II, GP, LLC formed a limited partnership, LMA Income Series II, LP and issued partnership interests to limited partners in a private placement offering. It was determined that LMA Series, LLC is the primary beneficiary of LMA Income Series II, LP and thus has fully consolidated the limited partnership in its consolidated financial statements for the year ended December 31, 2023. Non-Consolidation of Variable Interest Entities —On January 1, 2021, the Company entered into an option agreement with two commonly owned full-service origination, servicing, and investment providers (the “Providers”), in which the Company agreed to fund certain capital needs with an option to purchase the outstanding equity ownership of the Providers (the “Option Agreement”). The Company accounted for its investment in the call options under the Option Agreement as an equity security, pursuant to ASC 321, Investments—Equity Securities . In arriving at this accounting conclusion, the Company first considered whether the call options met the definition of a derivative pursuant to ASC 815, Derivatives and Hedging , and concluded that the options do not provide for net settlement and accordingly are not a derivative. The Company also concluded that the call options do not provide the Company with a controlling financial interest in the legal entity pursuant to ASC 810. The call options include material contingencies prior to exercisability that the Company does not anticipate will be resolved; additionally, the call options are in a legal entity for which the stock price has no readily determinable fair value. The Company’s basis in the call options, pursuant to ASC 321, is zero and accordingly the call options are not reflected in the statement of financial position. The Company provided $144,721 of working capital funding for the year ended December 31, 2023 which is included in other (expense) income on the consolidated statements of operations and comprehensive income and $347,013 of funding for the year ended December 31, 2022. See Note 11, Commitments and Contingencies, for further details. For the years ended December 31, 2023, and 2022, the Providers were considered to be VIEs, but were not consolidated in the Company’s consolidated financial statements due to a lack of the power criterion or the losses/benefits criterion. As of December 31, 2023, the unaudited financial information for the unconsolidated VIEs are as follows: held assets of $601,762 and liabilities of $2,900. As of December 31, 2022, the unaudited financial information for the unconsolidated VIEs are as follows: held assets of $987,964 and liabilities of $358,586.
Noncontrolling Interest	Noncontrolling Interest —Noncontrolling interest represents the share of consolidated entities owned by third parties. At the date of formation or upon acquisition, the Company recognizes noncontrolling interest on the consolidated balance sheets at an amount equal to the noncontrolling interest’s proportionate share of the relative fair value of any assets and liabilities acquired. Noncontrolling interest is subsequently adjusted for the noncontrolling stockholder’s additional contributions, distributions, and the stockholder’s share of the net earnings or losses of each respective consolidated entity. Net income of a consolidated entity is allocated to noncontrolling interests based on the noncontrolling stockholder’s ownership interest during the period. The net income or loss that is not attributable to the Company is reflected in net income (loss) attributable to noncontrolling interests in the consolidated statements of operations and comprehensive income.
Use of Estimates	Use of Estimates —The preparation of U.S. GAAP financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and changes therein, disclosure of contingent assets and liabilities at the date of financial statements, and the reported amounts of revenue and expenses during the reporting periods. Company’s estimates, judgments, and assumptions are continually evaluated based on available information and experience. Because of the use of estimates inherent in the financial reporting process, actual results could differ from the estimates. Estimates are used when accounting for purchase price allocation, the selection of useful lives of property and equipment, valuation of other receivables, valuation of life settlement policies, valuation of other investments and available-for-sale securities, valuation of long-term debt, impairment testing, income taxes, and legal reserves.
Accounts Receivable, Related Party and Other Receivables	Accounts Receivable, Related Party
Life Settlement Policies	Life Settlement Policies —The Company accounts for its holdings of life insurance settlement policies in accordance with ASC 325-30, Investments in Insurance Contracts . For all policies purchased after June 30, 2023, the Company accounts for these under the fair value method. For policies purchased before June 30, 2023, the Company elected to use either the fair value method or the investment method (cost, plus premiums paid). The valuation method is chosen upon contract acquisition and is irrevocable. The Company follows ASC 820, Fair Value Measurements and Disclosures , in estimating the fair value of its life insurance policies held at fair value. ASC 820 defines fair value as an exit price representing the amount that would be received if an asset were sold or that would be paid to transfer a liability in an orderly transaction between market participants at the measurement date. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. The Company’s valuation of life settlements is considered to be Level 3. The Company’s valuation model incorporates significant inputs that are not observable and reflect our assumptions about what factors market participants would use in pricing life settlement policies. We develop our inputs based on the best information available to us, including our own data. We believe that our model would be reasonably comparable to a model that an independent third-party would use. Refer to Note 12, Fair Value Measurements, for further details. For policies held at fair value, changes in fair value are reflected in the consolidated statement of operations and comprehensive income under active management revenue in the period the change is calculated. For policies held under the investment method, the Company tests the impairment if we become aware of information indicating that the carrying value plus undiscounted future premiums of a policy may not be recoverable. This information is gathered initially through extensive underwriting procedures at purchase of the settlement contract, as well as through periodic underwriting review that includes medical reports and life expectancy evaluations. The policies held by the Company using the investment method are expected to be owned for a shorter-term, and are actively marketed to potential buyers. The market feedback received through these interactions provides the Company with information related to a potential impairment. If a policy is determined to be impaired, the Company will adjust the carrying value to the fair value determined through the impairment analysis. The Company accounts for cash proceeds from sale and maturity of life insurance settlement policies, as well as cash outflows for premium payments, as operating activities within the consolidated statements of cash flows.
Cash and Cash Equivalents	Cash and Cash Equivalents —Cash and cash equivalents include short-term and all highly‐liquid debt instruments purchased with an original maturity of three months or less.
Going Concern	Going Concern —Management evaluates at each annual and interim period whether there are conditions or events, considered in the aggregate, that raise substantial doubt about Company’s ability to continue as a going concern within one year after the date that the consolidated financial statements are issued. Management’s evaluation is based on relevant conditions and events that are known and reasonably knowable at the date that the consolidated financial statements are issued. Management has concluded that there are no conditions or events, considered in the aggregate, that raise substantial doubt about Company’s ability to continue as a going concern within one year after the date these consolidated financial statements were issued.
Fair Value Measurements	Fair Value Measurements —The following fair value hierarchy is used in selecting inputs for those assets and liabilities measured at fair value that distinguishes between assumptions based on market data (observable inputs) and the Company’s assumptions (unobservable inputs). The Company evaluates these inputs and recognizes transfers between levels, if any, at the end of each reporting period. The hierarchy consists of three levels: Level 1 —Valuation based on quoted market prices in active markets for identical assets or liabilities that we have the ability to access at the measurement date. Level 2 —Valuation based on inputs other than Level 1 inputs that are observable for the assets or liabilities either directly or indirectly. Level 3 —Valuation based on inputs that reflect our assumptions about what factors market participants would use in pricing the asset or liability. The inputs are developed based on the best available information, including our own data. The Company’s financial instruments consist of cash, cash equivalents, accounts receivables, due to affiliates, equity investments in privately held companies, S&P options, life settlement policies, available for sale securities, market-indexed debt and secured borrowings. Cash, cash equivalents, accounts receivables, and due to affiliates are stated at their carrying value, which approximates fair value due to the short time to the expected receipt or payment date. Equity investments in privately held companies without readily determinable fair values are recognized at fair value on a nonrecurring basis when observable price changes from orderly transactions for identical or similar investments become available. Available-for-sale securities are measured at fair value using inputs that are not readily determinable. Unrealized holding gains and losses are excluded from earnings and reported in other comprehensive income until realized. S&P options are recognized at fair value using quoted market prices in active markets, with changes in fair value included in net income. Market-indexed debt is measured on a quarterly basis, with qualifying changes in fair value recognized in net income, except for the portion of the total change in the fair value of the liability that results from a change in the instrument-specific credit risk, which is separately included in other comprehensive income in accordance with ASC 825-10-45-5. The measurement approach for life settlement policies is included above within the Life Settlement Policies disclosure.
Other Investments	Other Investments —Equity investments without readily determinable fair values include the Company’s investments in privately-held companies in which the Company holds less than a 20% ownership interest and does not have the ability to exercise significant influence. The Company measures these investments at cost, and these investments are adjusted through net earnings when they are deemed to be impaired or when there is an adjustment from observable price changes (referred to as the “measurement alternative”). These investments are included in other investments on the financial statements, at cost on the consolidated balance sheets. In addition, the Company monitors these investments to determine if impairment charges are required based primarily on the financial condition and near-term prospects of these companies
Available-For-Sale Securities, at Fair Value and Equity Securities, at Fair Value	Available-for-sale Securities, at Fair Value Equity Securities, at Fair Value —The equity securities, at fair value balance consists of S&P 500 put and call options that were purchased through a broker as an economic hedge related to the market-indexed instruments that are included in Long-Term Debt. The Company records these options at fair value and recognizes changes in fair value as part of net income.
Property and Equipment, Net	Property and Equipment, Net —Property and equipment are stated at cost less accumulated depreciation and are depreciated on a straight-line basis over the following estimated useful lives: Estimated Useful Life Computer equipment 5 years Furniture and fixtures 5 years Leasehold improvements Shorter of remaining lease term or estimated useful life Costs incurred for maintenance and repairs that do not extend the useful lives of property and equipment are expensed as incurred. Upon retirement or sale of assets, the cost and related accumulated depreciation are written off and any resulting gain or loss is reflected in the accompanying consolidated statements of operations and comprehensive income. Property and equipment are tested for recoverability whenever events or changes in circumstance indicate that their carrying amounts may not be recoverable. An impairment loss is recognized if the carrying amount of property and equipment is not recoverable and exceeds its fair value. Recoverability is determined based on the undiscounted cash flows expected to result from the use and eventual disposition of the asset or asset group. There were no impairments recognized during the years ended December 31, 2023 and 2022, respectively. Property and equipment to be disposed of are reported at the lower of carrying amount or fair value less cost to sell.
Goodwill and Intangible Assets, Net	Goodwill and Intangible Assets, Net —Goodwill and intangible assets are recorded as a result of the Business Combination. Goodwill represents the excess of the purchase price over the fair value of the assets acquired and liabilities assumed. The Company amortizes identifiable intangible assets with a finite useful life over the period that the intangible asset is expected to contribute directly or indirectly to its future cash flows; however, it does not amortize indefinite lived intangible assets. The Company evaluates goodwill and indefinite intangible assets for recoverability annually in the fourth quarter or on an interim basis should events or changes in circumstances indicate that a carrying amount may not be recoverable. To test for impairment, a qualitative assessment is performed to determine if it is more likely-than-not that the fair value of a reporting unit is less than its carrying value, including goodwill. This initial assessment includes, among other factors, consideration of: (i) past, current and projected future earnings and equity; (ii) recent trends and market conditions; and (iii) valuation metrics involving similar companies that are publicly traded and acquisitions of similar companies, if available. If the more likely-than-not threshold is met, a quantitative impairment test is performed by comparing the estimated fair value with the carrying value. If the carrying value of the net assets associated with the reporting unit exceeds the fair value of the reporting unit, goodwill is considered impaired and will be determined as the amount by which the reporting unit’s carrying value exceeds its fair value, not to exceed the carrying amount of goodwill. The Company’s reporting units are at the operating segment level; each operating segment represents a business and discrete financial information is available and reviewed regularly by management. Determining the fair value of its reporting units is subjective in nature and involves the use of significant estimates and assumptions, including projected net cash flows, discount and long-term growth rates. The Company determines the fair value of its reporting units based on an income approach and market approach, whereby the fair value of the reporting unit is derived from the present value of estimated future cash flows associated with the reporting unit. The assumptions about estimated cash flows include factors such as future premiums, loss and expenses, general and administrative expenses and industry trends. The Company considers historical rates and current market conditions when determining the discount and long-term growth rates to use in its analysis. The Company considers other valuation methods if the facts and circumstances indicate these methods provide a more representative approximation of fair value. Changes in these estimates based on evolving economic conditions or business strategies could result in material impairment charges in future periods. The Company bases its fair value estimates on assumptions it believes to be reasonable. Actual results may differ from those estimates. As of December 31, 2023, there were no events or changes in circumstances that indicated that a carrying amount of goodwill or intangible asset may not be recoverable. The company has insignificant internal-use software accounted under ASC 350-40, Internal-Use Software
Revenue Recognition and Cost of Revenues	Revenue Recognition —The Company generally derives its revenue from life settlement servicing and consulting activities (Portfolio Servicing Revenue), life settlement trading activities (Active Management Revenue) and fees, commissions (Origination Services). Portfolio Servicing Revenue — Portfolio servicing is comprised of servicing activities and consulting activities. The Company enters into service agreements with the owners of life settlement contracts and is responsible for maintaining the policy, manages processing of claims in the event of death of the insured and ensuring timely payment of optimized premiums computed to derive maximum return on maturity of the policy. The company neither assumes the ownership of the contracts nor undertakes the responsibility to make the premium payments, which remains with the owner of the policy. These service arrangements have contractual terms typically ranging from one-month to ten years and include fixed charges within its contracts as part of the total transaction price which are recognized on gross basis. To the extent that variable consideration is not constrained, the Company includes an estimate of the variable amount, as appropriate, within the total transaction price and updates its assumptions over the duration of the contract. Variable consideration has not been material. The duties performed by the Company under these arrangements are considered as a single performance obligation that is satisfied on a monthly basis as the customer simultaneously receives and consumes the benefit provided by the Company as the Company performs the service. As such, revenue is recognized for services provided for the corresponding month. Under consulting engagements, the Company provides services typically for the owners of life settlement contracts who are often customers of the servicing business line, or customers of Abacus. These consulting engagements are comprised of valuation, actuarial services, and overall policy assessments related life settlement contracts and are short-term in nature. The performance obligations are typically identified as separate services with a specific deliverable or a group of deliverables to be provided in tandem, as agreed to in the engagement letter or contract. Each service provided under a contract is considered as a performance obligation and revenue is recognized at a point in time when the deliverable or group of deliverables is transferred to the customer. Active Management Revenue — The Company also engages in buying and selling life settlement policies whereby each potential policy is independently researched to determine if it would be a profitable investment. Some of the policies are purchased with the intent to hold to maturity, while others are held for trading to be sold for a gain. The Company elects to account for each investment in life settlement contracts using either the investment method or the fair value method. Once the accounting method is elected for each policy, it cannot be changed. Under the investment method, investments in contracts are based on the initial investment at the purchase price plus all initial direct costs. Continuing costs (e.g., policy premiums, statutory interest and direct external costs, if any) to keep the policy in force are capitalized. Under the fair value method, the company will record the initial investment of the transaction price and remeasures the investment at fair value at each subsequent reporting period. Changes in fair value are reported on earnings when they occur. Upon sale of a life settlement contract, the company will record revenue (gain/loss) for the difference between the agreed-upon purchase price with the buyer, and the carrying value of the contract. Originations Revenue — The Company through its Abacus subsidiary, recognizes revenue from origination activities by acting as a provider of life settlements and viatical settlements representing investors that are interested in purchasing life settlements on the secondary or tertiary market. Revenue from origination services consists of fees negotiated for each purchase and sale of a policy to an investor, which also include any agent and broker commissions received and the reimbursement of transaction costs. See below for revenue disaggregation based upon the source of the policy. The Company originates life settlements policies with third parties that include settlement brokers, life insurance agents, and direct consumers or policyholders. The Company then provides the administration services needed to initiate the transfer of the life settlement policies to investors in exchange for an origination fee. Such transactions are entirely performed through an escrow agent. In these arrangements, the customer is the investor, and the Company has a single performance obligation to originate a life settlement policy for the investor. The consideration transferred upon each policy is negotiated directly with the investor by the Company and is dependent upon the policy death benefits held by each life settlement policy. The revenue is recognized when the performance obligation under the terms of the contracts with customers are satisfied. The Company recognizes revenue from life settlement transactions when the closing has occurred and any right of rescission under applicable state law has expired (i.e., the customer obtains control over the policy and has the right to use and obtain the benefits from the policy). While rescission periods may vary by state, most states grant the owner the right to rescind the contract before the earlier of 30 calendar days after the execution date of the contract or 15 calendar days after life settlement proceeds have been sent to the owner. Purchase and sale of the policies generally occurs simultaneously, and only the fees received, including any agent and broker commissions and transaction costs reimbursed, are recorded as gross revenue. For agent and broker commissions received and transaction costs reimbursed, the Company has determined that it is acting as the principal in the relationship as it maintains control of the services being performed as part of performance obligation prior to facilitating the transfer of the life settlement policy to the investor. While the origination fees are fixed amounts based on the face value of the policy death benefit, there is variable consideration present due to the owners rescission right. When variable consideration is present in a contract, the Company estimates the amount of variable consideration to which it expects to be entitled at contract inception and again at each reporting period until the amount is known. The entity applies the variable consideration constraint so that variable consideration is included in the transaction price only to the extent it is probable that a subsequent change in estimate will not result in a significant revenue reversal. While origination fees are variable due to the rescission periods, given that the rescission periods are relatively short in nature, the Company has concluded that such fees are fully constrained until the rescission period lapses and thus records revenue at a fixed amount based on the face value of the policy death benefit after the rescission period is over. • Remaining performance obligation —The Company is recognizing revenue at a point in time when the closing has occurred and any right of rescission under applicable state law has expired. As of December 31, 2023, and 2022, there are $507,000 and $— in revenues allocated to performance obligations to be satisfied, of which all are expected to be recognized as revenue in the following year when the right of rescission has expired. • Disaggregated Revenue —The following table presents a disaggregation of the Company’s revenue by major sources as follows: Years Ended December 31, 2023 2022 Agent $ 1,750,911 $ — Broker 2,148,141 — Client direct 304,848 — Total $ 4,203,900 $ — • Contract Balances —The balances of contract liabilities arising from contracts with customers were as follows: December 31, 2023 December 31, 2022 Contract liabilities—beginning of year $ — $ — Additions to Contract Liabilities 507,000 — Recognition of revenue deferred in the prior year — — Contract liabilities—end of year 507,000 — Other Consideration — Payment terms and conditions vary by contract type, although terms generally require payment within 30 days of the invoice date. In certain arrangements, the Company receives payment from a customer either before or after the performance obligation has been satisfied; however, the Company’s contracts do not contain a significant financing component. Cost to Obtain and Fulfill Contracts — Costs to obtain contracts solely relate to commissions for brokers agents and employees who are directly involved in buying and selling policies as part of the active management revenue stream and include commissions for brokers or agents under specific agreements that would not be incurred without a contract being signed and executed under origination services revenue stream. The Company has elected to apply the ASC 606, Revenue from Contracts with Customers , ‘practical expedient’ which allows us to expense these costs as incurred if the amortization period related to the resulting asset would be one year or less. The Company has no significant instances of contracts that would be amortized for a period greater than a year, and therefore has no contract costs capitalized for these arrangements. These costs are included in cost of revenue. Cost of Revenues (excluding Depreciation and Amortization)
Segments	Segments — Operating segments are defined as components of an entity for which separate financial information is available and that is regularly reviewed by the chief operating decision maker (“CODM”) in deciding how to allocate resources to an individual segment and in assessing performance. The Company’s CODM is the President and Chief Executive Officer (“CEO”). The Company has determined that it operates in three operating segments and three reportable segments, portfolio servicing, active management and originations as the CODM reviews financial information presented for purposes of making operating decisions, allocating resources, and evaluating financial performance.
Income Taxes	Income Taxes —The provision for income taxes is determined using the asset and liability approach of accounting for income taxes. Under this approach, the provision for income taxes represents income taxes paid or payable (or received or receivable) for the current year plus the change in deferred taxes during the year. Deferred taxes represent the future tax consequences expected to occur when the reported amounts of assets and liabilities are recovered or paid, and result from differences between the financial and tax bases of the Company’s assets and liabilities and are adjusted for changes in tax rates and tax laws when enacted. Valuation allowances are recorded to reduce deferred tax assets when it is more likely than not (greater than 50%) that a tax benefit will not be realized. In evaluating the need for a valuation allowance, management considers all potential sources of taxable income, including income available in carryback periods, future reversals of taxable temporary differences, projections of taxable income, and income from tax planning strategies, as well as all available positive and negative evidence. Positive evidence includes factors such as a history of profitable operations, projections of future profitability within the carryforward period, including from tax planning strategies, and the Company’s experience with similar operations. Existing favorable contracts are additional positive evidence. Negative evidence includes items such as cumulative losses, projections of future losses, or carryforward periods that are not long enough to allow for the utilization of a deferred tax asset based on existing projections of income. Deferred tax assets for which no valuation allowance is recorded may not be realized upon changes in facts and circumstances, resulting in a future charge to establish a valuation allowance. Existing valuation allowances are re-examined under the same standards of positive and negative evidence. If it is determined that it is more likely than not that a deferred tax asset will be realized, the appropriate amount of the valuation allowance, if any, is released. Deferred tax assets and liabilities are also remeasured to reflect changes in underlying tax rates due to law changes and the granting and lapse of tax holidays. Tax benefits related to uncertain tax positions taken or expected to be taken on a tax return are recorded when such benefits meet a more likely than not threshold. Otherwise, these tax benefits are recorded when a tax position has been effectively settled, which means that the statute of limitations has expired, or the appropriate taxing authority has completed their examination even though the statute of limitations remains open. Interest and penalties related to uncertain tax positions are recognized as part of the provision for income taxes and are accrued beginning in the period that such interest and penalties would be applicable under relevant tax law until such time that the related tax benefits are recognized.
Concentrations	Concentrations —Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents, accounts receivable, and available-for-sale securities. The Company maintains its cash in bank deposit accounts with high-quality financial institutions, which, at times, may exceed federally insured limits. The Company has not experienced any losses in such accounts. The Company believes it is not exposed to any significant credit risk on its cash and cash equivalents. For accounts receivable, the Company is exposed to credit risk in the event of nonpayment by customers to the extent of the amounts recorded on the accompanying condensed consolidated balance sheets. The Company extends different levels of credit to its customers and maintains allowance for doubtful accounts based upon the expected collectability of accounts receivable. The Company’s procedures for determining this allowance includes evaluating individual customer receivables, considering a customer’s financial condition, monitoring credit history and current economic conditions, using historical experience applied to an aging of accounts, as well as management’s expectations of conditions in the future, as applicable.
Warrants	Warrants —The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in ASC 480, Distinguishing Liabilities from Equity , and ASC 815. The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, whether they meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own common stock and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding. For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of equity at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded as liabilities at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a non-cash gain or loss on the consolidated statements of operations and comprehensive income.
Stock-Based Compensation	Stock-Based Compensation —The Company account for stock-based compensation in accordance with ASC 718, Compensation - Stock Compensation , which requires that we measure the expense of employee services received in exchange for an award of equity instruments based on the grant-date fair value of the award. Generally, stock-based awards granted to our employees vest ratably over a three-year period. For stock-based awards with service only vesting conditions, the Company records compensation expense on a straight-line basis over the requisite service period. The Company accounts for forfeitures when they occur. The fair value of stock-based awards, granted or modified, is determined on the grant date (or modification dates, if applicable) at fair value, using appropriate valuation techniques. For stock-based awards granted to non-employee directors, the Company recognizes compensation expense on the grant date based on the fair value of the awards as of that date.
Leases	Leases — The Company accounts for its leases in accordance with ASC 842, Leases . A contract is or contains a lease if there is identified property, plant and equipment that is either explicitly or implicitly specified in the contract and the lessee has the right to control the use of the property, plant and equipment throughout the contract term, which is based on an evaluation of whether the lessee has the right to direct the use of the property, plant and equipment. The Company has one lease for office space in Orlando, Florida that is accounted for as an operating lease. The Company is responsible for utilities, maintenance, taxes and insurance, which are variable payments based on a reimbursement to the lessor of the lessor’s costs incurred. The Company excludes variable lease payments from the measurement of lease liabilities and right-of-use (“ROU”) assets recognized on the Company’s consolidated balance sheets. Variable lease payments are recognized as a lease expense on the Company’s consolidated statements of operations and comprehensive income in the period incurred. The Company has elected the practical expedient to account for lease components and non-lease components together as a single lease component for its real estate lease noted above. The Company has elected the short-term lease exemption, which permits the Company to not recognize a lease liability and ROU asset for leases with an original term of one year or less. Currently the Company does not have any short-term leases. The Company’s current lease includes a renewal option. The Company has determined that the renewal option is not reasonably certain of exercise based on an evaluation of contract, market and asset-based factors, and therefore does not include periods covered by renewal options in its lease term. The Company’s leases generally do not include purchase options, residual value guarantees, or material restrictive covenants. The Company determines its lease liability and ROU by calculating the present value of future lease payments. The present value of future lease payments is discounted using the Company’s incremental borrowing rate. As the Company’s leases generally do not have a readily determinable implicit rate, the Company uses its incremental borrowing rate based on market yields and comparable credit ratings, adjusted for lease term, to determine the present value of fixed lease payments based on information available at the lease commencement date. The Company does not have any finance leases, nor is the Company a lessor (or sub-lessor).
Earnings Per Share	Earnings Per Share —The Company has only one class of common stock. Basic net income per share is calculated by dividing net income by the weighted average number of shares outstanding during the applicable period. If the number of shares outstanding increases as a result of a stock dividend or stock split or decreases as a result of a reverse stock split, the computations of basic net income per share are adjusted retroactively for all periods presented to reflect that change in capital structure. If such changes occur after the close of the reporting period but before issuance of the financial statements, the per-share computations for that period and any prior-period financial statements presented are based on the new number of shares. Diluted earnings per share is computed in the same manner as basic earnings per share, except that the number of shares is increased to assume the issuance of potentially dilutive shares using the treasury stock method, unless the effect of such increase would be anti-dilutive. Diluted earnings or loss per share attributable to common stockholders is calculated to give effect to all potentially dilutive common shares that were outstanding during the reporting period. The dilutive effect of outstanding stock-based compensation awards is reflected in diluted earnings per share attributable to common stockholders by application of the treasury stock method. Any potentially dilutive shares are excluded from the calculation for periods when there is a net loss attributable to common stockholders to avoid anti-dilutive effects.
Recently Adopted Accounting Standards	Recently Adopted Accounting Standards In November 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update No. 2023-07, “Segment Reporting (ASC 280): Improvements to Reportable Segment Disclosures” (“ASU 2023-07”), which is intended to improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. The guidance is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. The guidance is to be applied retrospectively to all prior periods presented in the financial statements. Upon transition, the segment expense categories and amounts disclosed in the prior periods should be based on the significant segment expense categories identified and disclosed in the period of adoption. We are currently evaluating the potential impact of adopting this new guidance on our consolidated financial statements and related disclosures. In December 2023, the FASB issued Accounting Standards Update No. 2023-09, “Income Taxes (ASC 740): Improvements to Income Tax Disclosures” (“ASU 2023-09”), which modifies the rules on income tax disclosures to require entities to disclose (1) specific categories in the rate reconciliation, (2) the income or loss from continuing operations before income tax expense or benefit (separated between domestic and foreign) and (3) income tax expense or benefit from continuing operations (separated by federal, state and foreign). ASU 2023-09 also requires entities to disclose their income tax payments to international, federal, state and local jurisdictions, among other changes. The guidance is effective for annual periods beginning after December 15, 2024. Early adoption is permitted for annual financial statements that have not yet been issued or made available for issuance. ASU 2023-09 should be applied on a prospective basis, but retrospective application is permitted. We are currently evaluating the potential impact of adopting this new guidance on our consolidated financial statements and related disclosures. There have been no other recent accounting pronouncements, changes in accounting pronouncements or recently adopted accounting guidance during fiscal 2023 that are of significance or potential significance to us.
Reclassifications	Reclassifications —Certain prior period amounts have been reclassified to conform to current presentation.
Abacus Settlements, LLC
Subsidiary of Limited Liability Company or Limited Partnership [Line Items]
Basis of Presentation and Unaudited Condensed Consolidated Financial Statements	Basis of Presentation —The accompanying condensed financial statements are presented in accordance with the rules and regulations of the Securities and Exchange Commission (“SEC”) and are prepared in accordance with generally accepted accounting principles in the United States of America (“US GAAP”).
Use of Estimates	Use of Estimates —The preparation of US GAAP financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and changes therein, and disclosure of contingent assets and liabilities at the date of financial statements and the reports amounts of revenue and expenses during the reporting periods. Abacus’ estimates, judgments, and assumptions are continually evaluated based on available information and experience. Because of the use of estimates inherent in the financial reporting process, actual results could differ from the estimates. Estimates are used when accounting for revenue recognition and related costs, the selection of useful lives of property and equipment, impairment testing, valuation of other receivables from clients, income taxes, and legal reserves.
Accounts Receivable, Related Party and Other Receivables	Other receivables —Other receivables include origination fees for policies in which the rescission period has ended, but the funds have not been received yet from financing entities. These fees were collected in the subsequent month. Abacus provides an allowance for credit losses equal to the estimated collection losses that will be incurred in collection of all receivables. Management determines the allowance for credit losses based on a review of outstanding receivables, historical collection experience, current economic conditions, and reasonable and supportable forecasts. Account balances are charged off against the allowance for credit losses after all means of collection have been exhausted and the potential for recovery is deemed remote. Abacus does not have any material allowance for credit losses as of June 30, 2023 or December 31, 2022. If the financial condition of Abacus’ customers were to deteriorate, resulting in an impairment of their ability to make payments, additional allowances may be required. Abacus did not record material allowance for credit losses as of June 30, 2023, and December 31, 2022, respectively.
Going Concern	Going Concern —Management evaluates at each annual and interim period whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date that the financial statements are issued. Management’s evaluation is based on relevant conditions and events that are known and reasonably knowable at the date that the financial statements are issued. Management has concluded that there are no conditions or events, considered in the aggregate, that raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date these financial statements were issued.
Concentrations	Concentrations —All of Abacus’ revenues are derived from life settlement transactions in which Abacus represents Financing Entities that purchased existing life insurance policies. One financing entity, a company in which the Abacus’ members own interests, represented 23% and 60% of Abacus’ revenues in six months ended June 30, 2023 and year ended December 31, 2022, respectively. Abacus originates policies through three different channels: Direct to Consumer, Agent, and Broker. Two brokers represented the sellers for over 10% of Abacus’ life settlement commission expense during the period six months ended June 30, 2023. No single broker represented the sellers for over 10% of Abacus’ life settlement commission expense during the year ended December 31, 2022. Abacus maintains cash deposits with a major financial institution, which from time to time may exceed federally insured limits. Abacus periodically assesses the financial condition of the institution and believes that the risk of loss is minimal.
Advertising	Advertising

SUMMARY OF SIGNIFICANT ACCOUN_3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	12 Months Ended
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	Dec. 31, 2023
Accounting Policies [Abstract]
Summary of Property and Equipment, Net	Property and equipment are stated at cost less accumulated depreciation and are depreciated on a straight-line basis over the following estimated useful lives: Estimated Useful Life Computer equipment 5 years Furniture and fixtures 5 years Leasehold improvements Shorter of remaining lease term or estimated useful life Property and equipment—net composed of the following: December 31, December 31, Computer equipment $ 356,939 $ — Furniture and fixtures 91,125 19,444 Leasehold improvements 22,418 5,902 Property and equipment—gross 470,482 25,346 Less: accumulated depreciation (69,762) (6,729) Property and equipment—net $ 400,720 $ 18,617
Disaggregation of Revenue	The following table presents a disaggregation of the Company’s revenue by major sources as follows: Years Ended December 31, 2023 2022 Agent $ 1,750,911 $ — Broker 2,148,141 — Client direct 304,848 — Total $ 4,203,900 $ —
Schedule of Contract Liabilities	The balances of contract liabilities arising from contracts with customers were as follows: December 31, 2023 December 31, 2022 Contract liabilities—beginning of year $ — $ — Additions to Contract Liabilities 507,000 — Recognition of revenue deferred in the prior year — — Contract liabilities—end of year 507,000 —

BUSINESS COMBINATION (Tables)

BUSINESS COMBINATION (Tables)	12 Months Ended
BUSINESS COMBINATION (Tables)	Dec. 31, 2023
Business Combination and Asset Acquisition [Abstract]
Purchase price allocation	Net Assets Identified Fair Value Intangibles $ 32,900,000 Goodwill 140,287,000 Current Assets 1,280,100 Non-Current Assets 901,337 Deferred Tax Liabilities (8,310,966) Accrued Expenses (524,400) Other Liabilities (1,171,739) Total Fair Value $ 165,361,332
Value conveyed	Value Conveyed Amount Abacus Purchase Consideration $ 165,361,332 LMA Business Enterprise Value $ 366,388,668 Total Consideration $ 531,750,000
Intangible assets acquired	Intangible assets were comprised of the following: Asset Type Fair Value Useful Life Valuation Methodology Customer Relationships-Agents $ 12,600,000 5 years Multi-period excess earnings method Customer Relationships-Financing Entities 11,000,000 8 years Multi-period excess earnings method Internally Developed and Used Technology-APA 1,600,000 2 years Relief from royalty method Internally Developed and Used Technology-Marketplace 100,000 3 years Replacement cost method Trade Name 900,000 Indefinite Relief from royalty method Non-Compete Agreements 4,000,000 2 years With and without method State Insurance Licenses 2,700,000 Indefinite Replacement cost method Total Fair Value $ 32,900,000
Pro forma financial information	The supplemental pro forma financial information in the table below summarizes the combined results of operations for the Business Combination as if the Companies were combined for both reporting periods. The unaudited supplemental pro forma financial information as presented below is for illustrative purposes and does not purport to represent what the results of operations would actually have been if the business combinations occurred as of the date indicated or what the results would be for any future periods. Unaudited Year Ended December 31, 2023 2022 Proforma revenue $ 79,588,733 $ 69,917,015 Proforma net income 8,541,727 31,629,781

LIFE SETTLEMENT POLICIES (Table

LIFE SETTLEMENT POLICIES (Tables)	12 Months Ended
LIFE SETTLEMENT POLICIES (Tables)	Dec. 31, 2023
Investments, All Other Investments [Abstract]
Schedule of Life Settlement Contracts, Fair Value Method	The following tables summarize the Company’s life insurance policies grouped by remaining life expectancy as of December 31, 2023: Policies Carried at Fair Value — Remaining Life Expectancy (Years) Policies Face Value Fair Value 0-1 2 $ 383,461 $ 315,248 1-2 6 4,391,193 1,590,513 2-3 13 20,692,550 10,850,243 3-4 41 66,017,222 22,744,161 4-5 29 57,814,969 19,326,245 Thereafter 196 371,204,315 67,470,149 287 $ 520,503,710 $ 122,296,559
Schedule of Life Settlement Contracts, Investment Method	Policies accounted for using the investment method— Remaining Life Expectancy (Years) Number of Life Insurance Policies Face Value Carrying Value 0-1 0 $ — $ — 1-2 1 500,000 329,714 2-3 2 1,500,000 443,544 3-4 1 8,000,000 84,199 4-5 2 500,000 320,110 Thereafter 3 23,400,000 519,611 9 $ 33,900,000 $ 1,697,178 Estimated premiums to be paid by the Company for its portfolio accounted for using the investment method during each of the five succeeding calendar years and thereafter as of December 31, 2023, are as follows: 2024 $ 88,039 2025 100,785 2026 78,850 2027 50,388 2028 32,736 Thereafter 366,103 Total $ 716,901

PROPERTY AND EQUIPMENT_NET (Tab

PROPERTY AND EQUIPMENT—NET (Tables)	12 Months Ended
PROPERTY AND EQUIPMENT—NET (Tables)	Dec. 31, 2023
Property, Plant and Equipment [Abstract]
Summary of Property and Equipment, Net	Property and equipment are stated at cost less accumulated depreciation and are depreciated on a straight-line basis over the following estimated useful lives: Estimated Useful Life Computer equipment 5 years Furniture and fixtures 5 years Leasehold improvements Shorter of remaining lease term or estimated useful life Property and equipment—net composed of the following: December 31, December 31, Computer equipment $ 356,939 $ — Furniture and fixtures 91,125 19,444 Leasehold improvements 22,418 5,902 Property and equipment—gross 470,482 25,346 Less: accumulated depreciation (69,762) (6,729) Property and equipment—net $ 400,720 $ 18,617

GOODWILL AND OTHER INTANGIBLE_2

GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)	12 Months Ended
GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)	Dec. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill	The changes in the carrying amount of goodwill by reportable segments were as follows: Portfolio Servicing Active Management Originations Goodwill at January 1, 2023 $ — $ — $ — Additions — — 140,287,000 Goodwill at December 31, 2023 $ — $ — $ 140,287,000
Schedule of Finite-Lived Intangible Assets	Intangible Assets Acquired comprised of the following: Asset Type Fair Value Useful Life Valuation Methodology Customer Relationships - Agents $ 12,600,000 5 years Multi-period excess-earnings method Customer Relationships - Financial Relationships 11,000,000 8 years Multi-period excess-earnings method Internally Developed and Used Technology—APA 1,600,000 2 years Relief from Royalty Method Internally Developed and Used Technology—Market Place 100,000 3 years Replacement Cost Method Trade Name 900,000 Indefinite Relief from Royalty Method Non-Compete Agreements 4,000,000 2 years With or Without Method State Insurance Licenses 2,700,000 Indefinite Replacement Cost Method $ 32,900,000 Intangible assets and related accumulated amortization as of December 31, 2023 and 2022 are as follows: December 31, 2023 Definite Lived Intangible Assets: Gross Value Accumulated Amortization Net Book Value Customer Relationships - Agents $ 12,600,000 $ 1,260,000 $ 11,340,000 Customer Relationships - Financial Relationships 11,000,000 687,500 10,312,500 Internally Developed and Used Technology—APA 1,600,000 400,000 1,200,000 Internally Developed and Used Technology—Market Place 100,000 16,667 83,333 Non-Compete Agreements 4,000,000 1,000,000 3,000,000 Balance at December 31, 2023 $ 29,300,000 $ 3,364,167 $ 25,935,833 Indefinite Lived Intangible Assets: Trade Name 900,000 — 900,000 State Insurance Licenses 2,700,000 — 2,700,000 Total Intangible Asset Balance at December 31, 2023 $ 32,900,000 $ 3,364,167 $ 29,535,833
Schedule of Indefinite-Lived Intangible Assets	Intangible Assets Acquired comprised of the following: Asset Type Fair Value Useful Life Valuation Methodology Customer Relationships - Agents $ 12,600,000 5 years Multi-period excess-earnings method Customer Relationships - Financial Relationships 11,000,000 8 years Multi-period excess-earnings method Internally Developed and Used Technology—APA 1,600,000 2 years Relief from Royalty Method Internally Developed and Used Technology—Market Place 100,000 3 years Replacement Cost Method Trade Name 900,000 Indefinite Relief from Royalty Method Non-Compete Agreements 4,000,000 2 years With or Without Method State Insurance Licenses 2,700,000 Indefinite Replacement Cost Method $ 32,900,000 Intangible assets and related accumulated amortization as of December 31, 2023 and 2022 are as follows: December 31, 2023 Definite Lived Intangible Assets: Gross Value Accumulated Amortization Net Book Value Customer Relationships - Agents $ 12,600,000 $ 1,260,000 $ 11,340,000 Customer Relationships - Financial Relationships 11,000,000 687,500 10,312,500 Internally Developed and Used Technology—APA 1,600,000 400,000 1,200,000 Internally Developed and Used Technology—Market Place 100,000 16,667 83,333 Non-Compete Agreements 4,000,000 1,000,000 3,000,000 Balance at December 31, 2023 $ 29,300,000 $ 3,364,167 $ 25,935,833 Indefinite Lived Intangible Assets: Trade Name 900,000 — 900,000 State Insurance Licenses 2,700,000 — 2,700,000 Total Intangible Asset Balance at December 31, 2023 $ 32,900,000 $ 3,364,167 $ 29,535,833
Schedule of Estimated Annual Amortization for Intangible Assets	Estimated annual amortization of intangible assets for the next five years ending December 31 and thereafter is as follows: 2024 $ 6,728,333 2025 5,328,333 2026 3,911,667 2027 3,895,000 2028 2,635,000 Thereafter 3,437,500 Total $ 25,935,833

SEGMENT REPORTING (Tables)

SEGMENT REPORTING (Tables)	12 Months Ended
SEGMENT REPORTING (Tables)	Dec. 31, 2023
Segment Reporting [Abstract]
Summary of Revenue by Segment	Revenue related to the Company’s reporting segments is as follows: Years Ended December 31, 2023 2022 Portfolio servicing $ 1,002,174 $ 1,470,972 Active management 61,195,377 43,242,580 Originations 19,247,972 — Segment revenue (including inter-segment) 81,445,523 44,713,552 Intersegment elimination (15,044,072) — Total revenue $ 66,401,451 $ 44,713,552
Summary of Segment Information	Information related to the Company’s reporting segments for the years ended December 31, 2023 and 2022 is as follows: Years Ended December 31, 2023 2022 Portfolio servicing $ 278,115 $ 300,235 Active management 59,020,991 38,528,648 Originations 611,968 — Total gross profit 59,911,074 38,828,883 Sales and marketing (4,905,747) (2,596,140) General, administrative and other (including stock-based compensation) (26,482,571) (1,426,865) Depreciation and amortization expense (3,409,928) (4,282) Other (expense) income (146,443) (347,013) Loss on change in fair value of warrant liability (4,204,360) — Interest expense (9,866,821) (42,798) Interest income 594,764 1,474 Gain (Loss) on change in fair value of debt (2,356,058) (90,719) Unrealized (loss) gain on investments 1,369,112 (1,045,623) Provision for income taxes (1,468,535) (889,943) Less: Net gain (loss) attributable to non-controlling interests 482,139 (704,699) Net income attributable to Abacus Life, Inc. $ 9,516,626 $ 31,682,275

FAIR VALUE MEASUREMENTS (Tables

FAIR VALUE MEASUREMENTS (Tables)	12 Months Ended
FAIR VALUE MEASUREMENTS (Tables)	Dec. 31, 2023
Fair Value Disclosures [Abstract]
Fair Value Measurements, Recurring and Nonrecurring	The assets and liabilities measured at estimated fair value on a recurring basis and their corresponding placement in the fair value hierarchy are presented in the tables below. Fair Value Hierarchy As of December 31, 2023 Level 1 Level 2 Level 3 Total Assets: Life settlement policies $ — $ — $ 122,296,559 $ 122,296,559 Available-for-sale securities, at fair value — — 1,105,935 1,105,935 Other investments — — 1,650,000 1,650,000 S&P 500 options 2,348,998 — — 2,348,998 Other assets 998,945 — — 998,945 Total assets held at fair value $ 3,347,943 $ — $ 125,052,494 $ 128,400,437 Liabilities: Debt maturing within one year $ — $ — $ 13,029,632 $ 13,029,632 Long-term debt — — 55,318,924 55,318,924 Private placement warrants — — 6,642,960 6,642,960 Total liabilities held at fair value: $ — $ — $ 74,991,516 $ 74,991,516 Fair Value Hierarchy As of December 31, 2022 Level 1 Level 2 Level 3 Total Assets: Life settlement policies $ — $ — $ 13,809,352 $ 13,809,352 Available-for-sale securities, at fair value — — 1,000,000 1,000,000 Other investments — — 1,300,000 1,300,000 S&P 500 options 890,829 — — 890,829 Total assets held at fair value $ 890,829 $ — $ 16,109,352 $ 17,000,181 Liabilities: Long-term debt $ — $ — $ 28,249,653 $ 28,249,653 Total liabilities held at fair value: $ — $ — $ 28,249,653 $ 28,249,653
Fair Value Measurement Inputs and Valuation Techniques	If the discount rate increased or decreased by 2 percentage points and the other assumptions used to estimate fair value remained the same, the change in estimated fair value as of December 31, 2023, would be as follows: As of December 31, 2023 Fair Value Change in Rate Adjustment +2% $ 111,206,993 $ (11,089,566) No change 122,296,559 -2% 130,749,053 8,452,494 The following table presents the key assumptions in the analysis: Private Placement Warrants Expected implied volatility de minimis Risk-free interest rate 4.09% Term to expiration 5.0 years Exercise price $11.50 Common Stock Price $10.03 Dividend Yield —%
Schedules of Concentration of Risk, by Risk Factor	The following table provides information about the life insurance issuer concentrations that exceed 10% of total face value or 10% of total fair value of the Company’s life insurance policies as of December 31, 2023: Carrier Percentage of Percentage of Carrier John Hancock Life Insurance Company (U.S.A.) 28.0 % 20.0 % A+
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation	The following table provides a roll forward of the fair value of life insurance policies for the year ended December 31, 2023: Fair value at December 31, 2022 $ 13,809,352 Policies purchased 186,124,688 Realized gain (loss) on matured/sold policies 19,606,894 Premiums paid (4,281,610) Unrealized gain(loss) on held policies 27,889,106 Change in estimated fair value 43,214,390 Matured/sold policies (125,133,481) Premiums paid 4,281,610 Fair value at December 31, 2023 $ 122,296,559
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation	The following table provides a roll forward of the fair value of the issued notes for the year ended December 31, 2023: Fair value at December 31, 2022 $ 28,249,653 Debt issued to third parties 71,720,713 Debt issued to related parties 35,471,648 Unrealized loss on change in fair value (risk-free) 2,356,058 Unrealized loss on change in fair value (credit-adjusted) included in OCI 1,265,103 Unrealized gain on change in fair value (credit-adjusted) included in equity of NCI 407,028 Change in estimated fair value of debt 4,028,189 Accrued non-cash interest on related party debt 2,182,221 Deferred issuance costs and discounts (1,831,910) Fair value at December 31, 2023 $ 139,820,514

LONG-TERM DEBT (Tables)

LONG-TERM DEBT (Tables)	12 Months Ended
LONG-TERM DEBT (Tables)	Dec. 31, 2023
Debt Disclosure [Abstract]
Schedule of Carrying Values and Estimated Fair Values of Debt Instruments	Outstanding principal balances of Long-term debt comprises of the following: December 31, 2023 December 31, 2022 Cost Fair value Cost Fair value Market-indexed notes: LMATT Series 2024, Inc. $ 9,124,944 $ 9,477,780 $ 9,866,900 $ 8,067,291 LMATT Series 2.2024, Inc. 2,981,480 3,551,852 2,333,391 2,354,013 LMATT Growth & Income Series 1.2026, Inc 492,582 569,862 400,000 400,000 Secured borrowing: LMA Income Series, LP 21,889,444 22,368,209 17,428,349 17,428,349 LMA Income Series II, LP 32,380,852 32,380,852 — — Unsecured borrowing: Fixed Rate Senior Unsecured Notes 35,650,000 35,650,000 — — SPV Purchase and Sale Note 26,538,004 26,538,004 — — Sponsor PIK Note 11,115,865 11,115,865 — — Deferred issuance costs and discounts (1,831,910) (1,831,910) — — Total debt $ 138,341,261 $ 139,820,514 $ 30,028,640 $ 28,249,653 Less current portion of long-term debt $ (11,440,236) $ (13,029,632) — — Total long-term debt $ 126,901,025 $ 126,790,882 $ 30,028,640 $ 28,249,653
Schedule of Maturities of Long-Term Debt	The following table shows scheduled principal payments by year for our long-term debt as of December 31, 2023: Payments Year 2024 2025 2026 2027 2028 Thereafter Total Market-indexed notes: LMATT Series 2024, Inc. $ 9,477,780 $ — $ — $ — $ — $ — $ 9,477,780 LMATT Series 2.2024, Inc. 3,551,852 — — — — — 3,551,852 LMATT Growth & Income Series 1.2026, Inc. — — 569,862 — — — 569,862 Secured borrowing: LMA Income Series, LP — 22,368,209 — — — — 22,368,209 LMA Income Series II, LP — — 32,380,852 — — — 32,380,852 Unsecured borrowing: Fixed Rate Senior Unsecured Notes — — — — 35,650,000 — 35,650,000 SPV Purchase and Sale Note — — 26,538,004 — — — 26,538,004 Sponsor PIK Note — — — — 11,115,865 — 11,115,865 $ 13,029,632 $ 22,368,209 $ 59,488,718 $ — $ 46,765,865 $ — $ 141,652,424

SHAREHOLDERS' EQUITY (Tables)

SHAREHOLDERS' EQUITY (Tables)	12 Months Ended
SHAREHOLDERS' EQUITY (Tables)	Dec. 31, 2023
Equity [Abstract]
Schedule of Share Repurchase Activity	The following table summarizes stock repurchase activity under our share repurchase program: Total Number of Shares Purchased Cost of Shares Repurchased Average Price Paid per Share As of December 31, 2022 — $ — $ — December 1, 2023 - December 31, 2023 146,650 1,283,062 8.82 As of December 31, 2023 146,650 $ 1,283,062 $ 8.82

STOCK-BASED COMPENSATION (Table

STOCK-BASED COMPENSATION (Tables)	12 Months Ended
STOCK-BASED COMPENSATION (Tables)	Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]
Share-Based Payment Arrangement, Restricted Stock Unit, Activity	The following table shows a summary of the unvested restricted stock under the 2023 Long-Term Equity Compensation Incentive Plan as of December 31, 2023 as well as activity during the year: Weighted Average Number of shares Grant Date Fair Value Restricted stock units, unvested, December 31, 2022 — $ — Granted 2,468,500 6.16 Vested (39,000) 6.16 Forfeited — — Restricted stock units, unvested, December 31, 2023 2,429,500 6.16 Restricted Stock activity relative to the CEO for the year ended December 31, 2023 is summarized as follows: Number of Shares Weighted Average Grant Date Fair Value Outstanding at December 31, 2022 — $ — Granted 4,569,922 10.03 Forfeited — — Settled — — Outstanding at December 31, 2023 4,569,922 $ 10.03
Share-Based Payment Arrangement, Expense	CEO Stock-based compensation expense is recorded in general and administrative expense (including stock-based compensation) summarized as follows: Years Ended December 31, 2023 2022 Stock-based compensation expense $ 9,167,264 $ —

INCOME TAXES (Tables)

INCOME TAXES (Tables)	12 Months Ended
INCOME TAXES (Tables)	Dec. 31, 2023
Income Tax Disclosure [Abstract]
Schedule of Components of Income Tax Expense (Benefit)	The components of the provision for income taxes are as follows: For the Years Ended December 31, 2023 2022 Current provision: Federal $ 706,686 $ — State 195,679 — Foreign — — Total current tax 902,365 — Deferred provision: Federal 469,109 737,376 State 97,061 152,567 Foreign — — Total deferred tax 566,170 889,943 Provision for income taxes $ 1,468,535 $ 889,943
Schedule of Effective Income Tax Rate Reconciliation	The effective income tax rate differs from the federal statutory income tax rate applied to the profit loss before provision for income taxes due to the following: For the Years Ended December 31, 2023 2022 Income tax benefit computed at federal statutory rate $ 2,205,635 $ 6,988,538 Restricted stock award deductions limited by IRC 162(m) 2,069,993 — Change in tax status 1,414,469 — Effect of pass through entities and noncontrolling interests (3,812,977) (6,147,453) State income taxes, net of federal tax benefit (332,567) 174,024 Other (76,018) — Valuation allowance — (125,166) Income tax at effective rate $ 1,468,535 $ 889,943
Schedule of Deferred Tax Assets and Liabilities	The effects of temporary differences that give rise to significant components of deferred tax assets and liabilities at December 31, are as follows : 2023 2022 Deferred tax assets: Basis difference related to life insurance policy sales $ 1,798,639 $ 109,902 Warrant liability 1,683,658 — Interest expense carryforward 740,657 — Stock-based compensation 598,274 — Right of use liability 455,380 — Change in fair value of debt 405,804 — Change in fair value of investments — 264,196 Net operating loss carryforwards 21,470 167,554 5,703,882 541,652 Less: valuation allowance — — Deferred tax assets 5,703,882 541,652 Deferred tax liabilities: Basis difference in intangible assets (7,480,659) — Change in fair value of life insurance policies (policies held at fair value method) (4,318,194) (1,454,588) Basis difference in investments (2,398,987) — Change in fair value of debt — (450,884) Other (705,133) — Deferred tax liabilities (14,902,973) (1,905,472) Net deferred tax liability $ (9,199,091) $ (1,363,820)

RELATED-PARTY TRANSACTIONS (Tab

RELATED-PARTY TRANSACTIONS (Tables)	12 Months Ended
RELATED-PARTY TRANSACTIONS (Tables)	Dec. 31, 2023
Related Party Transactions [Abstract]
Schedule of Related Party Transactions	For the year ended December 31, 2023, revenue earned, and contracts originated are below. Year Ended December 31, 2023 Origination fee revenue $ 259,517 Transaction reimbursement revenue 235,455 Total $ 494,972 Cost $ 99,456 Face value $ 46,650,000 Total policies 7 Average Age 70

LEASES (Tables)

LEASES (Tables)	12 Months Ended
LEASES (Tables)	Dec. 31, 2023
Leases [Abstract]
ROU Assets and Lease Liabilities	The Company’s right-of-use assets and lease liabilities for its operating lease consisted of the following amounts as of December 31, 2023 and 2022: As of December 31, Assets: 2023 2022 Operating lease right-of-use assets $ 1,893,659 $ 77,011 Liabilities: Operating lease liability, current 118,058 48,127 Operating lease liability, non-current 1,796,727 29,268 Total lease liability $ 1,914,785 $ 77,395 The table below shows a weighted-average analysis for lease terms and discount rates for all operating leases for the periods presented: Years Ended December 31, 2023 2022 Weighted-average remaining lease term (in years) 6.01 1.58 Weighted-average discount rate 9.67 % 3.36 %
Lease Expense	The Company’s lease expense for the periods presented consisted of the following: Years Ended December 31, 2023 2022 Operating lease cost $ 207,508 $ 48,784 Variable lease cost 16,103 3,664 Total lease cost $ 223,611 $ 52,448 The following table shows supplemental cash flow information related to lease activities for the periods presented: Years Ended December 31, 2023 2022 Cash paid for amounts included in the measurement of the lease liability Operating cash outflows for operating leases $ 201,200 $ 48,399 ROU assets obtained in exchange for new lease liabilities 1,782,726 —
Future Minimum Noncancellable Lease Payments	Future minimum noncancellable lease payments under the Company’s operating leases on an undiscounted basis reconciled to the respective lease liability at December 31, 2023 are as follows: Operating leases 2024 $ 118,058 2025 471,239 2026 485402 2027 499,980 2028 514,946 Thereafter 530,391 Total operating lease payments (undiscounted) 2,620,016 Less: Imputed interest (705,231) Lease liability as of December 31, 2023 $ 1,914,785

EARNINGS PER SHARE (Tables)

EARNINGS PER SHARE (Tables)	12 Months Ended
EARNINGS PER SHARE (Tables)	Dec. 31, 2023
Earnings Per Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted	Basic and diluted weighted average shares outstanding and earnings per share were as follows: For Years Ended December 31, 2023 2022 Net income attributable to common stockholders (same for diluted earnings per share) $ 9,516,626 $ 31,682,275 Weighted-average common shares outstanding for basic earnings per share 56,951,414 50,369,350 Restricted stock units 816,484 — Shares used for diluted earnings per share 57,767,898 50,369,350 Earnings per share: Basic earnings per share $ 0.17 $ 0.63 Diluted earnings per share $ 0.16 $ 0.63

Abacus Settlements LLC - REVE_2

Abacus Settlements LLC - REVENUE (Tables)	12 Months Ended
Abacus Settlements LLC - REVENUE (Tables)	Dec. 31, 2023
Subsidiary of Limited Liability Company or Limited Partnership [Line Items]
Disaggregation of Revenue	The following table presents a disaggregation of the Company’s revenue by major sources as follows: Years Ended December 31, 2023 2022 Agent $ 1,750,911 $ — Broker 2,148,141 — Client direct 304,848 — Total $ 4,203,900 $ —
Abacus Settlements, LLC
Subsidiary of Limited Liability Company or Limited Partnership [Line Items]
Disaggregation of Revenue	The following table presents a disaggregation of Abacus’ revenue by major sources: Six Months Ended Year Ended December 31, 2023 2022 Agent $ 7,143,016 $ 12,156,552 Broker 4,675,973 9,938,808 Client direct 1,365,687 3,108,103 Total $ 13,184,676 $ 25,203,463

Abacus Settlements LLC - RELA_2

Abacus Settlements LLC - RELATED-PARTY TRANSACTIONS (Tables)	12 Months Ended
	Dec. 31, 2023
Subsidiary of Limited Liability Company or Limited Partnership [Line Items]
Schedule of Related Party Transactions	For the year ended December 31, 2023, revenue earned, and contracts originated are below. Year Ended December 31, 2023 Origination fee revenue $ 259,517 Transaction reimbursement revenue 235,455 Total $ 494,972 Cost $ 99,456 Face value $ 46,650,000 Total policies 7 Average Age 70
Abacus Settlements, LLC
Subsidiary of Limited Liability Company or Limited Partnership [Line Items]
Schedule of Related Party Transactions	For three months ended June 30, 2023 and 2022, and for the six months ended June 30, 2023 and nine months ended September 30, 2022, revenue earned, and contracts originated are as follows: Six Months Ended Year Ended December 31, 2023 2022 Origination fee revenue $ 2,952,837 $ 6,586,922 Commissions and transaction reimbursement revenue 140,960 8,656,885 Total $ 3,093,797 $ 15,243,806 Cost $ 11,656,637 $ 87,143,005 Face value 96,674,080 481,648,010 Total policies 72 333 Average Age 75 75

DESCRIPTION OF BUSINESS (Detail

DESCRIPTION OF BUSINESS (Details)	Dec. 31, 2023 $ / shares
Business Acquisition [Line Items]
Common stock, par value (in dollars per share)	$ 0.0001
LMA
Business Acquisition [Line Items]
Exchange ratio	0.8

SUMMARY OF SIGNIFICANT ACCOUN_4

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Consolidation of Variable Interest Entities (Details)		12 Months Ended
	Oct. 04, 2021 USD ($) investor	Dec. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)	Jan. 01, 2021 provider
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]
Assets		$ 331,826,067	$ 59,094,847
Liabilities		167,755,991	30,945,150
Number of unaffiliated investors \| investor	3
Option agreement, number of providers \| provider				2
Other income (expense)		(146,443)	(347,013)
Variable Interest Entity, Primary Beneficiary
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]
Assets		77,132,592	30,073,972
Liabilities		65,031,207	27,116,762
Contribution amount	$ 100
Variable Interest Entity, Primary Beneficiary \| LMX
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]
Ownership percentage	70%
Variable Interest Entity, Not Primary Beneficiary
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]
Assets		601,762	987,964
Liabilities		2,900	358,586
Variable Interest Entity, Not Primary Beneficiary \| Expense Support Agreement
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]
Other income (expense)		$ 144,721	$ 347,013

SUMMARY OF SIGNIFICANT ACCOUN_5

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Available-for-sale Securities (Details) - USD ($)	Dec. 31, 2023	Dec. 31, 2022
Accounting Policies [Abstract]
Accrued interest on available-for-sale securities	$ 105,935	$ 0
Debt Securities, Available-for-Sale, Accrued Interest, after Allowance for Credit Loss, Statement of Financial Position [Extensible Enumeration]	Available-for-sale securities, at fair value	Available-for-sale securities, at fair value

SUMMARY OF SIGNIFICANT ACCOUN_6

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Property and Equipment Useful Life (Details)	Dec. 31, 2023
Computer equipment
Property, Plant and Equipment [Line Items]
Property and equipment useful lives	5 years
Furniture and fixtures
Property, Plant and Equipment [Line Items]
Property and equipment useful lives	5 years

SUMMARY OF SIGNIFICANT ACCOUN_7

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Goodwill and Intangible Assets, Net (Details)	Dec. 31, 2023
Internal-Use Software
Finite-Lived Intangible Assets [Line Items]
Useful Life	3 years

SUMMARY OF SIGNIFICANT ACCOUN_8

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Revenue Recognition (Details) - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Revenue from External Customer [Line Items]
Performance obligations to be satisfied		$ 0
Minimum
Revenue from External Customer [Line Items]
Service arrangement contractual terms	1 month
Maximum
Revenue from External Customer [Line Items]
Service arrangement contractual terms	10 years
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-01-01
Revenue from External Customer [Line Items]
Performance obligations to be satisfied	$ 507,000
Performance obligations to be satisfied, period	1 year

SUMMARY OF SIGNIFICANT ACCOUN_9

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Disaggregated Revenue (Details) - Origination fee revenue - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Disaggregation of Revenue [Line Items]
Revenue	$ 4,203,900	$ 0
Agent
Disaggregation of Revenue [Line Items]
Revenue	1,750,911	0
Broker
Disaggregation of Revenue [Line Items]
Revenue	2,148,141	0
Client direct
Disaggregation of Revenue [Line Items]
Revenue	$ 304,848	$ 0

SUMMARY OF SIGNIFICANT ACCOU_10

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Contract Liabilities (Details) - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Change In Contract With Customer, Liability [Roll Forward]
Contract liabilities—beginning of year	$ 0	$ 0
Additions to Contract Liabilities	507,000	0
Recognition of revenue deferred in the prior year	0	0
Contract liabilities—end of year	$ 507,000	$ 0

SUMMARY OF SIGNIFICANT ACCOU_11

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Segments (Details) - segment	6 Months Ended	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2023
Accounting Policies [Abstract]
Number of operating segments		3
Number of reportable segments	3	3

SUMMARY OF SIGNIFICANT ACCOU_12

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Concentrations (Details) - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Concentration Risk [Line Items]
Allowance for doubtful accounts	$ 0	$ 0
Customer Concentration Risk \| Accounts Receivable \| Customer 1 \| Related Party
Concentration Risk [Line Items]
Concentration risk percentage	59%	75%
Customer Concentration Risk \| Accounts Receivable \| Customer 2 \| Related Party
Concentration Risk [Line Items]
Concentration risk percentage	33%	16%
Customer Concentration Risk \| Revenue Benchmark \| Customer 1 \| Related Party \| Portfolio servicing
Concentration Risk [Line Items]
Concentration risk percentage	78%	28%
Customer Concentration Risk \| Revenue Benchmark \| Customer 1 \| Nonrelated Party \| Active management
Concentration Risk [Line Items]
Concentration risk percentage	49%	51%
Customer Concentration Risk \| Revenue Benchmark \| Customer 2 \| Related Party \| Portfolio servicing
Concentration Risk [Line Items]
Concentration risk percentage		28%
Customer Concentration Risk \| Revenue Benchmark \| Customer 2 \| Nonrelated Party \| Active management
Concentration Risk [Line Items]
Concentration risk percentage	14%
Customer Concentration Risk \| Revenue Benchmark \| Customer 3 \| Nonrelated Party \| Active management
Concentration Risk [Line Items]
Concentration risk percentage	12%
Customer Concentration Risk \| Investment Method Revenue Benchmark \| Customer 1 \| Nonrelated Party
Concentration Risk [Line Items]
Concentration risk percentage		22%

SUMMARY OF SIGNIFICANT ACCOU_13

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Stock-Based Compensation (Details)	12 Months Ended
	Dec. 31, 2023
Accounting Policies [Abstract]
Stock-based awards vesting period	3 years

BUSINESS COMBINATION - Narrativ

BUSINESS COMBINATION - Narrative (Details)	Jun. 30, 2023 USD ($)
LMA and Abacus
Business Acquisition [Line Items]
Consideration	$ 531,750,000
LMA and Abacus \| Customer Relationships - Agents
Business Acquisition [Line Items]
Useful Life	5 years
LMA and Abacus \| Customer Relationships - Financial Relationships
Business Acquisition [Line Items]
Useful Life	8 years
LMA
Business Acquisition [Line Items]
Consideration	$ 366,388,668
Enterprise value	366,400,000
LMA \| Minimum \| Discounted cash flow method
Business Acquisition [Line Items]
Enterprise value	380,000,000
LMA \| Minimum \| Market approach
Business Acquisition [Line Items]
Enterprise value	400,000,000
LMA \| Maximum \| Discounted cash flow method
Business Acquisition [Line Items]
Enterprise value	460,000,000
LMA \| Maximum \| Market approach
Business Acquisition [Line Items]
Enterprise value	$ 440,000,000
LMA \| Discount rate
Business Acquisition [Line Items]
Measurement input	0.145
Abacus Settlements
Business Acquisition [Line Items]
Consideration	$ 165,361,332
Enterprise value	165,400,000
Abacus Settlements \| Minimum \| Discounted cash flow method
Business Acquisition [Line Items]
Enterprise value	180,000,000
Abacus Settlements \| Minimum \| Market approach
Business Acquisition [Line Items]
Enterprise value	180,000,000
Abacus Settlements \| Maximum \| Discounted cash flow method
Business Acquisition [Line Items]
Enterprise value	195,000,000
Abacus Settlements \| Maximum \| Market approach
Business Acquisition [Line Items]
Enterprise value	$ 190,000,000
Abacus Settlements \| Discount rate
Business Acquisition [Line Items]
Measurement input	0.165

BUSINESS COMBINATION - Purchase

BUSINESS COMBINATION - Purchase Price Allocation (Details) - USD ($)	Dec. 31, 2023	Jun. 30, 2023	Dec. 31, 2022
Business Acquisition [Line Items]
Intangibles	$ 32,900,000
Goodwill	140,287,000		$ 0
LMA and Abacus
Business Acquisition [Line Items]
Intangibles	$ 32,900,000	$ 32,900,000
Goodwill		140,287,000
Current Assets		1,280,100
Non-Current Assets		901,337
Deferred Tax Liabilities		(8,310,966)
Accrued Expenses		(524,400)
Other Liabilities		(1,171,739)
Total Fair Value		$ 165,361,332

BUSINESS COMBINATION - Value Co

BUSINESS COMBINATION - Value Conveyed (Details)	Jun. 30, 2023 USD ($)
Abacus Settlements
Business Acquisition [Line Items]
Consideration	$ 165,361,332
LMA
Business Acquisition [Line Items]
Consideration	366,388,668
LMA and Abacus
Business Acquisition [Line Items]
Consideration	$ 531,750,000

BUSINESS COMBINATION - Intangib

BUSINESS COMBINATION - Intangible Assets Acquired (Details) - USD ($)	Jun. 30, 2023	Dec. 31, 2023
Business Acquisition [Line Items]
Intangibles		$ 32,900,000
Trade Name
Business Acquisition [Line Items]
Intangibles		900,000
State Insurance Licenses
Business Acquisition [Line Items]
Intangibles		2,700,000
Customer Relationships - Agents
Business Acquisition [Line Items]
Intangibles		12,600,000
Customer Relationships - Financial Relationships
Business Acquisition [Line Items]
Intangibles		11,000,000
Internally Developed and Used Technology—APA
Business Acquisition [Line Items]
Intangibles		1,600,000
Internally Developed and Used Technology—Market Place
Business Acquisition [Line Items]
Intangibles		100,000
Non-Compete Agreements
Business Acquisition [Line Items]
Intangibles		4,000,000
LMA and Abacus
Business Acquisition [Line Items]
Intangibles	$ 32,900,000	$ 32,900,000
LMA and Abacus \| Trade Name
Business Acquisition [Line Items]
Intangibles	900,000
LMA and Abacus \| State Insurance Licenses
Business Acquisition [Line Items]
Intangibles	2,700,000
LMA and Abacus \| Customer Relationships - Agents
Business Acquisition [Line Items]
Intangibles	$ 12,600,000
Useful Life	5 years
LMA and Abacus \| Customer Relationships - Financial Relationships
Business Acquisition [Line Items]
Intangibles	$ 11,000,000
Useful Life	8 years
LMA and Abacus \| Internally Developed and Used Technology—APA
Business Acquisition [Line Items]
Intangibles	$ 1,600,000
Useful Life	2 years
LMA and Abacus \| Internally Developed and Used Technology—Market Place
Business Acquisition [Line Items]
Intangibles	$ 100,000
Useful Life	3 years
LMA and Abacus \| Non-Compete Agreements
Business Acquisition [Line Items]
Intangibles	$ 4,000,000
Useful Life	2 years

BUSINESS COMBINATION - Pro Form

BUSINESS COMBINATION - Pro Forma Financial Information (Details) - LMA and Abacus - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Business Acquisition [Line Items]
Proforma revenue	$ 79,588,733	$ 69,917,015
Proforma net income	$ 8,541,727	$ 31,629,781

LIFE SETTLEMENT POLICIES - Narr

LIFE SETTLEMENT POLICIES - Narrative (Details)	Dec. 31, 2023 USD ($) insurance_contract	Dec. 31, 2022 USD ($) insurance_contract
Investments, All Other Investments [Abstract]
Number of life settlement policies \| insurance_contract	296	53
Number of life settlement policies accounted for under fair value method \| insurance_contract	287	35
Number of life settlement policies accounted for under investment method \| insurance_contract	9	18
Face value of policies held at fair value	$ 520,503,710	$ 40,092,154
Life settlement policies, at fair value	122,296,559	13,809,352
Face value of policies accounted for using investment method	33,900,000	42,330,000
Life settlement policies, at cost	$ 1,697,178	$ 8,716,111

LIFE SETTLEMENT POLICIES - Fair

LIFE SETTLEMENT POLICIES - Fair Value (Details)	Dec. 31, 2023 USD ($) insurance_contract	Dec. 31, 2022 USD ($) insurance_contract
Policies
0-1 \| insurance_contract	2
1-2 \| insurance_contract	6
2-3 \| insurance_contract	13
3-4 \| insurance_contract	41
4-5 \| insurance_contract	29
Thereafter \| insurance_contract	196
Policies \| insurance_contract	287	35
Face Value
0-1	$ 383,461
1-2	4,391,193
2-3	20,692,550
3-4	66,017,222
4-5	57,814,969
Thereafter	371,204,315
Face Value	520,503,710	$ 40,092,154
Fair Value
0-1	315,248
1-2	1,590,513
2-3	10,850,243
3-4	22,744,161
4-5	19,326,245
Thereafter	67,470,149
Fair Value	$ 122,296,559	$ 13,809,352

LIFE SETTLEMENT POLICIES - Inve

LIFE SETTLEMENT POLICIES - Investment Method (Details)	Dec. 31, 2023 USD ($) insurance_contract	Dec. 31, 2022 USD ($) insurance_contract
Number of Life Insurance Policies
0-1 \| insurance_contract	0
1-2 \| insurance_contract	1
2-3 \| insurance_contract	2
3-4 \| insurance_contract	1
4-5 \| insurance_contract	2
Thereafter \| insurance_contract	3
Number of Life Insurance Policies \| insurance_contract	9	18
Face Value
0-1	$ 0
1-2	500,000
2-3	1,500,000
3-4	8,000,000
4-5	500,000
Thereafter	23,400,000
Face Value	33,900,000	$ 42,330,000
Carrying Value
0-1	0
1-2	329,714
2-3	443,544
3-4	84,199
4-5	320,110
Thereafter	519,611
Carrying Value	$ 1,697,178	$ 8,716,111

LIFE SETTLEMENT POLICIES - Esti

LIFE SETTLEMENT POLICIES - Estimated Premiums (Details)	Dec. 31, 2023 USD ($)
Investments, All Other Investments [Abstract]
2024	$ 88,039
2025	100,785
2026	78,850
2027	50,388
2028	32,736
Thereafter	366,103
Total	$ 716,901

PROPERTY AND EQUIPMENT_NET (Det

PROPERTY AND EQUIPMENT—NET (Details) - USD ($)	12 Months Ended
PROPERTY AND EQUIPMENT—NET (Details) - USD ($)	Dec. 31, 2023	Dec. 31, 2022
Property, Plant and Equipment [Line Items]
Property and equipment—gross	$ 470,482	$ 25,346
Less: accumulated depreciation	(69,762)	(6,729)
Property and equipment—net	400,720	18,617
Depreciation expense	63,033	4,282
Computer equipment
Property, Plant and Equipment [Line Items]
Property and equipment—gross	356,939	0
Furniture and fixtures
Property, Plant and Equipment [Line Items]
Property and equipment—gross	91,125	19,444
Leasehold improvements
Property, Plant and Equipment [Line Items]
Property and equipment—gross	$ 22,418	$ 5,902

GOODWILL AND OTHER INTANGIBLE_3

GOODWILL AND OTHER INTANGIBLE ASSETS - Changes in Goodwill by Reportable Segments (Details)	12 Months Ended
	Dec. 31, 2023 USD ($)
Goodwill [Roll Forward]
Goodwill at beginning of period	$ 0
Goodwill at end of period	140,287,000
Portfolio servicing
Goodwill [Roll Forward]
Goodwill at beginning of period	0
Additions	0
Goodwill at end of period	0
Active management
Goodwill [Roll Forward]
Goodwill at beginning of period	0
Additions	0
Goodwill at end of period	0
Originations
Goodwill [Roll Forward]
Goodwill at beginning of period	0
Additions	140,287,000
Goodwill at end of period	$ 140,287,000

GOODWILL AND OTHER INTANGIBLE_4

GOODWILL AND OTHER INTANGIBLE ASSETS - Intangible Assets Acquired (Details) $ in Thousands	Dec. 31, 2023 USD ($)
Finite-Lived Intangible Assets [Line Items]
Fair Value	$ 32,900
Indefinite-Lived Intangible Assets [Line Items]
Fair Value	32,900
Trade Name
Finite-Lived Intangible Assets [Line Items]
Fair Value	900
Indefinite-Lived Intangible Assets [Line Items]
Fair Value	900
State Insurance Licenses
Finite-Lived Intangible Assets [Line Items]
Fair Value	2,700
Indefinite-Lived Intangible Assets [Line Items]
Fair Value	2,700
Customer Relationships - Agents
Finite-Lived Intangible Assets [Line Items]
Fair Value	$ 12,600
Useful Life	5 years
Indefinite-Lived Intangible Assets [Line Items]
Fair Value	$ 12,600
Customer Relationships - Financial Relationships
Finite-Lived Intangible Assets [Line Items]
Fair Value	$ 11,000
Useful Life	8 years
Indefinite-Lived Intangible Assets [Line Items]
Fair Value	$ 11,000
Internally Developed and Used Technology—APA
Finite-Lived Intangible Assets [Line Items]
Fair Value	$ 1,600
Useful Life	2 years
Indefinite-Lived Intangible Assets [Line Items]
Fair Value	$ 1,600
Internally Developed and Used Technology—Market Place
Finite-Lived Intangible Assets [Line Items]
Fair Value	$ 100
Useful Life	3 years
Indefinite-Lived Intangible Assets [Line Items]
Fair Value	$ 100
Non-Compete Agreements
Finite-Lived Intangible Assets [Line Items]
Fair Value	$ 4,000
Useful Life	2 years
Indefinite-Lived Intangible Assets [Line Items]
Fair Value	$ 4,000

GOODWILL AND OTHER INTANGIBLE_5

GOODWILL AND OTHER INTANGIBLE ASSETS - Intangible Assets and Accumulated Amortization (Details) - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Schedule of Intangible Assets [Line Items]
Gross Value	$ 29,300,000
Accumulated Amortization	3,364,167
Net Book Value	25,935,833
Intangible assets, net	29,623,130	$ 0
Amortization expense	3,364,167	$ 0
Other intangible assets	87,297
Trade Name
Schedule of Intangible Assets [Line Items]
Indefinite Lived Intangible Assets	900,000
State Insurance Licenses
Schedule of Intangible Assets [Line Items]
Indefinite Lived Intangible Assets	2,700,000
Finite-Lived Intangible Assets Excluding Other Insignificant Amount \| Indefinite-Lived Intangible Assets Excluding Other Insignificant Amount
Schedule of Intangible Assets [Line Items]
Accumulated Amortization	3,364,167
Gross Value	32,900,000
Intangible assets, net	29,535,833
Customer Relationships - Agents
Schedule of Intangible Assets [Line Items]
Gross Value	12,600,000
Accumulated Amortization	1,260,000
Net Book Value	11,340,000
Customer Relationships - Financial Relationships
Schedule of Intangible Assets [Line Items]
Gross Value	11,000,000
Accumulated Amortization	687,500
Net Book Value	10,312,500
Internally Developed and Used Technology—APA
Schedule of Intangible Assets [Line Items]
Gross Value	1,600,000
Accumulated Amortization	400,000
Net Book Value	1,200,000
Internally Developed and Used Technology—Market Place
Schedule of Intangible Assets [Line Items]
Gross Value	100,000
Accumulated Amortization	16,667
Net Book Value	83,333
Non-Compete Agreements
Schedule of Intangible Assets [Line Items]
Gross Value	4,000,000
Accumulated Amortization	1,000,000
Net Book Value	$ 3,000,000

GOODWILL AND OTHER INTANGIBLE_6

GOODWILL AND OTHER INTANGIBLE ASSETS - Estimated Annual Amortization (Details)	Dec. 31, 2023 USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
2024	$ 6,728,333
2025	5,328,333
2026	3,911,667
2027	3,895,000
2028	2,635,000
Thereafter	3,437,500
Net Book Value	$ 25,935,833

AVAILABLE-FOR-SALE SECURITIES_2

AVAILABLE-FOR-SALE SECURITIES, AT FAIR VALUE (Details) - USD ($)		1 Months Ended			12 Months Ended
	Jan. 07, 2022	Oct. 31, 2022	Jan. 31, 2022	Nov. 30, 2021	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Investments, Debt and Equity Securities [Abstract]
Purchase of convertible promissory note	$ 250,000	$ 500,000	$ 250,000	$ 250,000	$ 0	$ 750,000	$ 250,000
Interest rate per annum		8%		6%
Equity financing threshold		$ 5,000,000		$ 1,000,000
Available-for-sale securities, at fair value					1,105,935	1,000,000
Accrued interest on available-for-sale securities					$ 105,935	$ 0

OTHER INVESTMENTS AND OTHER N_2

OTHER INVESTMENTS AND OTHER NONCURRENT ASSETS (Details)			1 Months Ended	12 Months Ended
OTHER INVESTMENTS AND OTHER NONCURRENT ASSETS (Details)	Dec. 21, 2020 USD ($) shares	Jul. 22, 2020 USD ($) shares	Dec. 31, 2022 USD ($) payment shares	Dec. 31, 2023 USD ($) entity	Dec. 31, 2022 USD ($) payment	Sep. 30, 2023 USD ($)	Jun. 30, 2023 USD ($)
Conversion of Stock [Line Items]
Number of entities, convertible preferred stock ownership \| entity				2
Equity securities without readily determinable fair value, amount			$ 1,300,000	$ 1,650,000	$ 1,300,000
Impairment of investments				0	0
Series Seed Preferred Units
Conversion of Stock [Line Items]
Units purchased (in shares) \| shares		224,551	119,760
Equity securities without readily determinable fair value, amount		$ 750,000	$ 400,000	$ 1,150,000	$ 400,000	$ 1,100,000	$ 950,000
Number of monthly payments \| payment			8		8
Monthly payment amount			$ 50,000
Equity ownership percentage				8.60%
Series B-1 Preferred Stock
Conversion of Stock [Line Items]
Units purchased (in shares) \| shares	207,476
Equity securities without readily determinable fair value, amount	$ 500,000
Equity ownership percentage	1%

CONSOLIDATION OF VARIABLE INT_2

CONSOLIDATION OF VARIABLE INTEREST ENTITIES (Details) - USD ($)	Dec. 31, 2023	Dec. 31, 2022
Variable Interest Entity [Line Items]
Assets	$ 331,826,067	$ 59,094,847
Liabilities	167,755,991	30,945,150
Variable Interest Entity, Primary Beneficiary
Variable Interest Entity [Line Items]
Assets	77,132,592	30,073,972
Liabilities	65,031,207	27,116,762
Variable Interest Entity, Not Primary Beneficiary
Variable Interest Entity [Line Items]
Assets	601,762	987,964
Liabilities	$ 2,900	$ 358,586

SEGMENT REPORTING - Narrative (

SEGMENT REPORTING - Narrative (Details) - segment	6 Months Ended		12 Months Ended
SEGMENT REPORTING - Narrative (Details) - segment	Dec. 31, 2023	Jun. 30, 2023	Dec. 31, 2023
Segment Reporting Information [Line Items]
Number of operating segments			3
Number of reportable segments	3		3
Abacus Settlements
Segment Reporting Information [Line Items]
Number of operating segments		1
Number of reportable segments		1
LMA
Segment Reporting Information [Line Items]
Number of operating segments		2

SEGMENT REPORTING - Revenue by

SEGMENT REPORTING - Revenue by Segment (Details) - USD ($)	12 Months Ended
SEGMENT REPORTING - Revenue by Segment (Details) - USD ($)	Dec. 31, 2023	Dec. 31, 2022
Segment Reporting Information [Line Items]
Total revenues	$ 66,401,451	$ 44,713,552
Operating Segments
Segment Reporting Information [Line Items]
Total revenues	81,445,523	44,713,552
Operating Segments \| Portfolio servicing
Segment Reporting Information [Line Items]
Revenue	1,002,174	1,470,972
Operating Segments \| Active management
Segment Reporting Information [Line Items]
Active management	61,195,377	43,242,580
Operating Segments \| Originations
Segment Reporting Information [Line Items]
Revenue	19,247,972	0
Intercompany Elimination
Segment Reporting Information [Line Items]
Total revenues	$ (15,044,072)	$ 0

SEGMENT REPORTING - Reconciliat

SEGMENT REPORTING - Reconciliation of Net Income (Details) - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Segment Reporting Information [Line Items]
Total gross profit	$ 59,911,074	$ 38,828,883
Sales and marketing	(4,905,747)	(2,596,140)
General, administrative and other (including stock-based compensation)	(26,482,571)	(1,426,865)
Depreciation and amortization expense	(3,409,928)	(4,282)
Other (expense) income	(146,443)	(347,013)
Loss on change in fair value of warrant liability	(4,204,360)	0
Interest expense	(9,866,821)	(42,798)
Interest income	594,764	1,474
Gain (Loss) on change in fair value of debt	(2,356,058)	(90,719)
Unrealized (loss) gain on investments	1,369,112	(1,045,623)
Provision for income taxes	(1,468,535)	(889,943)
Less: Net gain (loss) attributable to non-controlling interests	482,139	(704,699)
NET INCOME ATTRIBUTABLE TO COMMON STOCKHOLDERS	9,516,626	31,682,275
Portfolio servicing
Segment Reporting Information [Line Items]
Total gross profit	278,115	300,235
Active management
Segment Reporting Information [Line Items]
Total gross profit	59,020,991	38,528,648
Originations
Segment Reporting Information [Line Items]
Total gross profit	$ 611,968	$ 0

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Details) - USD ($)	12 Months Ended
COMMITMENTS AND CONTINGENCIES (Details) - USD ($)	Dec. 31, 2023	Dec. 31, 2022
Other Commitments [Line Items]
Other income (expense)	$ (146,443)	$ (347,013)
Expense Support Agreement \| Variable Interest Entity, Not Primary Beneficiary
Other Commitments [Line Items]
Other income (expense)	$ 144,721	$ 347,013

FAIR VALUE MEASUREMENTS - Recur

FAIR VALUE MEASUREMENTS - Recurring Fair Value Measurements (Details) - USD ($)	Dec. 31, 2023	Dec. 31, 2022
Assets:
Life settlement policies	$ 122,296,559	$ 13,809,352
Available-for-sale securities, at fair value	1,105,935	1,000,000
Other investments	1,650,000	1,300,000
Liabilities:
Private placement warrants	6,642,960	0
Fair Value, Recurring
Assets:
Life settlement policies	122,296,559	13,809,352
Available-for-sale securities, at fair value	1,105,935	1,000,000
Other investments	1,650,000	1,300,000
S&P 500 options	2,348,998	890,829
Other assets	998,945
Total assets held at fair value	128,400,437	17,000,181
Liabilities:
Debt maturing within one year	13,029,632
Long-term debt	55,318,924	28,249,653
Private placement warrants	6,642,960
Total liabilities held at fair value:	74,991,516	28,249,653
Fair Value, Recurring \| Level 1
Assets:
Life settlement policies	0	0
Available-for-sale securities, at fair value	0	0
Other investments	0	0
S&P 500 options	2,348,998	890,829
Other assets	998,945
Total assets held at fair value	3,347,943	890,829
Liabilities:
Debt maturing within one year	0
Long-term debt	0	0
Private placement warrants	0
Total liabilities held at fair value:	0	0
Fair Value, Recurring \| Level 2
Assets:
Life settlement policies	0	0
Available-for-sale securities, at fair value	0	0
Other investments	0	0
S&P 500 options	0	0
Other assets	0
Total assets held at fair value	0	0
Liabilities:
Debt maturing within one year	0
Long-term debt	0	0
Private placement warrants	0
Total liabilities held at fair value:	0	0
Fair Value, Recurring \| Level 3
Assets:
Life settlement policies	122,296,559	13,809,352
Available-for-sale securities, at fair value	1,105,935	1,000,000
Other investments	1,650,000	1,300,000
S&P 500 options	0	0
Other assets	0
Total assets held at fair value	125,052,494	16,109,352
Liabilities:
Debt maturing within one year	13,029,632
Long-term debt	55,318,924	28,249,653
Private placement warrants	6,642,960
Total liabilities held at fair value:	$ 74,991,516	$ 28,249,653

FAIR VALUE MEASUREMENTS - Narra

FAIR VALUE MEASUREMENTS - Narrative (Details) - USD ($)		1 Months Ended			12 Months Ended
FAIR VALUE MEASUREMENTS - Narrative (Details) - USD ($)	Jan. 07, 2022	Oct. 31, 2022	Jan. 31, 2022	Nov. 30, 2021	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021	Aug. 25, 2020
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Life settlement policies, at cost					$ 1,697,178	$ 8,716,111
Total change in fair value of debt					(4,028,189)
Gain (loss) on change in fair value of debt, included within other comprehensive income					$ 944,463
Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Liability, Gain (Loss), Statement of Other Comprehensive Income or Comprehensive Income [Extensible Enumeration]					Change in fair value of debt (risk adjusted)
Gain (loss) on change in fair value of debt, included within equity of noncontrolling interests					$ 303,867
Loss on change in fair value of debt					2,356,058	90,719
Purchase of convertible promissory note	$ 250,000	$ 500,000	$ 250,000	$ 250,000	0	750,000	$ 250,000
Available-for-sale securities, at fair value					1,105,935	1,000,000
Accrued interest on available-for-sale securities					105,935	0
Equity securities without readily determinable fair value, amount					$ 1,650,000	$ 1,300,000
Private Placement Warrant
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants outstanding (in shares)					8,900,000			900,000
Price per warrant (in dollars per share)					$ 1
Warrants outstanding					$ 8,900,000
Number of securities called by each warrant (in shares)					1
Exercise price of warrants (in dollars per share)					$ 11.50
Warrants term					30 days
Discount rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Life settlement policies, measurement input					21%
Discount rate \| Discounted cash flow method
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Life settlement policies, measurement input					21%	12%

FAIR VALUE MEASUREMENTS - Disco

FAIR VALUE MEASUREMENTS - Discount Rate Sensitivity (Details) - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Fair Value Disclosures [Abstract]
Life settlement policies, fair value, impact of +2% discount rate adjustment	$ 111,206,993
Life settlement policies, change in fair value, impact of +2% discount rate adjustment	(11,089,566)
Life settlement policies, at fair value	122,296,559	$ 13,809,352
Life settlement policies, fair value, impact of -2% discount rate adjustment	130,749,053
Life settlement policies, change in fair value, impact of -2% discount rate adjustment	$ 8,452,494

FAIR VALUE MEASUREMENTS - Credi

FAIR VALUE MEASUREMENTS - Credit Exposure to Insurance Companies (Details) - Life Insurance Carrier Concentration Risk - John Hancock Life Insurance Company (U.S.A.)	12 Months Ended
	Dec. 31, 2023
Life Insurance Contract, Face Value
Fair Value, Concentration of Risk, Financial Statement Captions [Line Items]
Concentration risk percentage	28%
Life Insurance Contract, Fair Value
Fair Value, Concentration of Risk, Financial Statement Captions [Line Items]
Concentration risk percentage	20%

FAIR VALUE MEASUREMENTS - Life

FAIR VALUE MEASUREMENTS - Life Insurance Policies (Details) - Life Insurance Policies	12 Months Ended
	Dec. 31, 2023 USD ($)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Fair value at beginning of period	$ 13,809,352
Policies purchased	186,124,688
Realized gain (loss) on matured/sold policies	19,606,894
Premiums paid	4,281,610
Unrealized gain(loss) on held policies	27,889,106
Change in estimated fair value	43,214,390
Matured/sold policies	(125,133,481)
Fair value at end of period	$ 122,296,559

FAIR VALUE MEASUREMENTS - Issue

FAIR VALUE MEASUREMENTS - Issued Notes (Details) - USD ($)	12 Months Ended
FAIR VALUE MEASUREMENTS - Issued Notes (Details) - USD ($)	Dec. 31, 2023	Dec. 31, 2022
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Fair value at beginning of period	$ 28,249,653
Unrealized loss on change in fair value (risk-free)	2,356,058	$ 90,719
Unrealized loss on change in fair value (credit-adjusted) included in OCI	1,265,103
Unrealized gain on change in fair value (credit-adjusted) included in equity of NCI	407,028
Change in estimated fair value of debt	4,028,189
Non-cash interest expense	2,182,221	0
Deferred issuance costs and discounts	(1,831,910)
Fair value at end of period	139,820,514	$ 28,249,653
Nonrelated Party
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Debt issued	71,720,713
Related Party
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Debt issued	35,471,648
Non-cash interest expense	$ 2,182,221

FAIR VALUE MEASUREMENTS - Assum

FAIR VALUE MEASUREMENTS - Assumptions (Details) - Private Placement Warrant	Dec. 31, 2023 $ / shares
Risk-free interest rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and rights outstanding, measurement input	0.0409
Term to expiration
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and rights outstanding, measurement input	5
Exercise price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and rights outstanding, measurement input	11.50
Common Stock Price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and rights outstanding, measurement input	10.03
Dividend Yield
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and rights outstanding, measurement input	0

LONG-TERM DEBT - Long-Term Debt

LONG-TERM DEBT - Long-Term Debt (Details) - USD ($)	Dec. 31, 2023	Dec. 31, 2022
Debt Instrument [Line Items]
long-term debt	$ (13,029,632)	$ 0
Cost
Debt Instrument [Line Items]
Total debt	138,341,261	30,028,640
long-term debt	(11,440,236)	0
Total long-term debt	126,901,025	30,028,640
Cost \| Market-indexed notes \| LMATT Series 2024, Inc.
Debt Instrument [Line Items]
Long-term debt, gross	9,124,944	9,866,900
Cost \| Market-indexed notes \| LMATT Series 2.2024, Inc.
Debt Instrument [Line Items]
Long-term debt, gross	2,981,480	2,333,391
Cost \| Market-indexed notes \| LMATT Growth & Income Series 1.2026, Inc.
Debt Instrument [Line Items]
Long-term debt, gross	492,582	400,000
Cost \| Secured borrowing \| LMA Income Series, LP
Debt Instrument [Line Items]
Long-term debt, gross	21,889,444	17,428,349
Cost \| Secured borrowing \| LMA Income Series II, LP
Debt Instrument [Line Items]
Long-term debt, gross	32,380,852	0
Cost \| Unsecured borrowing
Debt Instrument [Line Items]
Deferred issuance costs and discounts	(1,831,910)	0
Cost \| Unsecured borrowing \| Fixed Rate Senior Unsecured Notes
Debt Instrument [Line Items]
Long-term debt, gross	35,650,000	0
Cost \| Unsecured borrowing \| SPV Purchase and Sale Note
Debt Instrument [Line Items]
Long-term debt, gross	26,538,004	0
Cost \| Unsecured borrowing \| Sponsor PIK Note
Debt Instrument [Line Items]
Long-term debt, gross	11,115,865	0
Fair value
Debt Instrument [Line Items]
Long-term debt, gross	141,652,424
Total debt	139,820,514	28,249,653
long-term debt	(13,029,632)	0
Total long-term debt	126,790,882	28,249,653
Fair value \| Market-indexed notes \| LMATT Series 2024, Inc.
Debt Instrument [Line Items]
Long-term debt, gross	9,477,780	8,067,291
Fair value \| Market-indexed notes \| LMATT Series 2.2024, Inc.
Debt Instrument [Line Items]
Long-term debt, gross	3,551,852	2,354,013
Fair value \| Market-indexed notes \| LMATT Growth & Income Series 1.2026, Inc.
Debt Instrument [Line Items]
Long-term debt, gross	569,862	400,000
Fair value \| Secured borrowing \| LMA Income Series, LP
Debt Instrument [Line Items]
Long-term debt, gross	22,368,209	17,428,349
Fair value \| Secured borrowing \| LMA Income Series II, LP
Debt Instrument [Line Items]
Long-term debt, gross	32,380,852	0
Fair value \| Unsecured borrowing
Debt Instrument [Line Items]
Deferred issuance costs and discounts	(1,831,910)	0
Fair value \| Unsecured borrowing \| Fixed Rate Senior Unsecured Notes
Debt Instrument [Line Items]
Long-term debt, gross	35,650,000	0
Fair value \| Unsecured borrowing \| SPV Purchase and Sale Note
Debt Instrument [Line Items]
Long-term debt, gross	26,538,004	0
Fair value \| Unsecured borrowing \| Sponsor PIK Note
Debt Instrument [Line Items]
Long-term debt, gross	$ 11,115,865	$ 0

LONG-TERM DEBT - Fixed Rate Sen

LONG-TERM DEBT - Fixed Rate Senior Unsecured Notes (Details) - Fixed Rate Senior Unsecured Notes - Unsecured borrowing	Nov. 10, 2023 USD ($)
Debt Instrument [Line Items]
Face amount	$ 35,650,000
Interest rate (as a percent)	9.875%
Redemption percentage	100%

LONG-TERM DEBT - Owl Rock Credi

LONG-TERM DEBT - Owl Rock Credit Facility (Details) - USD ($)			12 Months Ended
	Nov. 10, 2023	Jul. 05, 2023	Dec. 31, 2023	Dec. 31, 2022
Debt Instrument [Line Items]
Loss on extinguishment of debt			$ 2,086,303	$ 0
Interest expense			$ 9,866,821	$ 42,798
Owl Rock Credit Facility \| Line of Credit
Debt Instrument [Line Items]
Additional borrowing capacity availability period		180 days
Commitment fee		0.50%
Debt repayment penalty percent	4%
Debt repayment penalty	$ 1,000,000
Legal fees	73,339
Loss on extinguishment of debt	2,086,303
Interest expense	$ 3,159,641
Owl Rock Credit Facility \| Line of Credit \| Debt Instrument, Interest Rate, Period One
Debt Instrument [Line Items]
SOFR adjustment		0.10%
SOFR adjustment period		1 month
Owl Rock Credit Facility \| Line of Credit \| Debt Instrument, Interest Rate, Period Two
Debt Instrument [Line Items]
SOFR adjustment		0.15%
SOFR adjustment period		3 months
Owl Rock Credit Facility \| Line of Credit \| Debt Instrument, Interest Rate, Period Three
Debt Instrument [Line Items]
SOFR adjustment		0.25%
SOFR adjustment period		6 months
Unsecured borrowing \| Owl Rock Credit Facility \| Line of Credit
Debt Instrument [Line Items]
Face amount		$ 25,000,000

LONG-TERM DEBT - Sponsor PIK No

LONG-TERM DEBT - Sponsor PIK Note (Details) - USD ($)	12 Months Ended
LONG-TERM DEBT - Sponsor PIK Note (Details) - USD ($)	Dec. 31, 2023	Dec. 31, 2022	Jun. 30, 2023
Debt Instrument [Line Items]
Non-cash interest expense	$ 2,182,221	$ 0
Unsecured borrowing \| Sponsor PIK Note
Debt Instrument [Line Items]
Face amount			$ 10,471,648
Interest rate (as a percent)			12%
Non-cash interest expense	$ 644,217	$ 0

LONG-TERM DEBT - LMATT Series 2

LONG-TERM DEBT - LMATT Series 2024, Inc. Market-Indexed Notes (Details) - USD ($)	Dec. 31, 2023	Dec. 31, 2022	Mar. 31, 2022
Debt Instrument [Line Items]
Assets	$ 331,826,067	$ 59,094,847
Fair value
Debt Instrument [Line Items]
Long-term debt, gross	141,652,424
LMATT Series 2024, Inc. \| Market-indexed notes
Debt Instrument [Line Items]
Face amount			$ 10,166,900
Market downturn protection percentage			40%
Note reduction ratio for losses below threshold			100%
LMATT Series 2024, Inc. \| Market-indexed notes \| Fair value
Debt Instrument [Line Items]
Long-term debt, gross	9,477,780	$ 8,067,291
LMATT Series 2024, Inc. \| Market-indexed notes \| Asset Pledged as Collateral
Debt Instrument [Line Items]
Assets	$ 9,883,554

LONG-TERM DEBT - LMATT Series_2

LONG-TERM DEBT - LMATT Series 2.2024, Inc. Market-Indexed Notes (Details) - USD ($)	Dec. 31, 2023	Dec. 31, 2022	Sep. 16, 2022
Debt Instrument [Line Items]
Assets	$ 331,826,067	$ 59,094,847
Fair value
Debt Instrument [Line Items]
Long-term debt, gross	141,652,424
LMATT Series 2.2024, Inc. \| Market-indexed notes
Debt Instrument [Line Items]
Face amount			$ 2,333,391
Upside performance participation cap			120%
Market downturn protection percentage			20%
Note reduction ratio for losses below threshold			100%
LMATT Series 2.2024, Inc. \| Market-indexed notes \| Asset Pledged as Collateral
Debt Instrument [Line Items]
Assets	3,389,167
LMATT Series 2.2024, Inc. \| Market-indexed notes \| Fair value
Debt Instrument [Line Items]
Long-term debt, gross	$ 3,551,852	$ 2,354,013
LMATT Series 2.2024, Inc.
Debt Instrument [Line Items]
Ownership percentage			100%

LONG-TERM DEBT - LMATT Growth a

LONG-TERM DEBT - LMATT Growth and Income Series 1.2026, Inc. Market-Indexed Notes (Details) - USD ($)	Dec. 31, 2023	Dec. 31, 2022	Sep. 16, 2022
Debt Instrument [Line Items]
Assets	$ 331,826,067	$ 59,094,847
Fair value
Debt Instrument [Line Items]
Long-term debt, gross	141,652,424
LMATT Growth & Income Series 1.2026, Inc. \| Market-indexed notes
Debt Instrument [Line Items]
Face amount			$ 400,000
Upside performance participation cap			140%
Market downturn protection percentage			10%
Note reduction ratio for losses below threshold			100%
Dividend percentage			4%
LMATT Growth & Income Series 1.2026, Inc. \| Market-indexed notes \| Asset Pledged as Collateral
Debt Instrument [Line Items]
Assets	374,458
LMATT Growth & Income Series 1.2026, Inc. \| Market-indexed notes \| Fair value
Debt Instrument [Line Items]
Long-term debt, gross	$ 569,862	$ 400,000
LMATT Growth & Income Series 1.2026, Inc.
Debt Instrument [Line Items]
Ownership percentage			100%

LONG-TERM DEBT - LMA Income Ser

LONG-TERM DEBT - LMA Income Series, LP and LMA Income Series, GP LLC Secured Borrowing (Details)	Sep. 02, 2022 option	Dec. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)
Fair value
Debt Instrument [Line Items]
Long-term debt, gross		$ 141,652,424
LMA Income Series, LP \| Secured borrowing
Debt Instrument [Line Items]
Debt instrument term	3 years
Debt Instrument extension options \| option	2
Debt instrument extension term	1 year
Dividend percentage	6.50%
Return rate in excess of minimum internal rate of return	25%
Minimum internal rate of return threshold	6.50%
Internal rate of return cap	9%
Net internal rate of return at cap	15%
LMA Income Series, LP \| Secured borrowing \| Fair value
Debt Instrument [Line Items]
Long-term debt, gross		$ 22,368,209	$ 17,428,349
LMA Income Series, LP \| Secured borrowing \| General Partner
Debt Instrument [Line Items]
Return rate in excess of minimum internal rate of return	75%
Minimum internal rate of return threshold	6.50%
LMA Income Series, LP \| Secured borrowing \| Limited Partner
Debt Instrument [Line Items]
Internal rate of return cap	15%
Return Rate in excess of capped internal rate of return threshold	100%

LONG-TERM DEBT - LMA Income S_2

LONG-TERM DEBT - LMA Income Series II, LP and LMA Income Series II, GP LLC Secured Borrowing (Details)	Jan. 31, 2023 USD ($) option	Dec. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)
Fair value
Debt Instrument [Line Items]
Long-term debt, gross		$ 141,652,424
LMA Income Series II, LP \| Secured borrowing
Debt Instrument [Line Items]
Debt instrument term	3 years
Debt Instrument extension options \| option	2
Debt instrument extension term	1 year
LMA Income Series II, LP \| Secured borrowing \| Fair value
Debt Instrument [Line Items]
Long-term debt, gross		$ 32,380,852	$ 0
LMA Income Series II, LP \| Secured borrowing \| General Partner
Debt Instrument [Line Items]
Dividend percentage	100%
LMA Income Series II, LP \| Secured borrowing \| Capital Commitment Threshold One \| Limited Partner
Debt Instrument [Line Items]
Dividend percentage	7.50%
LMA Income Series II, LP \| Secured borrowing \| Capital Commitment Threshold One \| Maximum \| Limited Partner
Debt Instrument [Line Items]
Capital commitment threshold to determine dividend rate	$ 500,000
LMA Income Series II, LP \| Secured borrowing \| Capital Commitment Threshold Two \| Limited Partner
Debt Instrument [Line Items]
Dividend percentage	7.75%
LMA Income Series II, LP \| Secured borrowing \| Capital Commitment Threshold Two \| Maximum \| Limited Partner
Debt Instrument [Line Items]
Capital commitment threshold to determine dividend rate	$ 1,000,000
LMA Income Series II, LP \| Secured borrowing \| Capital Commitment Threshold Two \| Minimum \| Limited Partner
Debt Instrument [Line Items]
Capital commitment threshold to determine dividend rate	$ 500,000
LMA Income Series II, LP \| Secured borrowing \| Capital Commitment Threshold Three \| Limited Partner
Debt Instrument [Line Items]
Dividend percentage	8%
LMA Income Series II, LP \| Secured borrowing \| Capital Commitment Threshold Three \| Minimum \| Limited Partner
Debt Instrument [Line Items]
Capital commitment threshold to determine dividend rate	$ 1,000,000

LONG-TERM DEBT - SPV Purchase a

LONG-TERM DEBT - SPV Purchase and Sale and SPV Investment Facility (Details)		12 Months Ended
	Jul. 05, 2023 USD ($) extension	Dec. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)
Debt Instrument [Line Items]
Non-cash interest expense		$ 2,182,221	$ 0
Policy APA
Debt Instrument [Line Items]
Insurance policies fair value	$ 10,000,000
SPV Investment Facility \| Line of Credit
Debt Instrument [Line Items]
Face amount	$ 25,000,000
Debt instrument term	3 years
Number of extensions \| extension	2
Debt instrument extension term	1 year
Interest rate (as a percent)	12%
Non-cash interest expense		750,000
Default rate	2%
Interest expense paid		$ 1,538,004	$ 0
SPV Investment Facility \| Line of Credit \| Line of Credit
Debt Instrument [Line Items]
Face amount	$ 10,000,000
SPV Investment Facility \| Line of Credit \| Secured borrowing
Debt Instrument [Line Items]
Face amount	$ 15,000,000

LONG-TERM DEBT - Principal Paym

LONG-TERM DEBT - Principal Payments by Year for Long-Term Debt (Details) - Fair value - USD ($)	Dec. 31, 2023	Dec. 31, 2022
Debt Instrument [Line Items]
2024	$ 13,029,632
2025	22,368,209
2026	59,488,718
2027	0
2028	46,765,865
Thereafter	0
Total	141,652,424
Market-indexed notes \| LMATT Series 2024, Inc.
Debt Instrument [Line Items]
2024	9,477,780
2025	0
2026	0
2027	0
2028	0
Thereafter	0
Total	9,477,780	$ 8,067,291
Market-indexed notes \| LMATT Series 2.2024, Inc.
Debt Instrument [Line Items]
2024	3,551,852
2025	0
2026	0
2027	0
2028	0
Thereafter	0
Total	3,551,852	2,354,013
Market-indexed notes \| LMATT Growth & Income Series 1.2026, Inc.
Debt Instrument [Line Items]
2024	0
2025	0
2026	569,862
2027	0
2028	0
Thereafter	0
Total	569,862	400,000
Secured borrowing \| LMA Income Series, LP
Debt Instrument [Line Items]
2024	0
2025	22,368,209
2026	0
2027	0
2028	0
Thereafter	0
Total	22,368,209	17,428,349
Secured borrowing \| LMA Income Series II, LP
Debt Instrument [Line Items]
2024	0
2025	0
2026	32,380,852
2027	0
2028	0
Thereafter	0
Total	32,380,852	0
Unsecured borrowing \| Fixed Rate Senior Unsecured Notes
Debt Instrument [Line Items]
2024	0
2025	0
2026	0
2027	0
2028	35,650,000
Thereafter	0
Total	35,650,000	0
Unsecured borrowing \| SPV Investment Facility
Debt Instrument [Line Items]
2024	0
2025	0
2026	26,538,004
2027	0
2028	0
Thereafter	0
Total	26,538,004	0
Unsecured borrowing \| Sponsor PIK Note
Debt Instrument [Line Items]
2024	0
2025	0
2026	0
2027	0
2028	11,115,865
Thereafter	0
Total	$ 11,115,865	$ 0

SHAREHOLDERS' EQUITY - Narrativ

SHAREHOLDERS' EQUITY - Narrative (Details) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2023 vote $ / shares shares	Dec. 31, 2022 $ / shares shares	Aug. 30, 2022 USD ($) $ / shares
Class of Warrant or Right [Line Items]
Common stock, shares authorized (in shares)	200,000,000
Common stock, par value (in dollars per share) \| $ / shares	$ 0.0001
Preferred stock, shares authorized (in shares)	1,000,000	1,000,000
Preferred stock, par value (in dollars per share) \| $ / shares	$ 0.0001	$ 0.0001
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Number of votes per share \| vote	1
Common stock, shares issued (in shares)	63,388,823	50,369,350
Common stock, shares outstanding (in shares)	63,242,173	50,369,350
Treasury stock (in shares)	146,650	0
Public Warrants
Class of Warrant or Right [Line Items]
Warrants outstanding (in shares)	17,249,984
Number of securities called by each warrant (in shares)	1
Exercise price of warrants (in dollars per share) \| $ / shares	$ 11.50
Warrants, business combination exercisable term	30 days
Warrants, proposed offering exercisable term	12 months
Warrants term	5 years
Redemption price per warrant (in dollars per share) \| $ / shares	$ 0.01
Warrant redemption notice period	30 days
Common stock price threshold (in dollars per share) \| $ / shares	$ 18
Trading days	20 days
Trading day period	30 days
Common stock price threshold for redemption for common stock (in dollars per share) \| $ / shares	$ 10
Warrants, common stock issuance threshold price (in dollars per share) \| $ / shares	$ 9.20
Warrants, common stock issuance trading day period	20 days
Warrant price adjustment percentage	115%
Redemption trigger price adjustment percentage	100%
Redemption for common stock trigger price adjustment percentage	180%
Warrants outstanding \| $			$ 4,730
Warrant outstanding fair value per share (in dollars per share) \| $ / shares			$ 0.274
Public Warrants \| Binomial Lattice Model
Class of Warrant or Right [Line Items]
Warrants term	5 years
Public Warrants \| Risk-free interest rate \| Binomial Lattice Model
Class of Warrant or Right [Line Items]
Warrants and rights outstanding, measurement input	0.0409
Public Warrants \| Exercise price \| Binomial Lattice Model
Class of Warrant or Right [Line Items]
Warrants and rights outstanding, measurement input	11.50
Public Warrants \| Common Stock Price \| Binomial Lattice Model
Class of Warrant or Right [Line Items]
Warrants and rights outstanding, measurement input	10.03
LMA
Class of Warrant or Right [Line Items]
Exchange ratio	0.8

SHAREHOLDERS' EQUITY - Stock Re

SHAREHOLDERS' EQUITY - Stock Repurchase Program (Details) - USD ($)			1 Months Ended	12 Months Ended
	Dec. 31, 2023	Dec. 11, 2023	Dec. 31, 2023	Dec. 31, 2023
Equity [Abstract]
Stock repurchase program authorized amount		$ 15,000,000
Amount remaining available for repurchase under stock repurchase program	$ 13,700,000		$ 13,700,000	$ 13,700,000
Stock repurchase program period		18 months
Stock Repurchase Program [Roll Forward]
Beginning balance, Treasury stock (in shares)				0
Total Number of Shares Purchased (in shares)				146,650
Ending balance, Treasury stock (in shares)	146,650		146,650	146,650
Cost of Shares Repurchased, Beginning of Period				$ 0
Cost of Shares Repurchased				1,283,062
Cost of Shares Repurchased, End of Period	$ 1,283,062		$ 1,283,062	$ 1,283,062
Average Price Paid per Share (in dollars per share)	$ 8.82		$ 8.82

STOCK-BASED COMPENSATION - Narr

STOCK-BASED COMPENSATION - Narrative (Details) - USD ($)		1 Months Ended	12 Months Ended
STOCK-BASED COMPENSATION - Narrative (Details) - USD ($)	Apr. 21, 2023	Oct. 31, 2023	Dec. 31, 2023	Dec. 31, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Stock-based awards vesting period			3 years
Restricted Stock Units (RSUs)
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Unamortized stock-based compensation expense weighted-average remaining contractual life			2 years 6 months
Stock-based compensation			$ 1,600,760	$ 0
Unamortized stock-based compensation expense for unvested stock			13,605,200
Restricted Stock Units (RSUs) \| Cost of Sales
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Stock-based compensation			1,278,153
Restricted Stock Units (RSUs) \| General and Administrative Expense
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Stock-based compensation			$ 322,607
Restricted Stock Units (RSUs) \| Long-term Incentive Plan
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Issuance of restricted stock units (in shares)		2,468,500
Common stock available for issuance (in shares)		621,500
Shares authorized (in shares)		3,090,000
Unamortized stock-based compensation expense weighted-average remaining contractual life		3 years
Vesting period, employment termination		9 months
Restricted Stock Units (RSUs) \| Long-term Incentive Plan \| Minimum
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Service period		1 year
Vesting percentage, employment termination		10%
Restricted Stock Units (RSUs) \| Long-term Incentive Plan \| Maximum
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Service period		3 years
Restricted Stock Units (RSUs) \| Long-term Incentive Plan \| Share-Based Payment Arrangement, Tranche One
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Vesting percentage		10%
Stock-based awards vesting period		9 months
Restricted Stock Units (RSUs) \| Long-term Incentive Plan \| Share-Based Payment Arrangement, Tranche Two
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Vesting percentage		90%
Stock-based awards vesting period		33 months
CEO Restricted Stock
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Shares authorized (in shares)	4,569,922
Unamortized stock-based compensation expense weighted-average remaining contractual life			2 years
Stock-based compensation			$ 9,167,264	$ 0
Unamortized stock-based compensation expense for unvested stock			$ 36,669,054
CEO Restricted Stock \| Share-Based Payment Arrangement, Tranche One
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Vesting percentage	50%
Stock-based awards vesting period	25 months
CEO Restricted Stock \| Share-Based Payment Arrangement, Tranche Two
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Vesting percentage	50%
Stock-based awards vesting period	30 months

STOCK-BASED COMPENSATION - Rest

STOCK-BASED COMPENSATION - Restricted Stock Activity (Details)	12 Months Ended
	Dec. 31, 2023 $ / shares shares
Weighted Average Grant Date Fair Value
Vested (in dollars per share) \| $ / shares	$ 6.16
Restricted Stock Units (RSUs)
Number of Shares
Outstanding at beginning of period (in shares)	0
Granted (in shares)	2,468,500
Vested (in shares)	(39,000)
Forfeited (in shares)	0
Outstanding at end of period (in shares)	2,429,500
Weighted Average Grant Date Fair Value
Outstanding at beginning of period (in dollars per share) \| $ / shares	$ 0
Granted (in dollars per share) \| $ / shares	6.16
Outstanding at end of period (in dollars per share) \| $ / shares	$ 6.16
CEO Restricted Stock
Number of Shares
Outstanding at beginning of period (in shares)	0
Granted (in shares)	4,569,922
Forfeited (in shares)	0
Settled (in shares)	0
Outstanding at end of period (in shares)	4,569,922
Weighted Average Grant Date Fair Value
Outstanding at beginning of period (in dollars per share) \| $ / shares	$ 0
Granted (in dollars per share) \| $ / shares	10.03
Outstanding at end of period (in dollars per share) \| $ / shares	$ 10.03

STOCK-BASED COMPENSATION - CEO

STOCK-BASED COMPENSATION - CEO Stock-Based Compensation Expense (Details) - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
CEO Restricted Stock
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Stock-based compensation	$ 9,167,264	$ 0

EMPLOYEE BENEFIT PLAN (Details)

EMPLOYEE BENEFIT PLAN (Details) - USD ($)	12 Months Ended
EMPLOYEE BENEFIT PLAN (Details) - USD ($)	Dec. 31, 2023	Dec. 31, 2022
Postemployment Benefits [Abstract]
Maximum annual contributions (as a percent)	100%
Employer match (as a percent)	4%
Benefit plan expense	$ 183,439	$ 22,559

INCOME TAXES - Narrative (Detai

INCOME TAXES - Narrative (Details) - USD ($)	12 Months Ended
INCOME TAXES - Narrative (Details) - USD ($)	Dec. 31, 2023	Dec. 31, 2022
Operating Loss Carryforwards [Line Items]
Income tax provision	$ 1,468,535	$ 889,943
Effective tax rate percentage	14%	2.70%
Unrecognized tax benefits	$ 0	$ 0
Interest and penalties related to uncertain tax positions	0	$ 0
Domestic Tax Authority
Operating Loss Carryforwards [Line Items]
Operating loss carryforwards	84,709
State and Local Jurisdiction
Operating Loss Carryforwards [Line Items]
Operating loss carryforwards	$ 84,709

INCOME TAXES - Components of In

INCOME TAXES - Components of Income Taxes (Details) - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Current provision:
Federal	$ 706,686	$ 0
State	195,679	0
Foreign	0	0
Total current tax	902,365	0
Deferred provision:
Federal	469,109	737,376
State	97,061	152,567
Foreign	0	0
Total deferred tax	566,170	889,943
Provision for income taxes	$ 1,468,535	$ 889,943

INCOME TAXES - Effective Income

INCOME TAXES - Effective Income Tax (Details) - USD ($)	12 Months Ended
INCOME TAXES - Effective Income Tax (Details) - USD ($)	Dec. 31, 2023	Dec. 31, 2022
Income Tax Disclosure [Abstract]
Income tax benefit computed at federal statutory rate	$ 2,205,635	$ 6,988,538
Restricted stock award deductions limited by IRC 162(m)	2,069,993	0
Change in tax status	1,414,469	0
Effect of pass through entities and noncontrolling interests	(3,812,977)	(6,147,453)
State income taxes, net of federal tax benefit	(332,567)	174,024
Other	(76,018)	0
Valuation allowance	0	(125,166)
Provision for income taxes	$ 1,468,535	$ 889,943

INCOME TAXES - Deferred Tax Ass

INCOME TAXES - Deferred Tax Assets and Liabilities (Details) - USD ($)	Dec. 31, 2023	Dec. 31, 2022
Deferred tax assets:
Basis difference related to life insurance policy sales	$ 1,798,639	$ 109,902
Warrant liability	1,683,658	0
Interest expense carryforward	740,657	0
Stock-based compensation	598,274	0
Right of use liability	455,380	0
Change in fair value of debt	405,804	0
Change in fair value of investments	0	264,196
Net operating loss carryforwards	21,470	167,554
Deferred tax assets, gross	5,703,882	541,652
Less: valuation allowance	0	0
Deferred tax assets	5,703,882	541,652
Deferred tax liabilities:
Basis difference in intangible assets	(7,480,659)	0
Change in fair value of life insurance policies (policies held at fair value method)	(4,318,194)	(1,454,588)
Basis difference in investments	(2,398,987)	0
Change in fair value of debt	0	(450,884)
Other	(705,133)	0
Deferred tax liabilities	(14,902,973)	(1,905,472)
Net deferred tax liability	$ (9,199,091)	$ (1,363,820)

RELATED-PARTY TRANSACTIONS - Na

RELATED-PARTY TRANSACTIONS - Narrative (Details) - USD ($)	12 Months Ended
RELATED-PARTY TRANSACTIONS - Narrative (Details) - USD ($)	Dec. 31, 2023	Dec. 31, 2022	Jul. 05, 2023	Jun. 30, 2023
SPV Investment Facility \| Line of Credit
Related Party Transaction [Line Items]
Face amount			$ 25,000,000
Sponsor PIK Note \| Unsecured borrowing
Related Party Transaction [Line Items]
Face amount				$ 10,471,648
Affiliated Entity
Related Party Transaction [Line Items]
Other current liabilities	$ 5,236	$ 263,785
Other receivables	1,007,528	2,904,646
Affiliated Entity \| Nova Funds
Related Party Transaction [Line Items]
Revenue	778,678	818,300
Affiliated Entity \| Transaction reimbursement revenue \| Nova Funds
Related Party Transaction [Line Items]
Accounts receivable	79,509	196,289
Former Members
Related Party Transaction [Line Items]
Other current liabilities	1,159,712	0
Related Party
Related Party Transaction [Line Items]
Accounts receivable	79,509	$ 198,364
Related Party \| Nova Funds
Related Party Transaction [Line Items]
Revenue	$ 494,972
Origination revenue percent	2%
Origination revenue	$ 20,000
Related Party \| Service Fee Agreement
Related Party Transaction [Line Items]
Related party transaction rate	0.50%
Related Party \| Transaction reimbursement revenue \| Nova Funds
Related Party Transaction [Line Items]
Revenue	$ 235,455
Related Party \| SPV Investment Facility \| Line of Credit
Related Party Transaction [Line Items]
Face amount	$ 25,000,000
Related Party \| Sponsor PIK Note \| Unsecured borrowing
Related Party Transaction [Line Items]
Face amount				$ 10,471,648

RELATED-PARTY TRANSACTIONS - Re

RELATED-PARTY TRANSACTIONS - Revenue Earned and Contracts Originated (Details) - Nova Funds - Related Party	12 Months Ended
	Dec. 31, 2023 USD ($) insurance_contract
Related Party Transaction [Line Items]
Revenue	$ 494,972
Origination expenses for life settlement policies	99,456
Face value	$ 46,650,000
Total policies \| insurance_contract	7
Average Age	70 years
Origination fee revenue
Related Party Transaction [Line Items]
Revenue	$ 259,517
Transaction reimbursement revenue
Related Party Transaction [Line Items]
Revenue	$ 235,455

LEASES - ROU Assets and Lease L

LEASES - ROU Assets and Lease Liabilities (Details) - USD ($)	Dec. 31, 2023	Dec. 31, 2022
Assets:
Operating lease right-of-use assets	$ 1,893,659	$ 77,011
Liabilities:
Operating lease liability, current	118,058	48,127
Operating lease liability, non-current	1,796,727	29,268
Total lease liability	$ 1,914,785	$ 77,395

LEASES - Lease Expense (Details

LEASES - Lease Expense (Details) - USD ($)	12 Months Ended
LEASES - Lease Expense (Details) - USD ($)	Dec. 31, 2023	Dec. 31, 2022
Leases [Abstract]
Operating lease cost	$ 207,508	$ 48,784
Variable lease cost	16,103	3,664
Total lease cost	$ 223,611	$ 52,448

LEASES - Supplemental Cash Flow

LEASES - Supplemental Cash Flow Information (Details) - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Leases [Abstract]
Operating cash outflows for operating leases	$ 201,200	$ 48,399
ROU assets obtained in exchange for new lease liabilities	$ 1,782,726	$ 0

LEASES - Lease Terms and Discou

LEASES - Lease Terms and Discount Rates (Details)	Dec. 31, 2023	Dec. 31, 2022
Leases [Abstract]
Weighted-average remaining lease term (in years)	6 years 3 days	1 year 6 months 29 days
Weighted-average discount rate	9.67%	3.36%

LEASES - Future Minimum Noncanc

LEASES - Future Minimum Noncancellable Lease Payments (Details) - USD ($)	Dec. 31, 2023	Dec. 31, 2022
Leases [Abstract]
2024	$ 118,058
2025	471,239
2026	485,402
2027	499,980
2028	514,946
Thereafter	530,391
Total operating lease payments (undiscounted)	2,620,016
Less: Imputed interest	(705,231)
Lease liability as of December 31, 2023	$ 1,914,785	$ 77,395

EARNINGS PER SHARE - Narrative

EARNINGS PER SHARE - Narrative (Details)	12 Months Ended
EARNINGS PER SHARE - Narrative (Details)	Dec. 31, 2023 $ / shares shares
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total Number of Shares Purchased (in shares)	146,650
Private Placement Warrant
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Exercise price of warrants (in dollars per share) \| $ / shares	$ 11.50
Private Placement Warrant
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities (in shares)	26,150,000

EARNINGS PER SHARE - Basic and

EARNINGS PER SHARE - Basic and Diluted (Details) - USD ($)		12 Months Ended
EARNINGS PER SHARE - Basic and Diluted (Details) - USD ($)		Dec. 31, 2023	Dec. 31, 2022
Earnings Per Share [Abstract]
Net income attributable to common stockholders - basic		$ 9,516,626	$ 31,682,275
Net income attributable to common stockholders - diluted		$ 9,516,626	$ 31,682,275
Weighted-average common shares outstanding for basic earnings per share (in shares)	[1]	56,951,414	50,369,350
Restricted stock units (in shares)		816,484	0
Shares used for diluted earnings per share (in shares)	[1]	57,767,898	50,369,350
Earnings per share:
Basic earnings per share (in dollars per share)		$ 0.17	$ 0.63
Diluted earnings per share (in dollars per share)		$ 0.16	$ 0.63

[1]Both the number of shares outstanding and their par value have been retrospectively recast for all prior periods presented to reflect the par value of the outstanding stock of Abacus Life, Inc. as a result of the Business Combination.

SUBSEQUENT EVENTS (Details)

SUBSEQUENT EVENTS (Details) - USD ($)	2 Months Ended
SUBSEQUENT EVENTS (Details) - USD ($)	Mar. 15, 2024	Mar. 20, 2024	Feb. 15, 2024	Jan. 18, 2024	Dec. 31, 2023	Nov. 10, 2023
Public Warrants
Subsequent Event [Line Items]
Exercise price of warrants (in dollars per share)					$ 11.50
Fixed Rate Senior Unsecured Notes \| Unsecured borrowing
Subsequent Event [Line Items]
Face amount						$ 35,650,000
Interest rate (as a percent)						9.875%
Subsequent Event \| Public Warrants
Subsequent Event [Line Items]
Exercise price of warrants (in dollars per share)				$ 11.50
Proceeds from warrant exercise	$ 3,506,753
Number of exercised warrants (in shares)	304,935
Subsequent Event \| Fixed Rate Senior Unsecured Notes \| Unsecured borrowing
Subsequent Event [Line Items]
Face amount			$ 25,000,000
Interest rate (as a percent)			9.875%
Subsequent Event \| LMA Income Series II, LP \| Secured borrowing \| Limited Partner
Subsequent Event [Line Items]
Face amount		$ 18,042,641

Abacus Settlements LLC - DESC_2

Abacus Settlements LLC - DESCRIPTION OF THE BUSINESS (Details) - USD ($)	Jun. 30, 2023	Jun. 29, 2023	Dec. 31, 2023
Business Acquisition [Line Items]
Common stock, par value (in dollars per share)			$ 0.0001
LMA and Abacus
Business Acquisition [Line Items]
Consideration	$ 531,750,000
Abacus Settlements, LLC \| LMA and Abacus
Business Acquisition [Line Items]
Consideration		$ 531,750,000
Share price (in dollars per share)		$ 10
Aggregate transaction proceeds threshold		$ 200,000,000
Abacus Settlements, LLC \| LMA and Abacus \| Minimum
Business Acquisition [Line Items]
Aggregate consideration election		$ 20,000,000
Abacus Settlements, LLC \| LMA and Abacus \| ERES Class A Common Stock
Business Acquisition [Line Items]
Common stock, par value (in dollars per share)		$ 0.0001

Abacus Settlements LLC - SUMM_2

Abacus Settlements LLC - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Abacus Settlements, LLC - USD ($)	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
Concentration Risk [Line Items]
Advertising expense	$ 741,789	$ 1,414,828
Revenue Benchmark \| Customer Concentration Risk
Concentration Risk [Line Items]
Concentration risk percentage	23%	60%
Life Settlement Commission Expense Benchmark \| Broker Concentration Risk \| Two Brokers
Concentration Risk [Line Items]
Concentration risk percentage	10%

Abacus Settlements LLC - SEGM_2

Abacus Settlements LLC - SEGMENT REPORTING (Details)	12 Months Ended
Abacus Settlements LLC - SEGMENT REPORTING (Details)	Dec. 31, 2023 segment
Segment Reporting Information [Line Items]
Number of operating segments	3
Abacus Settlements, LLC
Segment Reporting Information [Line Items]
Number of operating segments	1

Abacus Settlements LLC - REVE_3

Abacus Settlements LLC - REVENUE (Details) - Abacus Settlements, LLC - USD ($)	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
Disaggregation of Revenue [Line Items]
Revenue	$ 13,184,676	$ 25,203,463
Agent
Disaggregation of Revenue [Line Items]
Revenue	7,143,016	12,156,552
Broker
Disaggregation of Revenue [Line Items]
Revenue	4,675,973	9,938,808
Client direct
Disaggregation of Revenue [Line Items]
Revenue	$ 1,365,687	$ 3,108,103

Abacus Settlements LLC - INCO_2

Abacus Settlements LLC - INCOME TAXES (Details) - USD ($)	6 Months Ended	12 Months Ended
Abacus Settlements LLC - INCOME TAXES (Details) - USD ($)	Jun. 30, 2023	Dec. 31, 2023	Dec. 31, 2022
Income Tax Contingency [Line Items]
Income tax provision		$ 1,468,535	$ 889,943
Effective tax rate percentage		14%	2.70%
Abacus Settlements, LLC
Income Tax Contingency [Line Items]
Income tax provision	$ 2,289		$ 2,018
Effective tax rate percentage	0.24%		(4.00%)

Abacus Settlements LLC - RETI_2

Abacus Settlements LLC - RETIREMENT PLAN (Details)	6 Months Ended
Abacus Settlements LLC - RETIREMENT PLAN (Details)	Jun. 30, 2023
Abacus Settlements, LLC
Defined Contribution Plan Disclosure [Line Items]
Percent of employees gross pay (as a percent)	4%

Abacus Settlements LLC - RELA_3

Abacus Settlements LLC - RELATED-PARTY TRANSACTIONS - Narrative (Details)	6 Months Ended	12 Months Ended
	Jun. 30, 2023 USD ($) insurance_contract	Dec. 31, 2023 USD ($) insurance_contract	Dec. 31, 2022 USD ($) insurance_contract
Related Party Transaction [Line Items]
Total cost of revenue		$ 6,490,377	$ 5,884,669
Other assets		998,945	0
Related Party
Related Party Transaction [Line Items]
Total cost of revenue		$ 99,456	0
Related Party \| Nova Funds
Related Party Transaction [Line Items]
Total policies \| insurance_contract		7
Face value		$ 46,650,000
Origination revenue percent		2%
Origination revenue		$ 20,000
Revenue		494,972
Affiliated Entity \| Nova Funds
Related Party Transaction [Line Items]
Revenue		$ 778,678	818,300
Abacus Settlements, LLC
Related Party Transaction [Line Items]
Revenue	$ 13,184,676		25,203,463
Total cost of revenue	9,293,303		16,561,005
Abacus Settlements, LLC \| Related Party
Related Party Transaction [Line Items]
Revenue	9,931,938		18,153,456
Total cost of revenue	$ 6,558,354		$ 11,022,535
Abacus Settlements, LLC \| Related Party \| Nova Funds
Related Party Transaction [Line Items]
Total policies \| insurance_contract	72		333
Face value	$ 96,674,080		$ 481,648,010
Origination revenue percent	2%
Origination revenue	$ 20,000
Revenue	3,093,797		15,243,806
Abacus Settlements, LLC \| Related Party \| LMA
Related Party Transaction [Line Items]
Other assets	19,246		227,555
Abacus Settlements, LLC \| Affiliated Entity
Related Party Transaction [Line Items]
Revenue	6,838,141		2,909,650
Total cost of revenue	5,020,603		2,365,650
Abacus Settlements, LLC \| Affiliated Entity \| LMA
Related Party Transaction [Line Items]
Revenue	6,794,641		2,268,150
Total cost of revenue	$ 5,012,103		$ 1,899,150
Abacus Settlements, LLC \| Nova Funds
Related Party Transaction [Line Items]
Ownership percentage	11%

Abacus Settlements LLC - RELA_4

Abacus Settlements LLC - RELATED-PARTY TRANSACTIONS - Revenue Earned and Contracts Originated (Details)	6 Months Ended	12 Months Ended
	Jun. 30, 2023 USD ($) insurance_contract	Dec. 31, 2023 USD ($) insurance_contract	Dec. 31, 2022 USD ($) insurance_contract
Related Party \| Nova Funds
Related Party Transaction [Line Items]
Revenue		$ 494,972
Cost		99,456
Face value		$ 46,650,000
Total policies \| insurance_contract		7
Average Age		70 years
Related Party \| Origination fee revenue \| Nova Funds
Related Party Transaction [Line Items]
Revenue		$ 259,517
Related Party \| Commissions and transaction reimbursement revenue \| Nova Funds
Related Party Transaction [Line Items]
Revenue		$ 235,455
Abacus Settlements, LLC
Related Party Transaction [Line Items]
Revenue	$ 13,184,676		$ 25,203,463
Abacus Settlements, LLC \| Related Party
Related Party Transaction [Line Items]
Revenue	9,931,938		18,153,456
Abacus Settlements, LLC \| Related Party \| Nova Funds
Related Party Transaction [Line Items]
Revenue	3,093,797		15,243,806
Cost	11,656,637		87,143,005
Face value	$ 96,674,080		$ 481,648,010
Total policies \| insurance_contract	72		333
Average Age	75 years		75 years
Abacus Settlements, LLC \| Related Party \| Origination fee revenue \| Nova Funds
Related Party Transaction [Line Items]
Revenue	$ 2,952,837		$ 6,586,922
Abacus Settlements, LLC \| Related Party \| Commissions and transaction reimbursement revenue \| Nova Funds
Related Party Transaction [Line Items]
Revenue	$ 140,960		$ 8,656,885